window.searchData = [
  {
    "name": "ATTR_Amyloidosis",
    "disease_id": "MONDO:0007100",
    "category": "Genetic",
    "parents": [
      "Amyloidosis",
      "Neuromuscular Disorder",
      "Cardiomyopathy"
    ],
    "subtypes": [
      "ATTRm (hereditary)",
      "ATTRwt (wild-type/senile)"
    ],
    "description": "Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.",
    "pathophysiology": [
      "TTR Tetramer Destabilization",
      "Amyloid Fibril Formation",
      "Oxidative Stress and Mitochondrial Dysfunction",
      "Calcium Homeostasis Disruption",
      "Peripheral Nerve Degeneration"
    ],
    "cell_types": [
      "cardiomyocyte",
      "peripheral neuron",
      "Schwann cell"
    ],
    "cell_type_ids": [
      "CL:0000746",
      "CL:0000107",
      "CL:0002573"
    ],
    "biological_processes": [
      "protein tetramerization",
      "protein folding",
      "amyloid fibril formation",
      "extracellular matrix organization",
      "response to oxidative stress",
      "mitochondrion organization",
      "calcium ion homeostasis",
      "axonogenesis",
      "myelination"
    ],
    "phenotypes": [
      "Peripheral Neuropathy",
      "Cardiomyopathy",
      "Gastrointestinal Symptoms",
      "Vitreous Opacities",
      "Carpal Tunnel Syndrome",
      "Renal Dysfunction",
      "Fatigue",
      "Sensory Loss",
      "Numbness and Tingling",
      "Autonomic Dysfunction",
      "Heart Failure",
      "Arrhythmias",
      "Orthostatic Hypotension"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Cardiovascular",
      "Gastrointestinal",
      "Ocular",
      "Musculoskeletal",
      "Genitourinary",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0009830",
      "HP:0001638",
      "HP:0007710",
      "HP:0000083",
      "HP:0012378",
      "HP:0003474",
      "HP:0003401",
      "HP:0012332",
      "HP:0001635",
      "HP:0011675",
      "HP:0001278"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "TTR",
      "APCS",
      "CLU"
    ],
    "treatments": [
      "Tafamidis",
      "Patisiran",
      "Inotersen",
      "Liver Transplant",
      "Heart Transplant",
      "Supportive Care"
    ],
    "environmental": [
      "None Applicable"
    ],
    "biochemical": [
      "Serum Transthyretin Levels",
      "Amyloid P Component"
    ],
    "source_file": "ATTR_Amyloidosis.yaml",
    "page_url": "../pages/disorders/ATTR_Amyloidosis.html",
    "num_phenotypes": 13,
    "num_pathophysiology": 5,
    "num_genes": 3,
    "num_treatments": 6
  },
  {
    "name": "Achoo Syndrome",
    "disease_id": "MONDO:0007038",
    "category": "Genetic",
    "parents": [
      "Reflex Disorder"
    ],
    "subtypes": [],
    "description": "Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.",
    "pathophysiology": [
      "Optic-Trigeminal Cross-Activation",
      "Parasympathetic Generalization",
      "Central Cortical Processing",
      "Brainstem Sneeze Circuit"
    ],
    "cell_types": [
      "Retinal Ganglion Cell",
      "Autonomic Neuron",
      "Neuron",
      "Sensory Neuron"
    ],
    "cell_type_ids": [
      "CL:0000740",
      "CL:0000107",
      "CL:0000540",
      "CL:0000101"
    ],
    "biological_processes": [
      "Visual Perception",
      "Sensory Perception of Pain",
      "Sensory Processing",
      "Respiratory Reflex"
    ],
    "phenotypes": [
      "Light-Triggered Sneezing",
      "Nasal Prickle",
      "Migraine",
      "Psychological Distress",
      "Photophobia"
    ],
    "phenotype_categories": [
      "Neurological",
      "Behavioral"
    ],
    "phenotype_ids": [
      "HP:0002076",
      "HP:0000613"
    ],
    "frequencies": [
      "OBLIGATE",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "rs10427255",
      "rs1032507",
      "ZEB2",
      "CADM2",
      "NMB",
      "NMBR"
    ],
    "treatments": [
      "Sunglasses"
    ],
    "environmental": [
      "Bright Light Exposure"
    ],
    "biochemical": [],
    "source_file": "Achoo_Syndrome.yaml",
    "page_url": "../pages/disorders/Achoo_Syndrome.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 6,
    "num_treatments": 1
  },
  {
    "name": "Acquired Immunodeficiency Syndrome",
    "disease_id": "MONDO:0012268",
    "category": "",
    "parents": [],
    "subtypes": [
      "AIDS-defining conditions"
    ],
    "description": "HIV infects and destroys CD4 T-cells, critical for immune system function.",
    "pathophysiology": [
      "CD4 T-cell Depletion",
      "Immune System Collapse",
      "Opportunistic Infections",
      "CNS Reservoir and Neuroinflammation",
      "Host Restriction Factor Defense",
      "AIDS-related Cancers"
    ],
    "cell_types": [
      "CD4 T-lymphocyte",
      "microglia",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000624",
      "CL:0000129",
      "CL:0000235"
    ],
    "biological_processes": [
      "reverse transcription",
      "DNA integration",
      "T cell activation",
      "pyroptotic inflammatory response",
      "defense response to virus",
      "immune response to tumor cell"
    ],
    "phenotypes": [
      "Pneumocystis Pneumonia",
      "Candidiasis",
      "Kaposi Sarcoma",
      "HIV-associated Dementia",
      "Lymphopenia",
      "Anemia"
    ],
    "phenotype_categories": [
      "Infectious",
      "Neoplastic",
      "Neurologic",
      "Hematologic"
    ],
    "phenotype_ids": [
      "HP:0020102",
      "HP:0005401",
      "HP:0100726",
      "HP:0100543",
      "HP:0001888",
      "HP:0001903"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL",
      "VERY_FREQUENT"
    ],
    "genes": [
      "CD4",
      "CCR5",
      "CXCR4",
      "APOBEC3G",
      "SAMHD1",
      "TRIM5",
      "BST2",
      "SERINC5"
    ],
    "treatments": [
      "Antiretroviral Therapy",
      "Prophylaxis for Opportunistic Infections",
      "Treatment of Opportunistic Infections"
    ],
    "environmental": [],
    "biochemical": [
      "CD4 T-cell Count",
      "HIV Viral Load"
    ],
    "source_file": "Acquired_Immunodeficiency_Syndrome.yaml",
    "page_url": "../pages/disorders/Acquired_Immunodeficiency_Syndrome.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 6,
    "num_genes": 8,
    "num_treatments": 3
  },
  {
    "name": "Addison's Disease",
    "disease_id": "MONDO:0015128",
    "category": "Endocrine",
    "parents": [
      "Adrenal Insufficiency",
      "Autoimmune Disorder"
    ],
    "subtypes": [],
    "description": "Addison's Disease, also known as primary adrenal insufficiency, is a rare endocrine disorder where the adrenal glands do not produce sufficient steroid hormones, specifically cortisol and aldosterone.",
    "pathophysiology": [
      "Autoimmune Adrenalitis",
      "Reduced Cortisol Production",
      "Reduced Aldosterone Production",
      "Polygenic Susceptibility"
    ],
    "cell_types": [
      "CD8-positive, alpha-beta cytotoxic T cell",
      "T-helper 1 cell",
      "B cell"
    ],
    "cell_type_ids": [
      "CL:0000794",
      "CL:0000545",
      "CL:0000236"
    ],
    "biological_processes": [
      "adaptive immune response",
      "T cell mediated cytotoxicity",
      "type 1 immune response",
      "antigen processing and presentation of peptide antigen via MHC class II",
      "glucocorticoid biosynthetic process",
      "gluconeogenesis",
      "response to stress",
      "mineralocorticoid biosynthetic process",
      "sodium ion transport",
      "potassium ion transport",
      "negative regulation of T cell receptor signaling pathway",
      "antigen processing and presentation",
      "inflammatory response"
    ],
    "phenotypes": [
      "Fatigue",
      "Abdominal Pain",
      "Hyperpigmentation",
      "Muscle Weakness",
      "Weight Loss",
      "Hypotension",
      "Salt Craving",
      "Hypoglycemia",
      "Hyponatremia",
      "Hyperkalemia",
      "Adrenal Crisis",
      "Nausea and Vomiting"
    ],
    "phenotype_categories": [
      "Endocrine",
      "Gastrointestinal",
      "Musculoskeletal",
      "Systemic",
      "Cardiovascular",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0012378",
      "HP:0002027",
      "HP:0000953",
      "HP:0001324",
      "HP:0001824",
      "HP:0002615",
      "HP:0030083",
      "HP:0001943",
      "HP:0002902",
      "HP:0002153",
      "HP:0002017"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CYP21A2 (21-hydroxylase)",
      "AIRE",
      "HLA-DR3-DQ2 and HLA-DR4-DQ8",
      "CTLA4",
      "PTPN22",
      "BACH2",
      "CLEC16A",
      "NLRP1",
      "CIITA",
      "STAT4"
    ],
    "treatments": [
      "Glucocorticoid Replacement",
      "Mineralocorticoid Replacement",
      "Salt Supplementation",
      "Emergency Medical ID",
      "Stress Dose Adjustments"
    ],
    "environmental": [
      "Infections"
    ],
    "biochemical": [
      "Cortisol",
      "ACTH (Adrenocorticotropic Hormone)",
      "Aldosterone"
    ],
    "source_file": "Addisons_Disease.yaml",
    "page_url": "../pages/disorders/Addison's_Disease.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 4,
    "num_genes": 10,
    "num_treatments": 5
  },
  {
    "name": "Age-Related Macular Degeneration",
    "disease_id": "MONDO:0005150",
    "category": "Complex",
    "parents": [
      "Ophthalmological Disease"
    ],
    "subtypes": [
      "Dry AMD (Atrophic)",
      "Wet AMD (Neovascular)"
    ],
    "description": "Lipid and protein deposits accumulate between retinal pigment epithelium and Bruch's membrane. Drusen indicate RPE dysfunction and are early hallmark of AMD.\n",
    "pathophysiology": [
      "Drusen Accumulation",
      "RPE Dysfunction and Loss",
      "Complement Dysregulation",
      "Choroidal Neovascularization"
    ],
    "cell_types": [
      "Retinal Pigment Epithelial Cell"
    ],
    "cell_type_ids": [
      "CL:0002586"
    ],
    "biological_processes": [
      "Oxidative Stress Response",
      "Complement Activation",
      "Angiogenesis"
    ],
    "phenotypes": [
      "Central Vision Loss",
      "Metamorphopsia",
      "Difficulty Reading",
      "Scotoma",
      "Decreased Contrast Sensitivity"
    ],
    "phenotype_categories": [
      "Ophthalmological"
    ],
    "phenotype_ids": [
      "HP:0000551",
      "HP:0000505",
      "HP:0001123"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "CFH",
      "ARMS2/HTRA1",
      "C3",
      "CFB"
    ],
    "treatments": [
      "Anti-VEGF Injections",
      "AREDS2 Supplements",
      "Photodynamic Therapy",
      "Low Vision Rehabilitation",
      "Complement Inhibitors",
      "Smoking Cessation"
    ],
    "environmental": [
      "Age",
      "Smoking",
      "Family History",
      "Cardiovascular Disease",
      "Obesity",
      "UV Light Exposure"
    ],
    "biochemical": [
      "VEGF",
      "Complement factors"
    ],
    "source_file": "Age_Related_Macular_Degeneration.yaml",
    "page_url": "../pages/disorders/Age-Related_Macular_Degeneration.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 6
  },
  {
    "name": "Alhzeimer_Disease",
    "disease_id": "MONDO:0004975",
    "category": "Neurodegenerative Disorder",
    "parents": [
      "Dementia"
    ],
    "subtypes": [
      "Early-Onset Alzheimer's Disease",
      "Late-Onset Alzheimer's Disease"
    ],
    "description": "Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.",
    "pathophysiology": [
      "Amyloid Plaque Formation",
      "Neurofibrillary Tangle Formation",
      "Synaptic Dysfunction",
      "Neuroinflammation",
      "Oxidative Stress",
      "Vascular Dysfunction",
      "Autophagy-Lysosomal Dysfunction"
    ],
    "cell_types": [
      "Neurons",
      "Microglia",
      "Astrocytes",
      "Endothelial cells",
      "Pericytes"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0000129",
      "CL:0000127",
      "CL:0000115",
      "CL:0000669"
    ],
    "biological_processes": [
      "Protein misfolding",
      "Aggregation",
      "Neuroinflammation",
      "Protein hyperphosphorylation",
      "Microtubule destabilization",
      "Neurotransmitter release",
      "Synaptic plasticity",
      "Immune activation",
      "Cytokine production",
      "Phagocytosis",
      "Free radical production",
      "Antioxidant defense",
      "Blood-brain barrier regulation",
      "Cerebral blood flow",
      "Autophagy",
      "Lysosomal degradation",
      "Protein catabolic process"
    ],
    "phenotypes": [
      "Memory Loss",
      "Executive Dysfunction",
      "Behavioral Changes",
      "Aphasia",
      "Apraxia",
      "Agnosia"
    ],
    "phenotype_categories": [
      "Cognitive",
      "Psychiatric",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0002354",
      "HP:0100543",
      "HP:0000708",
      "HP:0002381",
      "HP:0002186"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "APP",
      "PSEN1",
      "PSEN2",
      "APOE",
      "TREM2",
      "NLRP3",
      "PYCARD",
      "LRP1"
    ],
    "treatments": [
      "Cholinesterase Inhibitors",
      "NMDA Receptor Antagonist",
      "Cognitive Therapy",
      "Supportive Care",
      "Lifestyle Modifications"
    ],
    "environmental": [],
    "biochemical": [
      "Amyloid Beta (A\u03b242)"
    ],
    "source_file": "Alhzeimer_Disease.yaml",
    "page_url": "../pages/disorders/Alhzeimer_Disease.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 7,
    "num_genes": 8,
    "num_treatments": 5
  },
  {
    "name": "Alopecia Areata",
    "disease_id": "MONDO:0005340",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Skin Disease"
    ],
    "subtypes": [],
    "description": "An autoimmune disease targeting hair follicles, resulting in non-scarring hair loss. Ranges from patchy hair loss to complete scalp (alopecia totalis) or body hair loss (alopecia universalis). Hair follicles retain regenerative capacity, allowing potential regrowth.",
    "pathophysiology": [
      "Loss of Hair Follicle Immune Privilege",
      "CD8+ T Cell-Mediated Attack",
      "JAK-STAT Signaling Activation",
      "Chemokine-Mediated Immune Cell Recruitment"
    ],
    "cell_types": [
      "CD8+ T Cell"
    ],
    "cell_type_ids": [
      "CL:0000625"
    ],
    "biological_processes": [
      "Immune Response",
      "T Cell Cytotoxicity",
      "JAK-STAT Signaling"
    ],
    "phenotypes": [
      "Patchy Hair Loss",
      "Nail Changes"
    ],
    "phenotype_categories": [
      "Dermatological"
    ],
    "phenotype_ids": [
      "HP:0001596",
      "HP:0001597"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DRB1",
      "CTLA4",
      "IL2RA",
      "PTPN22"
    ],
    "treatments": [
      "Topical Corticosteroids",
      "Intralesional Corticosteroids",
      "JAK Inhibitors",
      "Topical Immunotherapy"
    ],
    "environmental": [
      "Psychological Stress",
      "Viral Infections"
    ],
    "biochemical": [
      "Anti-Hair Follicle Antibodies"
    ],
    "source_file": "Alopecia_Areata.yaml",
    "page_url": "../pages/disorders/Alopecia_Areata.html",
    "num_phenotypes": 2,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 4
  },
  {
    "name": "Alpha-1 Antitrypsin Deficiency",
    "disease_id": "MONDO:0013282",
    "category": "Mendelian",
    "parents": [
      "Genetic Lung Diseases",
      "Hereditary Metabolic Diseases"
    ],
    "subtypes": [],
    "description": "Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.\n",
    "pathophysiology": [
      "Protease-Antiprotease Imbalance in Lung",
      "Hepatic Protein Aggregation",
      "Pulmonary Inflammation"
    ],
    "cell_types": [
      "neutrophil",
      "hepatocyte"
    ],
    "cell_type_ids": [
      "CL:0000775",
      "CL:0000182"
    ],
    "biological_processes": [
      "neutrophil degranulation",
      "response to endoplasmic reticulum stress",
      "inflammatory response"
    ],
    "phenotypes": [
      "Emphysema",
      "Chronic Obstructive Pulmonary Disease",
      "Liver Cirrhosis",
      "Hepatomegaly",
      "Dyspnea",
      "Wheezing",
      "Panniculitis"
    ],
    "phenotype_categories": [
      "Cutaneous"
    ],
    "phenotype_ids": [
      "HP:0032967",
      "HP:0002097",
      "HP:0001394",
      "HP:0002240",
      "HP:0002094",
      "HP:0030828",
      "HP:0012490"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "RARE"
    ],
    "genes": [],
    "treatments": [
      "Alpha-1 Antitrypsin Augmentation Therapy",
      "Smoking Cessation",
      "Bronchodilators",
      "Lung Transplantation",
      "Liver Transplantation"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Alpha_1_Antitrypsin_Deficiency.yaml",
    "page_url": "../pages/disorders/Alpha-1_Antitrypsin_Deficiency.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 5
  },
  {
    "name": "Alzheimer's Disease",
    "disease_id": "MONDO:0004975",
    "category": "Complex",
    "parents": [
      "Dementia",
      "Neurodegenerative Disease"
    ],
    "subtypes": [],
    "description": "Alzheimer's Disease is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral changes. It is the most common cause of dementia, involving the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain, leading to neuronal death and brain atrophy.\n",
    "pathophysiology": [
      "Amyloid-Beta Plaque Formation",
      "Neurofibrillary Tangle Formation",
      "Synaptic Dysfunction",
      "Neuroinflammation",
      "Neuronal Death"
    ],
    "cell_types": [
      "neuron",
      "microglial cell"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0000129"
    ],
    "biological_processes": [
      "amyloid precursor protein catabolic process"
    ],
    "phenotypes": [
      "Memory Impairment",
      "Cognitive Impairment",
      "Dementia"
    ],
    "phenotype_categories": [
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0002354",
      "HP:0100543",
      "HP:0000726"
    ],
    "frequencies": [
      "VERY_FREQUENT"
    ],
    "genes": [
      "APP",
      "PSEN1",
      "PSEN2",
      "APOE"
    ],
    "treatments": [
      "Cholinesterase Inhibitors",
      "NMDA Receptor Antagonist",
      "Cognitive Stimulation and Rehabilitation"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Alzheimers_Disease.yaml",
    "page_url": "../pages/disorders/Alzheimer's_Disease.html",
    "num_phenotypes": 3,
    "num_pathophysiology": 5,
    "num_genes": 4,
    "num_treatments": 3
  },
  {
    "name": "Ankylosing Spondylitis",
    "disease_id": "MONDO:0005306",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Spondyloarthropathy"
    ],
    "subtypes": [],
    "description": "A chronic inflammatory disease primarily affecting the axial skeleton, characterized by sacroiliitis and progressive spinal fusion. Strongly associated with HLA-B27. Part of the spondyloarthritis spectrum including enthesitis and potential peripheral joint and extra-articular involvement.",
    "pathophysiology": [
      "HLA-B27-Associated Immune Activation",
      "IL-23/IL-17 Axis Activation",
      "Enthesitis and New Bone Formation"
    ],
    "cell_types": [
      "T Helper Cell",
      "Osteoblast"
    ],
    "cell_type_ids": [
      "CL:0000492",
      "CL:0000062"
    ],
    "biological_processes": [
      "Antigen Presentation",
      "Inflammatory Response",
      "Bone Formation"
    ],
    "phenotypes": [
      "Inflammatory Back Pain",
      "Arthritis",
      "Spinal Stiffness",
      "Uveitis"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Ophthalmological"
    ],
    "phenotype_ids": [
      "HP:0003418",
      "HP:0001369",
      "HP:0003306",
      "HP:0000554"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-B27",
      "ERAP1",
      "IL23R"
    ],
    "treatments": [
      "NSAIDs",
      "TNF Inhibitors",
      "IL-17 Inhibitors",
      "Physical Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "ESR",
      "CRP"
    ],
    "source_file": "Ankylosing_Spondylitis.yaml",
    "page_url": "../pages/disorders/Ankylosing_Spondylitis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 4
  },
  {
    "name": "Antiphospholipid Syndrome",
    "disease_id": "MONDO:8000010",
    "category": "Complex",
    "parents": [
      "Autoimmune Disease"
    ],
    "subtypes": [
      "Primary APS",
      "Secondary APS",
      "Asymptomatic APS"
    ],
    "description": "A systemic autoimmune disorder characterized by the presence of antiphospholipid antibodies that increase the risk of blood clots and other complications.",
    "pathophysiology": [
      "Antibody Production",
      "Blood Clot Formation",
      "Impaired Blood Flow",
      "Organ Damage",
      "Pregnancy Complications",
      "Chronic Complications"
    ],
    "cell_types": [
      "B cell",
      "T cell"
    ],
    "cell_type_ids": [
      "CL:0000236",
      "CL:0000084"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Deep Vein Thrombosis",
      "Preterm Birth",
      "Thrombocytopenia",
      "Cardiac Valve Disease",
      "Preeclampsia",
      "Thrombocytopenia",
      "Cardiac Valve Disease",
      "Livedo Reticularis",
      "Migraine Headaches",
      "Pulmonary Embolism",
      "Stroke"
    ],
    "phenotype_categories": [
      "Thrombosis",
      "Pregnancy-Related",
      "Hematologic",
      "Cardiovascular",
      "Dermatologic",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0004850",
      "HP:0001622",
      "HP:0001873",
      "MONDO:0005081",
      "HP:0033505",
      "HP:0002204",
      "HP:0001297"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DR7",
      "HLA-DR4"
    ],
    "treatments": [],
    "environmental": [
      "Smoking",
      "Infection"
    ],
    "biochemical": [
      "Antiphospholipid Antibodies",
      "Lupus Anticoagulant",
      "Anti-Cardiolipin Antibodies",
      "Beta-2 Glycoprotein I Antibodies",
      "Anti-Smith Antibodies"
    ],
    "source_file": "Antiphospholipid_Syndrome.yaml",
    "page_url": "../pages/disorders/Antiphospholipid_Syndrome.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 6,
    "num_genes": 2,
    "num_treatments": 0
  },
  {
    "name": "Aromatase Deficiency",
    "disease_id": "MONDO:0013301",
    "category": "Genetic",
    "parents": [
      "Endocrine Disorder",
      "Inborn Error of Metabolism"
    ],
    "subtypes": [],
    "description": "Aromatase deficiency is a rare genetic disorder characterized by mutations in the CYP19A1 gene, leading to deficient aromatase enzyme activity and subsequent estrogen deficiency. This results in abnormal sexual development, delayed puberty, osteoporosis, and other systemic effects.",
    "pathophysiology": [
      "CYP19A1 Gene Mutation",
      "Estrogen Deficiency"
    ],
    "cell_types": [
      "granulosa cell",
      "trophoblast cell",
      "Leydig cell",
      "adipocyte",
      "osteoblast",
      "osteoclast"
    ],
    "cell_type_ids": [
      "CL:0000501",
      "CL:0000351",
      "CL:0000178",
      "CL:0000136",
      "CL:0000062",
      "CL:0000092"
    ],
    "biological_processes": [
      "estrogen biosynthetic process",
      "steroid biosynthetic process",
      "androgen metabolic process",
      "estrogen receptor signaling pathway",
      "regulation of gonadotropin secretion",
      "bone remodeling",
      "endochondral ossification"
    ],
    "phenotypes": [
      "Ambiguous Genitalia",
      "Delayed Puberty",
      "Osteoporosis",
      "Hypergonadotropic Hypogonadism",
      "Primary Amenorrhea",
      "Polycystic Ovaries",
      "Tall Stature",
      "Clitoromegaly",
      "Insulin Resistance",
      "Dyslipidemia",
      "Mild Cognitive Impairment"
    ],
    "phenotype_categories": [
      "Reproductive",
      "Musculoskeletal",
      "Systemic",
      "Metabolic",
      "Cognitive"
    ],
    "phenotype_ids": [
      "HP:0000823",
      "HP:0000939",
      "HP:0000815",
      "HP:0000786",
      "HP:0000147",
      "HP:0000098",
      "HP:0008665",
      "HP:0000855",
      "HP:0003119"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CYP19A1",
      "ESR1",
      "ESR2",
      "POR"
    ],
    "treatments": [
      "Estrogen Replacement Therapy",
      "Antiandrogen Therapy",
      "Surgical Management"
    ],
    "environmental": [
      "Hormone Replacement Therapy"
    ],
    "biochemical": [
      "Serum Estrogen Levels",
      "Serum Androgens"
    ],
    "source_file": "Aromatase_Deficiency.yaml",
    "page_url": "../pages/disorders/Aromatase_Deficiency.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 2,
    "num_genes": 4,
    "num_treatments": 3
  },
  {
    "name": "Asthma",
    "disease_id": "MONDO:0004979",
    "category": "Complex",
    "parents": [
      "Respiratory Disease",
      "Chronic Inflammatory Disease"
    ],
    "subtypes": [
      "Allergic Asthma",
      "Non-Allergic Asthma",
      "Adult-Onset Asthma",
      "Asthma-COPD Overlap",
      "Exercise-Induced Asthma"
    ],
    "description": "Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.",
    "pathophysiology": [
      "Airway Inflammation",
      "Bronchoconstriction",
      "Mucus Overproduction",
      "Airway Remodeling"
    ],
    "cell_types": [
      "Mast Cell",
      "Eosinophil",
      "T-Lymphocyte",
      "Bronchial Epithelial Cell",
      "Basophil",
      "Neutrophil",
      "Smooth Muscle Cells",
      "Goblet Cell",
      "Mucosal Epithelial Cell",
      "Fibroblast",
      "Smooth Muscle Cell"
    ],
    "cell_type_ids": [
      "CL:0000097",
      "CL:0000771",
      "CL:0000084",
      "CL:0002328",
      "CL:0000767",
      "CL:0000775",
      "CL:0000192",
      "CL:0000160",
      "CL:0002202",
      "CL:0000057"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Wheezing",
      "Coughing",
      "Breathlessness",
      "Chest Tightness",
      "Rapid Breathing",
      "Cyanosis",
      "Fatigue",
      "Exercise Intolerance",
      "Sleep Disturbance",
      "Anxiety",
      "Respiratory Distress",
      "Reduced Exercise Tolerance"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Systemic",
      "Activity",
      "Sleep",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0030828",
      "HP:0012735",
      "HP:0031352",
      "HP:0000961",
      "HP:0012378",
      "HP:0003546",
      "HP:0002360",
      "HP:0000739",
      "HP:0002098"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "IL4",
      "IL13",
      "ADAM33",
      "GSDMB",
      "HLA-DQ",
      "ORMDL3"
    ],
    "treatments": [
      "Inhaled Corticosteroid",
      "Long-acting Beta Agonist",
      "Leukotriene Modifier",
      "Anti-IgE Therapy",
      "Short-acting Beta Agonist"
    ],
    "environmental": [
      "Allergens",
      "Air Pollution",
      "Tobacco Smoke",
      "Occupational Exposures"
    ],
    "biochemical": [
      "Eosinophils",
      "Neutrophils",
      "IgE Antibodies"
    ],
    "source_file": "Asthma.yaml",
    "page_url": "../pages/disorders/Asthma.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 4,
    "num_genes": 6,
    "num_treatments": 5
  },
  {
    "name": "Atrial Fibrillation",
    "disease_id": "MONDO:0004981",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease",
      "Cardiac Arrhythmia"
    ],
    "subtypes": [
      "Paroxysmal Atrial Fibrillation",
      "Persistent Atrial Fibrillation",
      "Long-standing Persistent Atrial Fibrillation",
      "Permanent Atrial Fibrillation",
      "Valvular Atrial Fibrillation"
    ],
    "description": "Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.\n",
    "pathophysiology": [
      "Atrial Electrical Remodeling",
      "Atrial Structural Remodeling",
      "Pulmonary Vein Triggers",
      "Atrial Thrombus Formation"
    ],
    "cell_types": [
      "Atrial Cardiomyocyte",
      "Cardiac Fibroblast"
    ],
    "cell_type_ids": [
      "CL:0002129",
      "CL:0002548"
    ],
    "biological_processes": [
      "Cardiac Conduction"
    ],
    "phenotypes": [
      "Palpitations",
      "Irregular Pulse",
      "Fatigue",
      "Dyspnea",
      "Dizziness",
      "Stroke"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Systemic",
      "Respiratory",
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0001962",
      "HP:0011675",
      "HP:0012378",
      "HP:0002094",
      "HP:0002321",
      "HP:0001297"
    ],
    "frequencies": [
      "FREQUENT",
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "KCNQ1",
      "KCNE2",
      "KCNJ2",
      "SCN5A",
      "PITX2"
    ],
    "treatments": [
      "Anticoagulation",
      "Rate Control",
      "Rhythm Control",
      "Catheter Ablation",
      "Cardioversion",
      "Left Atrial Appendage Closure",
      "Risk Factor Modification"
    ],
    "environmental": [
      "Hypertension",
      "Obesity",
      "Obstructive Sleep Apnea",
      "Alcohol",
      "Hyperthyroidism"
    ],
    "biochemical": [],
    "source_file": "Atrial_Fibrillation.yaml",
    "page_url": "../pages/disorders/Atrial_Fibrillation.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 5,
    "num_treatments": 7
  },
  {
    "name": "Autoimmune Hemolytic Anemia",
    "disease_id": "MONDO:0020108",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Hematologic Disease"
    ],
    "subtypes": [],
    "description": "An acquired hemolytic anemia caused by autoantibodies against red blood cell surface antigens. Classified as warm (IgG, 70-80%) or cold (IgM, cold agglutinin disease) based on antibody thermal amplitude. May be primary or secondary to underlying disease.",
    "pathophysiology": [
      "Warm Autoantibody-Mediated Hemolysis",
      "Cold Agglutinin-Mediated Hemolysis",
      "B Cell Dysregulation"
    ],
    "cell_types": [
      "Macrophage",
      "Red Blood Cell",
      "B Cell"
    ],
    "cell_type_ids": [
      "CL:0000235",
      "CL:0000232",
      "CL:0000236"
    ],
    "biological_processes": [
      "Phagocytosis",
      "Complement Activation",
      "Immunoglobulin Production"
    ],
    "phenotypes": [
      "Anemia",
      "Jaundice",
      "Splenomegaly",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Hematological",
      "Hepatic",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0001903",
      "HP:0000952",
      "HP:0001744",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Corticosteroids",
      "Rituximab",
      "Splenectomy",
      "Complement Inhibitors"
    ],
    "environmental": [],
    "biochemical": [
      "Direct Antiglobulin Test (DAT)",
      "Reticulocytes",
      "LDH",
      "Haptoglobin",
      "Indirect Bilirubin"
    ],
    "source_file": "Autoimmune_Hemolytic_Anemia.yaml",
    "page_url": "../pages/disorders/Autoimmune_Hemolytic_Anemia.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Autoimmune Hepatitis",
    "disease_id": "MONDO:0016264",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Liver Disease"
    ],
    "subtypes": [],
    "description": "A chronic inflammatory liver disease characterized by interface hepatitis, hypergammaglobulinemia, and circulating autoantibodies. Without treatment, progresses to cirrhosis. Classified into type 1 (ANA/SMA positive) and type 2 (anti-LKM1/anti-LC1 positive).",
    "pathophysiology": [
      "T Cell-Mediated Hepatocyte Destruction",
      "Autoantibody Production",
      "Regulatory T Cell Deficiency"
    ],
    "cell_types": [
      "CD4+ T Cell",
      "CD8+ T Cell",
      "Hepatocyte",
      "Regulatory T Cell"
    ],
    "cell_type_ids": [
      "CL:0000624",
      "CL:0000625",
      "CL:0000182",
      "CL:0000815"
    ],
    "biological_processes": [
      "T Cell Cytotoxicity",
      "Immunoglobulin Production",
      "Immune Regulation"
    ],
    "phenotypes": [
      "Fatigue",
      "Jaundice",
      "Hepatomegaly",
      "Arthralgia"
    ],
    "phenotype_categories": [
      "Systemic",
      "Hepatic",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0012378",
      "HP:0000952",
      "HP:0002240",
      "HP:0002829"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DR3",
      "HLA-DR4",
      "HLA-B*35:01"
    ],
    "treatments": [
      "Corticosteroids",
      "Azathioprine",
      "Mycophenolate Mofetil",
      "Liver Transplantation"
    ],
    "environmental": [],
    "biochemical": [
      "ANA",
      "Anti-Smooth Muscle Antibodies (SMA)",
      "Anti-LKM1 Antibodies",
      "IgG",
      "ALT/AST"
    ],
    "source_file": "Autoimmune_Hepatitis.yaml",
    "page_url": "../pages/disorders/Autoimmune_Hepatitis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 4
  },
  {
    "name": "Axenfeld-Rieger_syndrome",
    "disease_id": "MONDO:0019187",
    "category": "Genetic",
    "parents": [
      "Congenital Eye Disorder",
      "Craniofacial Disorder"
    ],
    "subtypes": [
      "Axenfeld-Rieger Syndrome Type 1 (RIEG1)",
      "Axenfeld-Rieger Syndrome Type 3 (RIEG3)"
    ],
    "description": "PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.",
    "pathophysiology": [
      "Disrupted Neural Crest-Derived Periocular Mesenchyme Development",
      "Dysregulated Transcription Factor Activity",
      "Ocular Anomalies",
      "Systemic Anomalies",
      "Glaucoma-related Vision Loss"
    ],
    "cell_types": [
      "migratory neural crest cell"
    ],
    "cell_type_ids": [
      "CL:0000333"
    ],
    "biological_processes": [
      "neural crest cell migration",
      "eye morphogenesis",
      "canonical Wnt signaling pathway",
      "regulation of transcription by RNA polymerase II",
      "extracellular matrix organization"
    ],
    "phenotypes": [
      "Glaucoma",
      "Posterior Embryotoxon",
      "Iris Hypoplasia",
      "Corectopia",
      "Dental Anomalies",
      "Craniofacial Dysmorphism",
      "Redundant Periumbilical Skin",
      "Hearing Loss",
      "Congenital Heart Defects"
    ],
    "phenotype_categories": [
      "Ophthalmologic",
      "Craniofacial",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0000501",
      "HP:0000627",
      "HP:0006482",
      "HP:0000316",
      "HP:0000365",
      "HP:0001627"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "PITX2",
      "FOXC1"
    ],
    "treatments": [
      "Glaucoma Pharmacotherapy",
      "Glaucoma Surgery",
      "Dental Management",
      "Regular Ophthalmic Monitoring"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [],
    "source_file": "Axenfeld-Rieger_syndrome.yaml",
    "page_url": "../pages/disorders/Axenfeld-Rieger_syndrome.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 5,
    "num_genes": 2,
    "num_treatments": 4
  },
  {
    "name": "Bacterial meningitis",
    "disease_id": "MONDO:0006670",
    "category": "Infectious Disease",
    "parents": [
      "Meningitis",
      "Bacterial Infection"
    ],
    "subtypes": [],
    "description": "Bacterial meningitis is a severe infection of the meninges caused by invasive bacteria that overcome neurovascular barriers and replicate in the cerebrospinal fluid. The disease is characterized by robust neuroinflammation that damages brain tissue and raises intracranial pressure. Major causative bacteria include Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, and Listeria monocytogenes. Pathogenesis involves bacterial entry through the blood-brain barrier or blood-CSF barrier via receptor-mediated transcytosis or paracellular disruption, followed by activation of pattern recognition receptors (TLR2/TLR4), inflammasome activation, and breakdown of tight junctions. Clinical manifestations include headache, fever, neck stiffness, altered mental status, and in severe cases, seizures and focal neurological deficits. Without prompt antibiotic treatment, the case fatality rate approaches 70-100%.",
    "pathophysiology": [
      "Bacterial Invasion",
      "Inflammation",
      "Increased Intracranial Pressure",
      "TLR-Mediated Innate Immune Activation",
      "Inflammasome Activation and Pyroptosis",
      "Blood-Brain Barrier Disruption"
    ],
    "cell_types": [
      "brain microvascular endothelial cell",
      "choroid plexus epithelial cell",
      "microglial cell",
      "astrocyte",
      "neutrophil",
      "macrophage"
    ],
    "cell_type_ids": [],
    "biological_processes": [
      "inflammatory response",
      "innate immune response",
      "toll-like receptor signaling pathway",
      "I-kappaB kinase/NF-kappaB signaling",
      "inflammasome complex assembly",
      "pyroptosis",
      "JAK-STAT cascade",
      "VEGF-activated receptor activity",
      "tight junction organization",
      "extracellular matrix disassembly"
    ],
    "phenotypes": [
      "Headache",
      "Neck Stiffness",
      "Altered Mental Status",
      "Fever",
      "Photophobia",
      "Hearing Loss",
      "Hydrocephalus",
      "Petechial Rash",
      "Lumbar Puncture",
      "CSF Culture",
      "Blood Culture",
      "CT or MRI",
      "Seizures",
      "Focal Neurological Deficits"
    ],
    "phenotype_categories": [
      "Neurological",
      "Systemic",
      "Integumentary",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0002315",
      "HP:0001945",
      "HP:0000613",
      "HP:0000365",
      "HP:0000238",
      "HP:0001250",
      "HP:0007340"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [],
    "treatments": [
      "Empiric Antibiotic Therapy",
      "Targeted Antibiotic Therapy",
      "Dexamethasone",
      "Supportive Care",
      "Vaccination"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Bacterial_meningitis.yaml",
    "page_url": "../pages/disorders/Bacterial_meningitis.html",
    "num_phenotypes": 14,
    "num_pathophysiology": 6,
    "num_genes": 0,
    "num_treatments": 5
  },
  {
    "name": "Bardet-Biedl Syndrome",
    "disease_id": "MONDO:0015229",
    "category": "Genetic",
    "parents": [
      "Syndromic Obesity",
      "Ciliopathy"
    ],
    "subtypes": [
      "BBS1",
      "BBS2",
      "Other BBS Subtypes"
    ],
    "description": "Bardet-Biedl syndrome is a rare autosomal recessive ciliopathy characterized by rod-cone dystrophy leading to blindness, obesity, polydactyly, renal anomalies, learning difficulties, and hypogonadism. It results from mutations in genes encoding components of the BBSome, a protein complex essential for ciliary trafficking.",
    "pathophysiology": [
      "Ciliary Dysfunction",
      "BBSome Assembly and Intraflagellar Transport Defects",
      "Hypothalamic Leptin Resistance",
      "Renal Ciliary Dysfunction"
    ],
    "cell_types": [
      "Neuron",
      "Renal Tubular Epithelial Cell"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0002306"
    ],
    "biological_processes": [
      "Intraflagellar Transport",
      "Protein Localization to Cilium",
      "Regulation of Appetite",
      "Leptin Receptor Signaling"
    ],
    "phenotypes": [
      "Retinitis Pigmentosa",
      "Polydactyly",
      "Truncal Obesity",
      "Hyperphagia",
      "Intellectual Disability",
      "Renal Anomalies",
      "Developmental Delay",
      "Renal Anomalies",
      "Hypogonadism",
      "Behavioral Abnormalities",
      "Dysmorphic Facial Features",
      "Congenital Heart Defects",
      "Hirschsprung Disease",
      "Night Blindness",
      "Progressive Vision Loss"
    ],
    "phenotype_categories": [
      "Ophthalmologic",
      "Skeletal",
      "Obesity",
      "Behavioral",
      "Developmental",
      "Genitourinary",
      "Neurologic",
      "Craniofacial",
      "Cardiovascular",
      "Gastrointestinal",
      "Ocular"
    ],
    "phenotype_ids": [
      "HP:0000510",
      "HP:0010442",
      "HP:0001956",
      "HP:0002591",
      "HP:0001249",
      "HP:0001263",
      "HP:0000135",
      "HP:0000662",
      "HP:0000529"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "BBS1",
      "BBS2",
      "Other BBS Genes"
    ],
    "treatments": [
      "Supportive Therapy",
      "Genetic Counseling",
      "Surgical Interventions",
      "Dietary and Lifestyle Modifications",
      "Gene Therapy",
      "Setmelanotide"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "Elevated Serum Leptin"
    ],
    "source_file": "Bardet-Biedl_Syndrome.yaml",
    "page_url": "../pages/disorders/Bardet-Biedl_Syndrome.html",
    "num_phenotypes": 15,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 6
  },
  {
    "name": "Behcet's Disease",
    "disease_id": "MONDO:0007191",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Vasculitis"
    ],
    "subtypes": [],
    "description": "A systemic inflammatory disorder characterized by recurrent oral and genital ulcers, uveitis, and skin lesions. Involves both arterial and venous vessels of all sizes. Highly prevalent along the ancient Silk Road. Classified as a variable vessel vasculitis with autoinflammatory features.",
    "pathophysiology": [
      "HLA-B51-Associated Immune Dysregulation",
      "Neutrophil Hyperactivation",
      "Th1/Th17 Cytokine Imbalance"
    ],
    "cell_types": [
      "Neutrophil",
      "T Helper Cell"
    ],
    "cell_type_ids": [
      "CL:0000775",
      "CL:0000492"
    ],
    "biological_processes": [
      "Antigen Presentation",
      "Neutrophil Activation",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Oral Ulcers",
      "Genital Ulcers",
      "Uveitis",
      "Skin Lesions"
    ],
    "phenotype_categories": [
      "Oral",
      "Genitourinary",
      "Ophthalmological",
      "Dermatological"
    ],
    "phenotype_ids": [
      "HP:0000155",
      "HP:0000119",
      "HP:0000554",
      "HP:0000988"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-B51",
      "ERAP1",
      "IL10"
    ],
    "treatments": [
      "Colchicine",
      "Corticosteroids",
      "Azathioprine",
      "TNF Inhibitors",
      "Apremilast"
    ],
    "environmental": [],
    "biochemical": [
      "ESR",
      "CRP"
    ],
    "source_file": "Behcets_Disease.yaml",
    "page_url": "../pages/disorders/Behcet's_Disease.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 5
  },
  {
    "name": "Benign Prostatic Hyperplasia",
    "disease_id": "MONDO:0010811",
    "category": "Complex",
    "parents": [
      "Urological Disease"
    ],
    "subtypes": [],
    "description": "Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.\n",
    "pathophysiology": [
      "Prostatic Stromal and Epithelial Proliferation",
      "Bladder Outlet Obstruction",
      "Detrusor Dysfunction",
      "Androgen-Dependent Growth",
      "Hypoxia-Induced Epithelial-Mesenchymal Transition",
      "TGF-beta/ROCK1 Mediated Stromal Hyperplasia",
      "ROCK-Mediated Fibrosis and Beta-Catenin Signaling",
      "Oxidative Stress and Epithelial Plasticity",
      "Inflammation and IL-6 Signaling"
    ],
    "cell_types": [
      "Prostatic Epithelial Cell",
      "Smooth Muscle Cell"
    ],
    "cell_type_ids": [
      "CL:0002231",
      "CL:0000192"
    ],
    "biological_processes": [
      "Cell Proliferation",
      "Androgen Response",
      "Epithelial to Mesenchymal Transition",
      "TGF-beta Signaling",
      "Wnt Signaling Pathway",
      "Response to Oxidative Stress",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Urinary Frequency",
      "Nocturia",
      "Weak Urinary Stream",
      "Hesitancy",
      "Incomplete Emptying",
      "Urinary Retention"
    ],
    "phenotype_categories": [
      "Urological"
    ],
    "phenotype_ids": [
      "HP:0000012",
      "HP:0000017",
      "HP:0000016"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SRD5A2",
      "AR",
      "ROCK1",
      "ROCK2",
      "FOS"
    ],
    "treatments": [
      "Alpha-Blockers",
      "5-Alpha Reductase Inhibitors",
      "Combination Therapy",
      "PDE5 Inhibitors",
      "TURP",
      "Laser Procedures",
      "Minimally Invasive Therapies",
      "ROCK Inhibitors (Experimental)",
      "Antioxidant Therapy (Experimental)"
    ],
    "environmental": [
      "Age",
      "Obesity",
      "Diabetes",
      "Physical Inactivity"
    ],
    "biochemical": [
      "PSA",
      "Testosterone"
    ],
    "source_file": "Benign_Prostatic_Hyperplasia.yaml",
    "page_url": "../pages/disorders/Benign_Prostatic_Hyperplasia.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 9,
    "num_genes": 5,
    "num_treatments": 9
  },
  {
    "name": "Beta Mannosidosis",
    "disease_id": "MONDO:0009562",
    "category": "Mendelian",
    "parents": [
      "Lysosomal storage diseases",
      "Oligosaccharidoses"
    ],
    "subtypes": [],
    "description": "A rare autosomal recessive lysosomal storage disorder caused by deficiency of lysosomal beta-mannosidase enzyme, leading to accumulation of mannose-containing oligosaccharides in tissues and body fluids. Clinical manifestations include intellectual disability, hearing loss, and variable neurological involvement.\n",
    "pathophysiology": [
      "Beta-mannosidase deficiency"
    ],
    "cell_types": [
      "Neuron",
      "Keratinocyte",
      "Fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0000312",
      "CL:0000057"
    ],
    "biological_processes": [
      "Glycoprotein catabolism"
    ],
    "phenotypes": [
      "Intellectual disability",
      "Sensorineural hearing impairment",
      "Seizures",
      "Angiokeratoma"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0001249",
      "HP:0000407",
      "HP:0001250",
      "HP:0001014"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "MANBA gene mutations"
    ],
    "treatments": [
      "Supportive care"
    ],
    "environmental": [],
    "biochemical": [
      "Urinary free oligosaccharides",
      "Beta-mannosidase activity"
    ],
    "source_file": "Beta_Mannosidosis.yaml",
    "page_url": "../pages/disorders/Beta_Mannosidosis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 1,
    "num_genes": 1,
    "num_treatments": 1
  },
  {
    "name": "Bipolar Disorder",
    "disease_id": "MONDO:0004985",
    "category": "Complex",
    "parents": [
      "Psychiatric Disease"
    ],
    "subtypes": [
      "Bipolar I Disorder",
      "Bipolar II Disorder",
      "Cyclothymic Disorder"
    ],
    "description": "Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.\n",
    "pathophysiology": [
      "Monoamine Dysregulation",
      "Mitochondrial Dysfunction",
      "Circadian Rhythm Disruption",
      "Neuroplasticity Alterations",
      "Neuroinflammation"
    ],
    "cell_types": [
      "Microglia"
    ],
    "cell_type_ids": [
      "CL:0000129"
    ],
    "biological_processes": [
      "Neurotransmitter Signaling",
      "Mitochondrial Function",
      "Circadian Rhythm",
      "Synaptic Plasticity",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Manic Episodes",
      "Depressive Episodes",
      "Sleep Disturbance",
      "Psychosis",
      "Anxiety",
      "Cognitive Impairment"
    ],
    "phenotype_categories": [
      "Psychiatric",
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0100754",
      "HP:0000716",
      "HP:0002360",
      "HP:0000709",
      "HP:0000739",
      "HP:0100543"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [
      "CACNA1C",
      "ANK3",
      "ODZ4",
      "NCAN"
    ],
    "treatments": [
      "Lithium",
      "Valproate",
      "Lamotrigine",
      "Atypical Antipsychotics",
      "Antidepressants",
      "Psychotherapy",
      "ECT"
    ],
    "environmental": [
      "Childhood Trauma",
      "Sleep Deprivation",
      "Substance Use",
      "Stress"
    ],
    "biochemical": [
      "BDNF",
      "Cortisol",
      "Inflammatory Markers"
    ],
    "source_file": "Bipolar_Disorder.yaml",
    "page_url": "../pages/disorders/Bipolar_Disorder.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 5,
    "num_genes": 4,
    "num_treatments": 7
  },
  {
    "name": "Bronchiectasis",
    "disease_id": "MONDO:0004822",
    "category": "Respiratory Disease",
    "parents": [
      "Chronic Lung Disease",
      "Inflammatory Lung Disease"
    ],
    "subtypes": [],
    "description": "Persistent microbial infections and inflammation damage airway walls, leading to dilation and thickening.",
    "pathophysiology": [
      "Chronic Infection and Inflammation",
      "Airway Dilation",
      "Impaired Mucociliary Clearance",
      "Neutrophil-Driven Inflammation",
      "Protease-Antiprotease Imbalance",
      "Goblet Cell Hyperplasia and Mucus Hypersecretion",
      "Inflammasome Activation and IL-1beta Signaling",
      "Microbiome Dysbiosis"
    ],
    "cell_types": [
      "airway epithelial cell",
      "ciliated epithelial cell",
      "neutrophil",
      "goblet cell"
    ],
    "cell_type_ids": [
      "CL:0002368",
      "CL:0000067",
      "CL:0000775",
      "CL:0000160"
    ],
    "biological_processes": [
      "mucociliary clearance",
      "cilium movement",
      "neutrophil degranulation",
      "neutrophil extracellular trap formation",
      "inflammatory response",
      "proteolysis",
      "mucus secretion",
      "NLRP3 inflammasome complex assembly",
      "interleukin-1 beta production"
    ],
    "phenotypes": [
      "Chronic Cough",
      "Sputum Production",
      "Dyspnea",
      "Hemoptysis",
      "Recurrent Respiratory Infections",
      "Fixed Airflow Obstruction",
      "Wheezing"
    ],
    "phenotype_categories": [
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0034315",
      "HP:0033709",
      "HP:0002094",
      "HP:0002105",
      "HP:0002205",
      "HP:0006510",
      "HP:0030828"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CFTR",
      "SCNN1A"
    ],
    "treatments": [
      "Airway Clearance Techniques",
      "Antibiotic Therapy",
      "Bronchodilators",
      "Inhaled Corticosteroids",
      "Surgery",
      "Vaccinations"
    ],
    "environmental": [
      "Pollution",
      "Smoking"
    ],
    "biochemical": [
      "C-Reactive Protein (CRP)",
      "Sputum Culture",
      "Neutrophil Elastase (NE)",
      "Interleukin-1 beta (IL-1beta)",
      "Neutrophil Extracellular Traps (NETs)"
    ],
    "source_file": "Bronchiectasis.yaml",
    "page_url": "../pages/disorders/Bronchiectasis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 8,
    "num_genes": 2,
    "num_treatments": 6
  },
  {
    "name": "CHIME_syndrome",
    "disease_id": "MONDO:0010221",
    "category": "Genetic",
    "parents": [
      "Neuroectodermal Disorder"
    ],
    "subtypes": [],
    "description": "A rare autosomal recessive neuroectodermal disorder characterized by colobomas, congenital heart defects, ichthyosiform dermatosis, intellectual disability, and ear anomalies caused by mutations in the PIGL gene affecting glycosylphosphatidylinositol (GPI) anchor biosynthesis.",
    "pathophysiology": [
      "PIGL Gene Mutations",
      "GPI Anchor Deficiency"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "glycosylphosphatidylinositol biosynthetic process",
      "cell adhesion",
      "signal transduction",
      "immune response"
    ],
    "phenotypes": [
      "Chorioretinal Coloboma",
      "Congenital Heart Defects",
      "Ichthyosiform Dermatosis",
      "Intellectual Disability",
      "Conductive Hearing Loss",
      "Seizure Disorder",
      "Dysmorphic Facial Features",
      "Genitourinary Abnormalities",
      "Large Birth Size",
      "Feeding Difficulties"
    ],
    "phenotype_categories": [
      "Ophthalmic",
      "Cardiac",
      "Dermatologic",
      "Neurologic",
      "Auditory",
      "Craniofacial",
      "Genitourinary",
      "Growth",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0000567",
      "HP:0001627",
      "HP:0008064",
      "HP:0001249",
      "HP:0000405",
      "HP:0001250",
      "HP:0001999",
      "HP:0000119",
      "HP:0001520",
      "HP:0011968"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "PIGL"
    ],
    "treatments": [
      "Supportive Care",
      "Cardiac Surgery",
      "Seizure Management",
      "Dermatologic Care",
      "Hearing Aids",
      "Educational Support"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "CHIME_syndrome.yaml",
    "page_url": "../pages/disorders/CHIME_syndrome.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 6
  },
  {
    "name": "CTCF-related Neurodevelopmental Disorder",
    "disease_id": "MONDO:0700294",
    "category": "Mendelian",
    "parents": [
      "Neurodevelopmental Disorder",
      "Chromatin Disorder"
    ],
    "subtypes": [],
    "description": "CTCF-related neurodevelopmental disorder is a rare Mendelian condition caused by heterozygous de novo mutations in the CTCF gene, which encodes a critical chromatin architecture protein. CTCF (CCCTC-binding factor) is an 11-zinc finger transcription factor essential for establishing topologically associating domains (TADs) and regulating three-dimensional genome structure. Affected individuals typically present with intellectual disability of variable severity, developmental delay, feeding difficulties, behavioral abnormalities, and variable dysmorphic features. The pathophysiology involves haploinsufficiency leading to disrupted chromatin looping, aberrant enhancer-promoter interactions, and dysregulation of neurodevelopmental genes.\n",
    "pathophysiology": [
      "CTCF Haploinsufficiency",
      "Chromatin Architecture Disruption",
      "Neurodevelopmental Gene Dysregulation",
      "Abnormal Neural Progenitor Cell Development"
    ],
    "cell_types": [
      "neural progenitor cell",
      "neuron",
      "cerebral cortex neuron",
      "cerebral cortex GABAergic interneuron"
    ],
    "cell_type_ids": [
      "CL:0011020",
      "CL:0000540",
      "CL:0010012",
      "CL:0010011"
    ],
    "biological_processes": [
      "chromatin organization",
      "regulation of gene expression",
      "chromosome organization",
      "regulation of chromatin organization"
    ],
    "phenotypes": [
      "Intellectual Disability",
      "Global Developmental Delay",
      "Feeding Difficulties",
      "Microcephaly",
      "Short Stature",
      "Behavioral Abnormalities",
      "Hypotonia",
      "Congenital Heart Defects",
      "Cleft Palate",
      "Hearing Loss",
      "Seizures",
      "Facial Dysmorphism"
    ],
    "phenotype_categories": [
      "Cognitive",
      "Developmental",
      "Growth",
      "Neurologic",
      "Behavioral",
      "Cardiovascular",
      "Craniofacial",
      "Sensory"
    ],
    "phenotype_ids": [
      "HP:0001249",
      "HP:0001263",
      "HP:0008872",
      "HP:0000252",
      "HP:0004322",
      "HP:0000729",
      "HP:0001252",
      "HP:0001627",
      "HP:0000175",
      "HP:0000407",
      "HP:0001250"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CTCF"
    ],
    "treatments": [
      "Supportive Developmental Therapies",
      "Educational Support",
      "Feeding Support",
      "Behavioral Management",
      "Genetic Counseling"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "CTCF-related_Neurodevelopmental_Disorder.yaml",
    "page_url": "../pages/disorders/CTCF-related_Neurodevelopmental_Disorder.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Camptodactyly",
    "disease_id": "MONDO:0007250",
    "category": "Musculoskeletal Disorder",
    "parents": [
      "Congenital Limb Malformation",
      "Joint Disorder"
    ],
    "subtypes": [],
    "description": "Camptodactyly is a congenital or acquired condition characterized by permanent flexion contracture of one or more fingers, most commonly affecting the proximal interphalangeal joint of the fifth finger. It can occur as an isolated finding or as part of syndromic conditions including distal arthrogryposis and CACP syndrome.",
    "pathophysiology": [
      "Fetal Akinesia",
      "Sarcomere Dysfunction",
      "PRG4/Lubricin Deficiency",
      "Flexor Tendon Abnormalities",
      "Joint Contracture"
    ],
    "cell_types": [
      "skeletal muscle fiber",
      "type B synovial cell",
      "chondrocyte"
    ],
    "cell_type_ids": [
      "CL:0008002",
      "CL:0002301",
      "CL:0000138"
    ],
    "biological_processes": [
      "sarcomere organization",
      "muscle contraction",
      "extracellular matrix organization"
    ],
    "phenotypes": [
      "Camptodactyly",
      "Finger Flexion Contracture",
      "Joint Stiffness",
      "Distal Arthrogryposis",
      "Arachnodactyly"
    ],
    "phenotype_categories": [
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0012385",
      "HP:0012785",
      "HP:0001387",
      "HP:0001166"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "PRG4",
      "TNNT3",
      "TNNI2",
      "TPM2",
      "MYH3",
      "ACTC1",
      "FBN2",
      "ECEL1"
    ],
    "treatments": [
      "Physical Therapy",
      "Serial Splinting",
      "Surgical Release",
      "Orthotic Interventions",
      "Genetic Counseling"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Camptodactyly.yaml",
    "page_url": "../pages/disorders/Camptodactyly.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 5,
    "num_genes": 8,
    "num_treatments": 5
  },
  {
    "name": "Celiac Disease",
    "disease_id": "MONDO:0005130",
    "category": "Complex",
    "parents": [
      "Gastrointestinal Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [],
    "description": "Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.\n",
    "pathophysiology": [
      "Gluten-Triggered Immune Response",
      "Intestinal Epithelial Damage",
      "Autoantibody Production",
      "Barrier Dysfunction"
    ],
    "cell_types": [
      "T Helper Cell",
      "Intestinal Epithelial Cell",
      "Plasma Cell"
    ],
    "cell_type_ids": [
      "CL:0000492",
      "CL:0002563",
      "CL:0000786"
    ],
    "biological_processes": [
      "Antigen Processing",
      "Apoptosis"
    ],
    "phenotypes": [
      "Chronic Diarrhea",
      "Abdominal Pain",
      "Bloating",
      "Weight Loss",
      "Iron Deficiency Anemia",
      "Fatigue",
      "Dermatitis Herpetiformis",
      "Osteoporosis"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Hematologic",
      "Dermatological",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0002028",
      "HP:0002027",
      "HP:0003270",
      "HP:0001824",
      "HP:0001903",
      "HP:0012378",
      "HP:0000988",
      "HP:0004349"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DQ2",
      "HLA-DQ8",
      "IL2",
      "IL21"
    ],
    "treatments": [
      "Gluten-Free Diet",
      "Nutritional Supplementation",
      "Monitoring",
      "Corticosteroids",
      "Dietitian Counseling"
    ],
    "environmental": [
      "Gluten Exposure",
      "Early Gluten Introduction",
      "Gastrointestinal Infections",
      "Gut Microbiome"
    ],
    "biochemical": [
      "Anti-tTG IgA",
      "Anti-Endomysial Antibodies",
      "Anti-DGP Antibodies",
      "Total IgA"
    ],
    "source_file": "Celiac_Disease.yaml",
    "page_url": "../pages/disorders/Celiac_Disease.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 5
  },
  {
    "name": "Cholera",
    "disease_id": "MONDO:0015766",
    "category": "Infectious Disease",
    "parents": [
      "Bacterial Infection"
    ],
    "subtypes": [],
    "description": "Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.",
    "pathophysiology": [
      "Cholera Toxin Binding and Uptake",
      "ERAD-mediated CTA1 Translocation",
      "Gs\u03b1 ADP-Ribosylation",
      "Cholera Toxin",
      "Increased cAMP",
      "Profuse Watery Diarrhea",
      "Colonization and Biofilm Formation",
      "Accessory Toxins and Virulence Factors",
      "Host Metabolic Reprogramming"
    ],
    "cell_types": [
      "intestinal epithelial cell"
    ],
    "cell_type_ids": [
      "CL:0002563"
    ],
    "biological_processes": [
      "endocytosis",
      "retrograde vesicle-mediated transport",
      "ERAD pathway",
      "adenylate cyclase-activating G protein-coupled receptor signaling pathway",
      "cAMP-mediated signaling",
      "chloride transmembrane transport",
      "biofilm formation",
      "bacterial adhesion to host",
      "disruption of cells of other organism",
      "tight junction organization",
      "regulation of lipid metabolic process"
    ],
    "phenotypes": [
      "Profuse Watery Diarrhea",
      "Dehydration",
      "Hypovolemic Shock",
      "Dehydration",
      "Hypovolemic Shock",
      "Hypokalemia",
      "Metabolic Acidosis",
      "Muscle Cramps",
      "Severe Dehydration",
      "Shock",
      "Sunken Eyes",
      "Low Blood Pressure",
      "Tachycardia",
      "Acute Kidney Injury"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Electrolyte/Metabolic",
      "Musculoskeletal",
      "Cardiovascular",
      "Renal"
    ],
    "phenotype_ids": [
      "HP:0001944",
      "HP:0031274",
      "HP:0002900",
      "HP:0001942",
      "HP:0003394",
      "HP:0031273",
      "HP:0000490",
      "HP:0002615",
      "HP:0001649",
      "HP:0001919"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Oral Rehydration Solution (ORS)",
      "Intravenous Rehydration",
      "Antibiotics",
      "Zinc Supplementation",
      "Vaccination"
    ],
    "environmental": [
      "Contaminated Water",
      "Poor Sanitation"
    ],
    "biochemical": [
      "Electrolytes"
    ],
    "source_file": "Cholera.yaml",
    "page_url": "../pages/disorders/Cholera.html",
    "num_phenotypes": 14,
    "num_pathophysiology": 9,
    "num_genes": 0,
    "num_treatments": 5
  },
  {
    "name": "Chronic Inflammatory Demyelinating Polyneuropathy",
    "disease_id": "MONDO:0006702",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Peripheral Neuropathy"
    ],
    "subtypes": [],
    "description": "A chronic acquired immune-mediated neuropathy characterized by progressive or relapsing-remitting symmetric proximal and distal weakness with sensory involvement. Distinguished from GBS by duration greater than 8 weeks and chronic course.",
    "pathophysiology": [
      "T Cell-Mediated Demyelination",
      "Antibody and Complement-Mediated Damage",
      "Macrophage-Mediated Myelin Stripping"
    ],
    "cell_types": [
      "CD4+ T Cell",
      "CD8+ T Cell",
      "Macrophage"
    ],
    "cell_type_ids": [
      "CL:0000624",
      "CL:0000625",
      "CL:0000235"
    ],
    "biological_processes": [
      "Adaptive Immune Response",
      "Complement Activation",
      "Immunoglobulin Production",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Progressive Weakness",
      "Areflexia",
      "Sensory Loss",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Neurological",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0003690",
      "HP:0001284",
      "HP:0000763",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "IVIG",
      "Corticosteroids",
      "Plasmapheresis",
      "Rituximab"
    ],
    "environmental": [],
    "biochemical": [
      "CSF Protein",
      "Anti-Neurofascin Antibodies",
      "Anti-Contactin-1 Antibodies"
    ],
    "source_file": "Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml",
    "page_url": "../pages/disorders/Chronic_Inflammatory_Demyelinating_Polyneuropathy.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Chronic Kidney Disease",
    "disease_id": "MONDO:0005300",
    "category": "Complex",
    "parents": [
      "Renal Disease"
    ],
    "subtypes": [
      "Diabetic Nephropathy",
      "Hypertensive Nephrosclerosis",
      "Glomerulonephritis",
      "Polycystic Kidney Disease"
    ],
    "description": "Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.\n",
    "pathophysiology": [
      "Nephron Loss",
      "Glomerulosclerosis",
      "Tubulointerstitial Fibrosis",
      "RAAS Activation"
    ],
    "cell_types": [
      "Podocyte",
      "Tubular Epithelial Cell",
      "Myofibroblast"
    ],
    "cell_type_ids": [
      "CL:0000653",
      "CL:0002306",
      "CL:0000186"
    ],
    "biological_processes": [
      "Fibrosis",
      "RAAS Signaling"
    ],
    "phenotypes": [
      "Decreased GFR",
      "Proteinuria",
      "Hypertension",
      "Anemia",
      "Metabolic Acidosis",
      "Fatigue",
      "Peripheral Edema"
    ],
    "phenotype_categories": [
      "Renal",
      "Cardiovascular",
      "Hematologic",
      "Metabolic",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0012622",
      "HP:0000093",
      "HP:0000822",
      "HP:0001903",
      "HP:0001942",
      "HP:0012378",
      "HP:0012398"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "PKD1",
      "PKD2",
      "APOL1"
    ],
    "treatments": [
      "ACE Inhibitors/ARBs",
      "SGLT2 Inhibitors",
      "Blood Pressure Control",
      "Dietary Protein Restriction",
      "Erythropoiesis-Stimulating Agents",
      "Phosphate Binders",
      "Dialysis",
      "Kidney Transplantation"
    ],
    "environmental": [
      "Diabetes",
      "Hypertension",
      "NSAIDs",
      "Nephrotoxic Medications"
    ],
    "biochemical": [
      "Creatinine",
      "Blood Urea Nitrogen",
      "Phosphate",
      "PTH"
    ],
    "source_file": "Chronic_Kidney_Disease.yaml",
    "page_url": "../pages/disorders/Chronic_Kidney_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 8
  },
  {
    "name": "Chronic_Obstructive_Pulmonary_Disease",
    "disease_id": "MONDO:0005002",
    "category": "Complex",
    "parents": [
      "Respiratory Disease",
      "Smoking-Related Disease"
    ],
    "subtypes": [
      "Chronic Bronchitis",
      "Emphysema"
    ],
    "description": "Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.",
    "pathophysiology": [
      "Airflow Limitation",
      "Chronic Inflammation",
      "Airway Remodeling",
      "Alveolar Destruction",
      "Oxidative Stress and Mitochondrial Dysfunction",
      "Mucus Hypersecretion",
      "NLRP3 Inflammasome Activation",
      "Cellular Senescence"
    ],
    "cell_types": [
      "Epithelial Cell",
      "Neutrophil",
      "Macrophage",
      "T-lymphocyte",
      "Smooth Muscle Cell",
      "Alveolar Macrophage",
      "airway epithelial cell",
      "goblet cell",
      "club cell",
      "fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000066",
      "CL:0000775",
      "CL:0000235",
      "CL:0000084",
      "CL:0000192",
      "CL:0000583",
      "CL:0002368",
      "CL:0000160",
      "CL:0000158",
      "CL:0000057"
    ],
    "biological_processes": [
      "inflammatory response",
      "airway remodeling",
      "neutrophil degranulation",
      "extracellular matrix organization",
      "fibrosis",
      "proteolysis",
      "response to oxidative stress",
      "mitochondrion organization",
      "mitophagy",
      "mucus secretion",
      "cilium movement",
      "NLRP3 inflammasome complex assembly",
      "cellular senescence"
    ],
    "phenotypes": [
      "Dyspnea",
      "Chronic Cough",
      "Sputum Production",
      "Wheezing",
      "Barrel Chest",
      "Respiratory Failure",
      "Fatigue",
      "Weight Loss",
      "Exercise Intolerance",
      "Hypoxemia",
      "Hypercapnia"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Systemic",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0002094",
      "HP:0034315",
      "HP:0033709",
      "HP:0030828",
      "HP:0002878",
      "HP:0012378",
      "HP:0001824",
      "HP:0003546",
      "HP:0012418",
      "HP:0012416"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SERPINA1",
      "MMP12",
      "NLRP3",
      "TNF",
      "IL1B",
      "IL6",
      "NFE2L2"
    ],
    "treatments": [
      "Smoking Cessation",
      "Bronchodilators",
      "Inhaled Corticosteroids",
      "Phosphodiesterase-4 Inhibitors",
      "Oxygen Therapy",
      "Pulmonary Rehabilitation",
      "Lung Volume Reduction Surgery",
      "Lung Transplantation",
      "Mucolytic Therapy",
      "Macrolide Antibiotics",
      "Biologic Therapies"
    ],
    "environmental": [
      "Smoking",
      "Air Pollution",
      "Occupational Dust and Chemicals"
    ],
    "biochemical": [
      "Arterial Blood Gases",
      "C-Reactive Protein (CRP)"
    ],
    "source_file": "Chronic_Obstructive_Pulmonary_Disease.yaml",
    "page_url": "../pages/disorders/Chronic_Obstructive_Pulmonary_Disease.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 8,
    "num_genes": 7,
    "num_treatments": 11
  },
  {
    "name": "Chronic Pancreatitis",
    "disease_id": "MONDO:0005003",
    "category": "Complex",
    "parents": [
      "Gastrointestinal Disease"
    ],
    "subtypes": [],
    "description": "Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.\n",
    "pathophysiology": [
      "Recurrent Acinar Cell Injury",
      "Pancreatic Fibrosis",
      "Exocrine Insufficiency",
      "Endocrine Insufficiency"
    ],
    "cell_types": [
      "Pancreatic Acinar Cell",
      "Pancreatic Stellate Cell",
      "Pancreatic Beta Cell"
    ],
    "cell_type_ids": [
      "CL:0002064",
      "CL:0002410",
      "CL:0000169"
    ],
    "biological_processes": [
      "Inflammatory Response",
      "Extracellular Matrix Organization",
      "Digestive System Process"
    ],
    "phenotypes": [
      "Chronic Abdominal Pain",
      "Steatorrhea",
      "Weight Loss",
      "Diabetes Mellitus",
      "Nausea and Vomiting"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0002027",
      "HP:0002570",
      "HP:0001824",
      "HP:0000819",
      "HP:0002017"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "PRSS1",
      "SPINK1",
      "CFTR",
      "CTRC"
    ],
    "treatments": [
      "Pain Management",
      "Pancreatic Enzyme Replacement",
      "Diabetes Management",
      "Nutritional Support",
      "Alcohol Cessation",
      "Smoking Cessation",
      "Endoscopic Therapy",
      "Surgery"
    ],
    "environmental": [
      "Alcohol",
      "Smoking",
      "Hypertriglyceridemia",
      "Hypercalcemia"
    ],
    "biochemical": [
      "Fecal Elastase",
      "Amylase",
      "Lipase",
      "HbA1c"
    ],
    "source_file": "Chronic_Pancreatitis.yaml",
    "page_url": "../pages/disorders/Chronic_Pancreatitis.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Clostridioides difficile Infection",
    "disease_id": "MONDO:0000705",
    "category": "Infectious",
    "parents": [
      "Infectious colitis",
      "Healthcare-associated infections"
    ],
    "subtypes": [],
    "description": "C. difficile produces toxins A and B that damage colonic epithelium, causing inflammation, fluid secretion, and in severe cases pseudomembranous colitis. Disruption of normal gut microbiota, often by antibiotics, allows C. difficile to proliferate.\n",
    "pathophysiology": [
      "Toxin-mediated colonic injury"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [],
    "phenotypes": [
      "Diarrhea",
      "Abdominal pain",
      "Fever"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0002014",
      "HP:0002027",
      "HP:0001945"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Vancomycin",
      "Fidaxomicin",
      "Fecal microbiota transplantation"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Clostridioides_difficile_Infection.yaml",
    "page_url": "../pages/disorders/Clostridioides_difficile_Infection.html",
    "num_phenotypes": 3,
    "num_pathophysiology": 1,
    "num_genes": 0,
    "num_treatments": 3
  },
  {
    "name": "Coronary Artery Disease",
    "disease_id": "MONDO:1060134",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease",
      "Atherosclerotic Disease"
    ],
    "subtypes": [],
    "description": "Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.\n",
    "pathophysiology": [
      "Atherosclerotic Plaque Formation",
      "Endothelial Dysfunction",
      "Plaque Rupture and Thrombosis"
    ],
    "cell_types": [
      "Macrophage",
      "Foam Cell",
      "Vascular Smooth Muscle Cell",
      "Endothelial Cell",
      "Platelet"
    ],
    "cell_type_ids": [
      "CL:0000235",
      "CL:0000891",
      "CL:0000359",
      "CL:0000115",
      "CL:0000233"
    ],
    "biological_processes": [
      "Lipid Accumulation",
      "Nitric Oxide Production",
      "Thrombosis"
    ],
    "phenotypes": [
      "Angina Pectoris",
      "Dyspnea on Exertion",
      "Myocardial Infarction"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001681",
      "HP:0002094",
      "HP:0001658"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "APOE",
      "LDLR",
      "PCSK9",
      "9p21 Locus"
    ],
    "treatments": [
      "Statins",
      "Antiplatelet Therapy",
      "ACE Inhibitors",
      "Beta Blockers",
      "Percutaneous Coronary Intervention",
      "Coronary Artery Bypass Grafting"
    ],
    "environmental": [
      "Smoking",
      "High-Fat Diet",
      "Sedentary Lifestyle",
      "Obesity"
    ],
    "biochemical": [
      "LDL Cholesterol",
      "HDL Cholesterol",
      "C-Reactive Protein"
    ],
    "source_file": "Coronary_Artery_Disease.yaml",
    "page_url": "../pages/disorders/Coronary_Artery_Disease.html",
    "num_phenotypes": 3,
    "num_pathophysiology": 3,
    "num_genes": 4,
    "num_treatments": 6
  },
  {
    "name": "Crohn Disease",
    "disease_id": "MONDO:0005011",
    "category": "Complex",
    "parents": [
      "Inflammatory Bowel Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [
      "Ileal Crohn's Disease",
      "Colonic Crohn's Disease",
      "Ileocolonic Crohn's Disease"
    ],
    "description": "A chronic inflammatory bowel disease that affects the lining of the digestive tract, causing a wide range of gastrointestinal and systemic symptoms.",
    "pathophysiology": [
      "Dysregulated Immune Response",
      "Microbiome Imbalance",
      "Autophagy and Paneth Cell Dysfunction",
      "IL-23/Th17 Axis Dysregulation",
      "Fibrosis and Stricture Formation",
      "Fistula Formation via Myeloid-Stromal Crosstalk"
    ],
    "cell_types": [
      "Paneth cell",
      "Macrophage",
      "Th17 cell",
      "Dendritic cell",
      "Fibroblast",
      "Myofibroblast",
      "T cell"
    ],
    "cell_type_ids": [
      "CL:0000510",
      "CL:0000235",
      "CL:0000899",
      "CL:0000451",
      "CL:0000057",
      "CL:0000186",
      "CL:0000084"
    ],
    "biological_processes": [
      "Autophagy",
      "Antimicrobial peptide secretion",
      "Th17 cell differentiation",
      "IL-23 signaling",
      "Extracellular matrix organization",
      "Tissue remodeling",
      "Type II interferon signaling",
      "T-cell costimulation"
    ],
    "phenotypes": [
      "Abdominal Pain",
      "Diarrhea",
      "Fatigue",
      "Perianal Disease",
      "Intestinal Obstruction",
      "Arthritis",
      "Erythema Nodosum",
      "Uveitis",
      "Fatigue",
      "Fever",
      "Weight Loss",
      "Malnutrition",
      "Dehydration",
      "Intestinal Stricture",
      "Perianal Fistula",
      "Transmural Inflammation"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Musculoskeletal",
      "Dermatologic",
      "Ocular"
    ],
    "phenotype_ids": [
      "HP:0002027",
      "HP:0002014",
      "HP:0012378",
      "HP:0004796",
      "HP:0001369",
      "HP:0012219",
      "HP:0000554",
      "HP:0001945",
      "HP:0001824",
      "HP:0004395",
      "HP:0001944",
      "HP:0009789"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "NOD2",
      "ATG16L1",
      "IL23R",
      "LRRK2",
      "TNFSF15",
      "CARD9"
    ],
    "treatments": [
      "Aminosalicylates",
      "Corticosteroids",
      "Immunomodulators",
      "Biologics",
      "Nutritional Therapy",
      "Surgery",
      "Anti-IL-23 Biologics",
      "TL1A Inhibitors",
      "JAK Inhibitors"
    ],
    "environmental": [
      "Smoking",
      "Diet",
      "Stress"
    ],
    "biochemical": [
      "C-Reactive Protein (CRP)",
      "Fecal Calprotectin"
    ],
    "source_file": "Crohn_Disease.yaml",
    "page_url": "../pages/disorders/Crohn_Disease.html",
    "num_phenotypes": 16,
    "num_pathophysiology": 6,
    "num_genes": 6,
    "num_treatments": 9
  },
  {
    "name": "Cronkhite-Canada syndrome",
    "disease_id": "MONDO:0008283",
    "category": "Complex",
    "parents": [
      "Gastrointestinal polyposis syndromes",
      "Genetic disorders with cutaneous manifestations"
    ],
    "subtypes": [],
    "description": "Cronkhite-Canada syndrome (CCS) is a rare, non-hereditary gastrointestinal polyposis syndrome characterized by the association of extensive hamartomatous polyps throughout the gastrointestinal tract with a distinctive cutaneous triad of alopecia, nail changes (onychodystrophy), and hyperpigmentation. The condition has significant gastrointestinal morbidity including protein-losing enteropathy, chronic diarrhea, and increased cancer risk. Although historically considered a relentlessly progressive disease with high mortality, modern advances in understanding and treatment with corticosteroids and immunomodulators have substantially improved prognosis and overall survival.\n",
    "pathophysiology": [
      "Hamartomatous polyp formation in the gastrointestinal tract",
      "Autoimmune and IgG4-mediated inflammation",
      "Epithelial barrier dysfunction and protein-losing enteropathy",
      "Helicobacter pylori infection and dysbiosis"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Epithelial cell proliferation",
      "Epithelial cell morphogenesis",
      "Plasma cell differentiation",
      "Cytokine production",
      "Tight junction",
      "Defense response to bacterium"
    ],
    "phenotypes": [
      "Gastrointestinal polyposis",
      "Alopecia",
      "Nail changes",
      "Hyperpigmentation",
      "Chronic diarrhea",
      "Protein-losing enteropathy"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Cutaneous"
    ],
    "phenotype_ids": [
      "HP:0004390",
      "HP:0001596",
      "HP:0008394",
      "HP:0000953",
      "HP:0002014",
      "HP:0002243"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Corticosteroids",
      "Immunosuppressive agents",
      "Supportive care"
    ],
    "environmental": [],
    "biochemical": [
      "Serum albumin",
      "Serum iron",
      "Total serum protein"
    ],
    "source_file": "Cronkhite-Canada_syndrome.yaml",
    "page_url": "../pages/disorders/Cronkhite-Canada_syndrome.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 0,
    "num_treatments": 3
  },
  {
    "name": "Cushing's Syndrome",
    "disease_id": "MONDO:0018912",
    "category": "Complex",
    "parents": [
      "Endocrine Disorders",
      "Adrenal Gland Diseases"
    ],
    "subtypes": [],
    "description": "Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.\n",
    "pathophysiology": [
      "Chronic Cortisol Excess",
      "Hypothalamic-Pituitary-Adrenal Axis Dysregulation",
      "Metabolic Consequences of Hypercortisolism"
    ],
    "cell_types": [
      "glucocorticoid secreting cell",
      "corticotroph"
    ],
    "cell_type_ids": [
      "CL:0000460",
      "CL:0002309"
    ],
    "biological_processes": [
      "glucocorticoid secretion",
      "response to glucocorticoid"
    ],
    "phenotypes": [
      "Central Obesity",
      "Purple Striae",
      "Proximal Muscle Weakness",
      "Hypertension",
      "Glucose Intolerance",
      "Osteoporosis",
      "Easy Bruising"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0001956",
      "HP:0001065",
      "HP:0003701",
      "HP:0000822",
      "HP:0001952",
      "HP:0000939",
      "HP:0000978"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Surgical Resection",
      "Medical Therapy",
      "Radiation Therapy",
      "Bilateral Adrenalectomy"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Cushings_Syndrome.yaml",
    "page_url": "../pages/disorders/Cushing's_Syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Cystic Fibrosis",
    "disease_id": "MONDO:0009061",
    "category": "Genetic",
    "parents": [
      "Respiratory Disease",
      "Inborn Error of Metabolism"
    ],
    "subtypes": [
      "Classic CF",
      "Atypical CF",
      "CFTR-Related Metabolic Syndrome"
    ],
    "description": "Mutations in CFTR gene cause defective chloride channel function. Impaired chloride and bicarbonate transport leads to thick, dehydrated secretions in airways, pancreas, and other organs.\n",
    "pathophysiology": [
      "CFTR Dysfunction",
      "Airway Mucus Obstruction",
      "Pancreatic Insufficiency"
    ],
    "cell_types": [
      "Airway Epithelial Cell",
      "Pancreatic Acinar Cell"
    ],
    "cell_type_ids": [
      "CL:0002328",
      "CL:0002064"
    ],
    "biological_processes": [
      "Chloride Transport",
      "Mucus Secretion"
    ],
    "phenotypes": [
      "Recurrent Respiratory Infections",
      "Bronchiectasis",
      "Exocrine Pancreatic Insufficiency",
      "Steatorrhea",
      "Failure to Thrive",
      "Meconium Ileus",
      "Male Infertility"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Gastrointestinal",
      "Growth",
      "Reproductive"
    ],
    "phenotype_ids": [
      "HP:0002205",
      "HP:0002110",
      "HP:0001738",
      "HP:0002570",
      "HP:0001508",
      "HP:0004401",
      "HP:0003251"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CFTR"
    ],
    "treatments": [
      "CFTR Modulators",
      "Airway Clearance Therapy",
      "Inhaled Mucolytics",
      "Pancreatic Enzyme Replacement",
      "Antibiotics",
      "Lung Transplantation",
      "Nutritional Support"
    ],
    "environmental": [
      "Pseudomonas aeruginosa",
      "Burkholderia cepacia complex",
      "Tobacco Smoke"
    ],
    "biochemical": [
      "Sweat Chloride",
      "Fecal Elastase",
      "Fat-Soluble Vitamins"
    ],
    "source_file": "Cystic_Fibrosis.yaml",
    "page_url": "../pages/disorders/Cystic_Fibrosis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 7
  },
  {
    "name": "Dementia with Lewy Bodies",
    "disease_id": "MONDO:0007488",
    "category": "Complex",
    "parents": [
      "Dementia",
      "Neurodegenerative Disease",
      "Synucleinopathy"
    ],
    "subtypes": [],
    "description": "Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, parkinsonism, and fluctuating cognition. It is pathologically defined by the presence of Lewy bodies containing aggregated alpha-synuclein protein in the brain. DLB is the second most common cause of neurodegenerative dementia after Alzheimer's disease.\n",
    "pathophysiology": [
      "Alpha-Synuclein Aggregation and Lewy Body Formation",
      "Autophagy-Lysosome Dysfunction",
      "Neuronal Death"
    ],
    "cell_types": [
      "neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Visual Hallucinations",
      "Parkinsonism",
      "Dementia",
      "REM Sleep Behavior Disorder"
    ],
    "phenotype_categories": [
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0002367",
      "HP:0001300",
      "HP:0000726",
      "HP:5200291"
    ],
    "frequencies": [
      "VERY_FREQUENT"
    ],
    "genes": [
      "APOE",
      "GBA",
      "SNCA"
    ],
    "treatments": [
      "Cholinesterase Inhibitors",
      "Symptomatic Management"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Dementia_with_Lewy_Bodies.yaml",
    "page_url": "../pages/disorders/Dementia_with_Lewy_Bodies.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 2
  },
  {
    "name": "Dengue",
    "disease_id": "MONDO:0005502",
    "category": "Infectious Disease",
    "parents": [
      "Arbovirus Infection"
    ],
    "subtypes": [],
    "description": "A Flavivirus transmitted by Aedes mosquitoes, causing a wide range of symptoms from mild fever to severe hemorrhagic fever and shock.",
    "pathophysiology": [
      "Dengue Virus (DENV) Infection",
      "Viral Replication",
      "Immune System Activation",
      "Cytokine Release",
      "Antibody-Dependent Enhancement (ADE)",
      "Endothelial Dysfunction",
      "NS1-Mediated Endothelial Glycocalyx Degradation",
      "NS1-Mediated Complement Activation and Modulation",
      "Inflammasome Activation by NS1",
      "Mast Cell Degranulation and Mediator Release",
      "Platelet and Megakaryocyte Dysfunction",
      "Innate Immune Antagonism",
      "Coagulopathy",
      "Organ Involvement",
      "Severe Dengue",
      "Dengue Hemorrhagic Fever (DHF)",
      "Dengue Shock Syndrome (DSS)",
      "Vascular Leakage",
      "Plasma Leakage"
    ],
    "cell_types": [
      "Dendritic Cell",
      "Monocyte",
      "Macrophage",
      "Endothelial Cell",
      "Mast Cell",
      "Natural Killer Cell",
      "T Cell",
      "B Cell",
      "Platelet",
      "Megakaryocyte"
    ],
    "cell_type_ids": [
      "CL:0000451",
      "CL:0000576",
      "CL:0000235",
      "CL:0000115",
      "CL:0000097",
      "CL:0000623",
      "CL:0000084",
      "CL:0000236",
      "CL:0000233",
      "CL:0000556"
    ],
    "biological_processes": [
      "Viral Infection",
      "TNF-alpha Production",
      "IL-1beta Production",
      "IL-6 Production",
      "IL-8 Production",
      "IFN-gamma Production",
      "Endothelial Glycocalyx Organization",
      "Inflammatory Response",
      "Complement Activation",
      "Inflammasome Complex Assembly",
      "Mast Cell Degranulation",
      "Platelet Activation",
      "Platelet Degranulation",
      "Type I Interferon Signaling",
      "Innate Immune Response"
    ],
    "phenotypes": [
      "Fever",
      "Severe Muscle and Joint Pain",
      "Vomiting",
      "Diarrhea",
      "Petechiae",
      "Epistaxis",
      "Gum Bleeding",
      "Severe Headache",
      "Fatigue",
      "Maculopapular Rash",
      "Conjunctival Injection",
      "Abdominal Pain",
      "Lymphadenopathy",
      "Cough",
      "Altered Mental Status",
      "Hypotension",
      "Hepatomegaly",
      "Leukopenia",
      "Elevated Liver Enzymes",
      "Hemorrhage",
      "Myocarditis",
      "Pleural Effusion",
      "Shock",
      "Acute Kidney Injury",
      "Encephalitis",
      "Hepatitis",
      "Hemorrhagic Manifestations",
      "Hemoconcentration",
      "Neurological Complications"
    ],
    "phenotype_categories": [
      "Systemic",
      "Musculoskeletal",
      "Gastrointestinal",
      "Hemorrhagic",
      "Neurologic",
      "Dermatologic",
      "Ocular",
      "Respiratory",
      "Cardiovascular",
      "Hepatic",
      "Laboratory",
      "Renal",
      "Hematologic"
    ],
    "phenotype_ids": [
      "HP:0001945",
      "HP:0002013",
      "HP:0002014",
      "HP:0000967",
      "HP:0000421",
      "HP:0012378",
      "HP:0002027",
      "HP:0002716",
      "HP:0012735",
      "HP:0002615",
      "HP:0002240",
      "HP:0001882",
      "HP:0001892",
      "HP:0012819",
      "HP:0002202",
      "HP:0031273",
      "HP:0001919",
      "HP:0002383",
      "HP:0012115",
      "HP:0001899",
      "HP:0000707"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL",
      "RARE"
    ],
    "genes": [],
    "treatments": [
      "Supportive Care",
      "Platelet Transfusions",
      "Pain Relief",
      "Vector Control"
    ],
    "environmental": [],
    "biochemical": [
      "Dengue NS1 Antigen",
      "Dengue IgM Antibodies",
      "Dengue IgG Antibodies",
      "Platelet Count",
      "Hematocrit"
    ],
    "source_file": "Dengue.yaml",
    "page_url": "../pages/disorders/Dengue.html",
    "num_phenotypes": 29,
    "num_pathophysiology": 19,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Dermatomyositis",
    "disease_id": "MONDO:0016367",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Inflammatory Myopathy"
    ],
    "subtypes": [],
    "description": "An idiopathic inflammatory myopathy characterized by proximal muscle weakness and distinctive skin manifestations including heliotrope rash and Gottron's papules. Associated with increased risk of malignancy and interstitial lung disease in certain autoantibody subsets.",
    "pathophysiology": [
      "Complement-Mediated Microangiopathy",
      "Type I Interferon Pathway Activation",
      "Myositis-Specific Autoantibodies",
      "CD4+ T Cell and B Cell Infiltration"
    ],
    "cell_types": [
      "Endothelial Cell",
      "Plasmacytoid Dendritic Cell",
      "CD4+ T Cell",
      "B Cell"
    ],
    "cell_type_ids": [
      "CL:0000115",
      "CL:0000784",
      "CL:0000624",
      "CL:0000236"
    ],
    "biological_processes": [
      "Complement Activation",
      "Type I Interferon Response",
      "Immunoglobulin Production",
      "Adaptive Immune Response"
    ],
    "phenotypes": [
      "Proximal Muscle Weakness",
      "Skin Rash",
      "Pulmonary Fibrosis",
      "Dysphagia"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Dermatological",
      "Respiratory",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0003690",
      "HP:0000988",
      "HP:0002206",
      "HP:0002015"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*0301"
    ],
    "treatments": [
      "Corticosteroids",
      "Methotrexate",
      "IVIG",
      "Rituximab",
      "JAK Inhibitors"
    ],
    "environmental": [],
    "biochemical": [
      "Creatine Kinase",
      "Aldolase",
      "Anti-Mi-2 Antibodies",
      "Anti-MDA5 Antibodies"
    ],
    "source_file": "Dermatomyositis.yaml",
    "page_url": "../pages/disorders/Dermatomyositis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Down_syndrome",
    "disease_id": "MONDO:0008608",
    "category": "Genetic",
    "parents": [
      "Chromosomal Disorder"
    ],
    "subtypes": [],
    "description": "A chromosomal disorder caused by trisomy 21, characterized by intellectual disability, distinctive facial features, hypotonia, and increased risk of congenital heart defects, hypothyroidism, and leukemia.",
    "pathophysiology": [
      "Extra Chromosome 21",
      "Interferon Hyperactivation",
      "Neurodevelopmental Alterations"
    ],
    "cell_types": [
      "microglial cell",
      "astrocyte"
    ],
    "cell_type_ids": [
      "CL:0000129",
      "CL:0000127"
    ],
    "biological_processes": [
      "type I interferon-mediated signaling pathway",
      "cell surface receptor signaling pathway via JAK-STAT"
    ],
    "phenotypes": [
      "Dysmorphic Facial Features",
      "Intellectual Disability",
      "Developmental Delay",
      "Hypotonia",
      "Congenital Heart Defects",
      "Hypothyroidism",
      "Leukemia Risk",
      "Sleep Apnea",
      "Autoimmunity",
      "Alzheimer Disease"
    ],
    "phenotype_categories": [
      "Craniofacial",
      "Neurologic",
      "Developmental",
      "Musculoskeletal",
      "Cardiac",
      "Endocrine",
      "Hematologic",
      "Respiratory",
      "Immunologic"
    ],
    "phenotype_ids": [
      "HP:0000582",
      "HP:0001249",
      "HP:0001263",
      "HP:0001252",
      "HP:0001627",
      "HP:0000821",
      "HP:0001909",
      "HP:0002870",
      "HP:0002960",
      "HP:0002511"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "Trisomy 21",
      "APP",
      "DYRK1A",
      "IFNAR1",
      "IFNAR2",
      "IFNGR2",
      "IL10RB",
      "OLIG2"
    ],
    "treatments": [
      "Early Intervention Programs",
      "Cardiac Surgery",
      "Hormone Replacement Therapy",
      "Educational Support"
    ],
    "environmental": [
      "Prenatal Screening"
    ],
    "biochemical": [
      "TSH (Thyroid-Stimulating Hormone)"
    ],
    "source_file": "Down_syndrome.yaml",
    "page_url": "../pages/disorders/Down_syndrome.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 3,
    "num_genes": 8,
    "num_treatments": 4
  },
  {
    "name": "Dravet_syndrome",
    "disease_id": "MONDO:0100135",
    "category": "Genetic",
    "parents": [
      "Epileptic Encephalopathy",
      "Neurologic Disorder"
    ],
    "subtypes": [],
    "description": "Dravet syndrome is a severe developmental and epileptic encephalopathy characterized by treatment-resistant seizures beginning in infancy, developmental regression, and cognitive impairment. It is primarily caused by de novo loss-of-function mutations in SCN1A, encoding the Nav1.1 voltage-gated sodium channel.",
    "pathophysiology": [
      "SCN1A Gene Mutation",
      "Neuronal Hyperexcitability",
      "Astrocyte Dysregulation"
    ],
    "cell_types": [
      "inhibitory interneuron",
      "astrocyte"
    ],
    "cell_type_ids": [
      "CL:0000498",
      "CL:0000127"
    ],
    "biological_processes": [
      "voltage-gated sodium channel activity",
      "neuronal action potential",
      "synaptic transmission, GABAergic"
    ],
    "phenotypes": [
      "Seizures",
      "Developmental Delay",
      "Intellectual Disability",
      "Hyperactivity",
      "Febrile Seizures",
      "Ataxia",
      "Autism",
      "Respiratory Failure",
      "Sudden Unexpected Death in Epilepsy"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Developmental",
      "Cognitive",
      "Behavioral",
      "Respiratory",
      "Mortality"
    ],
    "phenotype_ids": [
      "HP:0001250",
      "HP:0001263",
      "HP:0001249",
      "HP:0000752",
      "HP:0002373",
      "HP:0001251",
      "HP:0000717",
      "HP:0002878",
      "HP:0033258"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SCN1A",
      "SCN1B",
      "SCN9A",
      "GABRA1",
      "GABRG2",
      "STXBP1",
      "HCN1",
      "CHD2",
      "DEPDC5"
    ],
    "treatments": [
      "Antiepileptic Medications",
      "Ketogenic Diet",
      "Supportive Therapies",
      "Vagus Nerve Stimulation (VNS)",
      "Antisense Oligonucleotide Therapy (STK-001/Zorevunersen)",
      "AAV Gene Therapy (ETX101)",
      "Cannabidiol",
      "Fenfluramine",
      "Stiripentol"
    ],
    "environmental": [
      "Fever",
      "Excessive Heat and Overexertion"
    ],
    "biochemical": [],
    "source_file": "Dravet_syndrome.yaml",
    "page_url": "../pages/disorders/Dravet_syndrome.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 3,
    "num_genes": 9,
    "num_treatments": 9
  },
  {
    "name": "Duchenne Muscular Dystrophy",
    "disease_id": "MONDO:0010679",
    "category": "Genetic",
    "parents": [
      "Muscular Dystrophy",
      "Neuromuscular Disease"
    ],
    "subtypes": [
      "Classic Duchenne",
      "Intermediate DMD"
    ],
    "description": "Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.\n",
    "pathophysiology": [
      "Dystrophin Deficiency",
      "Progressive Muscle Degeneration"
    ],
    "cell_types": [
      "Skeletal Muscle Fiber"
    ],
    "cell_type_ids": [
      "CL:0000188"
    ],
    "biological_processes": [
      "Muscle Contraction",
      "Muscle Degeneration"
    ],
    "phenotypes": [
      "Progressive Muscle Weakness",
      "Gowers Sign",
      "Pseudohypertrophy of Calves",
      "Elevated Creatine Kinase",
      "Cardiomyopathy",
      "Respiratory Insufficiency"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Neurological",
      "Laboratory",
      "Cardiovascular",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0003323",
      "HP:0003391",
      "HP:0003707",
      "HP:0003236",
      "HP:0001644",
      "HP:0002093"
    ],
    "frequencies": [
      "VERY_FREQUENT"
    ],
    "genes": [
      "DMD"
    ],
    "treatments": [
      "Corticosteroids",
      "Cardiac Management",
      "Respiratory Support",
      "Exon Skipping Therapy",
      "Gene Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "Creatine Kinase",
      "Dystrophin"
    ],
    "source_file": "Duchenne_Muscular_Dystrophy.yaml",
    "page_url": "../pages/disorders/Duchenne_Muscular_Dystrophy.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Ebola Virus Disease (EVD)",
    "disease_id": "MONDO:0005737",
    "category": "",
    "parents": [],
    "subtypes": [
      "Zaire Ebolavirus",
      "Sudan Ebolavirus",
      "Bundibugyo Ebolavirus",
      "Ta\u00ef Forest Ebolavirus",
      "Reston Ebolavirus"
    ],
    "description": "Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.",
    "pathophysiology": [
      "Viral Entry via Endocytosis",
      "Immune Evasion and Viral Replication",
      "Endothelial Dysfunction and Vascular Leak",
      "Coagulopathy and Disseminated Intravascular Coagulation",
      "Multiorgan Involvement"
    ],
    "cell_types": [
      "monocyte",
      "macrophage",
      "dendritic cell",
      "endothelial cell"
    ],
    "cell_type_ids": [
      "CL:0000576",
      "CL:0000235",
      "CL:0000451",
      "CL:0000115"
    ],
    "biological_processes": [
      "symbiont entry into host cell",
      "blood coagulation"
    ],
    "phenotypes": [
      "Fever",
      "Hemorrhage",
      "Vomiting",
      "Diarrhea",
      "Maculopapular Rash",
      "Fatigue",
      "Myalgia",
      "Headache",
      "Abdominal Pain",
      "Thrombocytopenia",
      "Hepatitis",
      "Hypovolemic Shock",
      "Dehydration",
      "Electrolyte Imbalances",
      "Multiorgan Failure",
      "Elevated Liver Enzymes",
      "Impaired Liver Function",
      "Increased Risk of Bleeding"
    ],
    "phenotype_categories": [
      "Systemic",
      "Gastrointestinal",
      "Dermatologic",
      "Musculoskeletal",
      "Neurologic",
      "Hematologic",
      "Hepatic",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0001945",
      "HP:0001892",
      "HP:0002013",
      "HP:0002014",
      "HP:0012378",
      "HP:0003326",
      "HP:0002315",
      "HP:0002027",
      "HP:0001873",
      "HP:0012115",
      "HP:0031273",
      "HP:0001944",
      "HP:0003111",
      "HP:0002910",
      "HP:0001410"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "NPC1",
      "HAVCR1",
      "SLC39A9",
      "PIK3C3",
      "CTSB",
      "CTSL"
    ],
    "treatments": [
      "Supportive Care",
      "Experimental Therapies",
      "Vaccination"
    ],
    "environmental": [
      "Animal Reservoirs"
    ],
    "biochemical": [
      "Ebola Virus Antigen",
      "Ebola Virus RNA"
    ],
    "source_file": "Ebola_Virus_Disease_EVD.yaml",
    "page_url": "../pages/disorders/Ebola_Virus_Disease_EVD.html",
    "num_phenotypes": 18,
    "num_pathophysiology": 5,
    "num_genes": 6,
    "num_treatments": 3
  },
  {
    "name": "Ehlers-Danlos Syndrome",
    "disease_id": "MONDO:0020066",
    "category": "Genetic",
    "parents": [
      "Connective Tissue Disorder",
      "Inherited Disorder"
    ],
    "subtypes": [
      "Classical EDS (cEDS)",
      "Hypermobile EDS (hEDS)",
      "Vascular EDS (vEDS)",
      "Kyphoscoliotic EDS (kEDS)"
    ],
    "description": "Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly.",
    "pathophysiology": [
      "Collagen Abnormalities",
      "Connective Tissue Fragility",
      "Tissue Injury and Dysfunction",
      "Integrin-Mediated Mechanotransduction Dysregulation",
      "Autophagy and Proteostasis Dysfunction",
      "Complement-Mediated ECM Degradation"
    ],
    "cell_types": [
      "fibroblast",
      "vascular associated smooth muscle cell"
    ],
    "cell_type_ids": [
      "CL:0000057",
      "CL:0000359"
    ],
    "biological_processes": [
      "collagen fibril organization",
      "collagen biosynthetic process",
      "extracellular matrix organization",
      "integrin-mediated signaling pathway",
      "inflammatory response",
      "autophagy",
      "protein folding",
      "complement activation, classical pathway",
      "proteolysis"
    ],
    "phenotypes": [
      "Joint Hypermobility",
      "Skin Hyperextensibility",
      "Poor Wound Healing",
      "Arterial Dissection and Rupture",
      "Keratoconus",
      "Mitral Valve Prolapse",
      "Arterial Dissection and Rupture",
      "Gastroesophageal Reflux",
      "Keratoconus",
      "Recurrent Joint Dislocations",
      "Chronic Joint Pain",
      "Decreased Bone Density",
      "Hypotonia"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Dermatologic",
      "Cardiovascular",
      "Ophthalmologic",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0001382",
      "HP:0001058",
      "HP:0000563",
      "HP:0001634",
      "HP:0002020",
      "HP:0002829",
      "HP:0004349",
      "HP:0001252"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "COL1A1",
      "COL3A1",
      "COL5A1",
      "COL5A2",
      "ADAMTS2",
      "TNXB",
      "C1R",
      "C1S",
      "PLOD1"
    ],
    "treatments": [
      "Supportive Care",
      "Surgical Interventions",
      "Lifestyle Modifications",
      "Orthotic Interventions"
    ],
    "environmental": [
      "Physical Trauma",
      "Repetitive Motion"
    ],
    "biochemical": [
      "Collagen Type III"
    ],
    "source_file": "Ehlers-Danlos_Syndrome.yaml",
    "page_url": "../pages/disorders/Ehlers-Danlos_Syndrome.html",
    "num_phenotypes": 13,
    "num_pathophysiology": 6,
    "num_genes": 9,
    "num_treatments": 4
  },
  {
    "name": "Ehlers-Danlos Syndrome, COL5A1-related",
    "disease_id": "MONDO:0007522",
    "category": "Genetic",
    "parents": [
      "Ehlers-Danlos Syndrome"
    ],
    "subtypes": [],
    "description": "A hereditary connective tissue disorder caused by pathogenic variants in the COL5A1 gene, which encodes the alpha-1 chain of type V collagen. This form accounts for approximately 50% of classic Ehlers-Danlos syndrome cases and is characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, easy bruising, and generalized joint hypermobility. The disease follows autosomal dominant inheritance with variable expressivity.",
    "pathophysiology": [
      "Collagen Type V Abnormalities",
      "Connective Tissue Fragility",
      "Tissue Injury and Dysfunction"
    ],
    "cell_types": [
      "fibroblast",
      "dermal fibroblast",
      "keratinocyte"
    ],
    "cell_type_ids": [
      "CL:0000057",
      "CL:0002620",
      "CL:0000312"
    ],
    "biological_processes": [
      "collagen fibril organization",
      "collagen biosynthetic process",
      "extracellular matrix organization",
      "wound healing",
      "signal transduction",
      "integrin-mediated signaling pathway"
    ],
    "phenotypes": [
      "Joint Hypermobility",
      "Skin Hyperextensibility",
      "Atrophic Scarring",
      "Easy Bruising",
      "Mitral Valve Prolapse",
      "Gastroesophageal Reflux",
      "Molluscoid Pseudotumors",
      "Myopia",
      "Recurrent Joint Dislocations",
      "Chronic Joint Pain",
      "Delayed Wound Healing"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Dermatologic",
      "Cardiovascular",
      "Gastrointestinal",
      "Ocular"
    ],
    "phenotype_ids": [
      "HP:0001382",
      "HP:0001634",
      "HP:0002020",
      "HP:0000993",
      "HP:0000545",
      "HP:0001373",
      "HP:0002829",
      "HP:0001030"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "COL5A1"
    ],
    "treatments": [
      "Supportive Care",
      "Wound Care",
      "Cardiovascular Monitoring",
      "Gastrointestinal Management",
      "Lifestyle Modifications"
    ],
    "environmental": [
      "Physical Trauma"
    ],
    "biochemical": [
      "Collagen Type V"
    ],
    "source_file": "Ehlers-Danlos_Syndrome_COL5A1-related.yaml",
    "page_url": "../pages/disorders/Ehlers-Danlos_Syndrome,_COL5A1-related.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Endometriosis",
    "disease_id": "MONDO:0005133",
    "category": "Complex",
    "parents": [
      "Reproductive Disease"
    ],
    "subtypes": [],
    "description": "Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.\n",
    "pathophysiology": [
      "Ectopic Endometrial Tissue",
      "Retrograde Menstruation",
      "Chronic Inflammation",
      "Estrogen Dependence",
      "Immune Dysfunction",
      "Hypoxia and Angiogenesis",
      "Adhesion Formation"
    ],
    "cell_types": [
      "Endometrial Stromal Cell"
    ],
    "cell_type_ids": [
      "CL:0002255"
    ],
    "biological_processes": [
      "Cell Proliferation",
      "Inflammatory Response",
      "Estrogen Response",
      "Response to Hypoxia",
      "Angiogenesis"
    ],
    "phenotypes": [
      "Pelvic Pain",
      "Dysmenorrhea",
      "Dyspareunia",
      "Infertility",
      "Heavy Menstrual Bleeding",
      "Painful Bowel Movements",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Reproductive",
      "Gastrointestinal",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0030016",
      "HP:0100607",
      "HP:0000789",
      "HP:0000132",
      "HP:0002027",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "WNT4",
      "VEZT",
      "GREB1",
      "ID4"
    ],
    "treatments": [
      "NSAIDs",
      "Combined Oral Contraceptives",
      "Progestins",
      "GnRH Agonists",
      "GnRH Antagonists",
      "Aromatase Inhibitors",
      "Laparoscopic Surgery",
      "Hysterectomy"
    ],
    "environmental": [
      "Early Menarche",
      "Short Menstrual Cycles",
      "Nulliparity",
      "Low BMI"
    ],
    "biochemical": [
      "CA-125",
      "Estradiol"
    ],
    "source_file": "Endometriosis.yaml",
    "page_url": "../pages/disorders/Endometriosis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 7,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Epilepsy",
    "disease_id": "MONDO:0005027",
    "category": "Complex",
    "parents": [
      "Neurological Disease"
    ],
    "subtypes": [
      "Focal Epilepsy",
      "Generalized Epilepsy",
      "Temporal Lobe Epilepsy",
      "Juvenile Myoclonic Epilepsy",
      "Childhood Absence Epilepsy"
    ],
    "description": "Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.\n",
    "pathophysiology": [
      "Neuronal Hyperexcitability",
      "Abnormal Network Synchronization",
      "Epileptogenesis"
    ],
    "cell_types": [
      "Pyramidal Neuron",
      "GABAergic Interneuron",
      "Astrocyte",
      "Microglia"
    ],
    "cell_type_ids": [
      "CL:0000598",
      "CL:0000617",
      "CL:0000127",
      "CL:0000129"
    ],
    "biological_processes": [
      "Synaptic Transmission",
      "Neuronal Activity"
    ],
    "phenotypes": [
      "Seizures",
      "Postictal Confusion",
      "Aura",
      "Memory Impairment",
      "Depression",
      "Anxiety"
    ],
    "phenotype_categories": [
      "Neurological",
      "Cognitive",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0001250",
      "HP:0001289",
      "HP:0003474",
      "HP:0002354",
      "HP:0000716",
      "HP:0000739"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SCN1A",
      "SCN2A",
      "KCNQ2",
      "GABRA1",
      "CDKL5"
    ],
    "treatments": [
      "Antiseizure Medications",
      "Ketogenic Diet",
      "Vagus Nerve Stimulation",
      "Epilepsy Surgery",
      "Responsive Neurostimulation",
      "Deep Brain Stimulation"
    ],
    "environmental": [
      "Traumatic Brain Injury",
      "CNS Infections",
      "Stroke",
      "Brain Tumors",
      "Perinatal Injury"
    ],
    "biochemical": [],
    "source_file": "Epilepsy.yaml",
    "page_url": "../pages/disorders/Epilepsy.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 3,
    "num_genes": 5,
    "num_treatments": 6
  },
  {
    "name": "Essential Hypertension",
    "disease_id": "MONDO:0001134",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease"
    ],
    "subtypes": [],
    "description": "Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.\n",
    "pathophysiology": [
      "Vascular Resistance",
      "Renin-Angiotensin-Aldosterone System Dysregulation",
      "Sympathetic Nervous System Overactivity",
      "Immune and Inflammatory Activation",
      "Oxidative Stress"
    ],
    "cell_types": [
      "Vascular Smooth Muscle Cell",
      "Endothelial Cell",
      "Kidney Granular Cell",
      "T Cell",
      "Macrophage",
      "Dendritic Cell"
    ],
    "cell_type_ids": [
      "CL:0000359",
      "CL:0000115",
      "CL:0000648",
      "CL:0000084",
      "CL:0000235",
      "CL:0000451"
    ],
    "biological_processes": [
      "Blood Pressure Regulation",
      "RAAS Pathway",
      "Sympathetic Regulation",
      "Inflammatory Response",
      "ROS Metabolic Process"
    ],
    "phenotypes": [
      "Elevated Blood Pressure",
      "Headache",
      "Left Ventricular Hypertrophy",
      "Renal Damage"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Neurological",
      "Renal"
    ],
    "phenotype_ids": [
      "HP:0000822",
      "HP:0002315",
      "HP:0001712",
      "HP:0000083"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [
      "ACE",
      "AGT",
      "ADD1"
    ],
    "treatments": [
      "ACE Inhibitors",
      "Angiotensin Receptor Blockers",
      "Calcium Channel Blockers",
      "Thiazide Diuretics",
      "Beta Blockers",
      "Lifestyle Modification"
    ],
    "environmental": [
      "High Sodium Diet",
      "Obesity",
      "Chronic Stress",
      "Alcohol Consumption"
    ],
    "biochemical": [],
    "source_file": "Essential_Hypertension.yaml",
    "page_url": "../pages/disorders/Essential_Hypertension.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 5,
    "num_genes": 3,
    "num_treatments": 6
  },
  {
    "name": "Fabry disease",
    "disease_id": "MONDO:0010526",
    "category": "Mendelian",
    "parents": [
      "Lysosomal storage diseases",
      "X-linked genetic disorders"
    ],
    "subtypes": [],
    "description": "Fabry disease is an X-linked lysosomal storage disorder caused by pathogenic variants in GLA that reduce or abolish \u03b1-galactosidase A activity, leading to lysosomal accumulation of glycosphingolipids, principally globotriaosylceramide (Gb3) and its deacylated derivative globotriaosylsphingosine (lyso-Gb3). Substrate accumulation initiates a network of cellular stress responses including endoplasmic reticulum stress, autophagy impairment, mitochondrial dysfunction, and activation of innate immune pathways, leading to progressive organ damage in kidney, heart, vasculature, and nervous system.\n",
    "pathophysiology": [
      "Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation",
      "Endoplasmic reticulum stress and unfolded protein response",
      "Mitochondrial dysfunction and oxidative stress",
      "Autophagy impairment",
      "Innate immune activation and inflammation",
      "Endothelial dysfunction and vascular remodeling",
      "Fibrosis and extracellular matrix remodeling"
    ],
    "cell_types": [
      "endothelial cell"
    ],
    "cell_type_ids": [
      "CL:0000115"
    ],
    "biological_processes": [
      "glycosphingolipid metabolic process",
      "lysosomal catabolic process",
      "response to unfolded protein",
      "NF-kappaB signaling pathway",
      "reactive oxygen species metabolic process",
      "regulation of mitochondrial membrane potential",
      "autophagy",
      "complement activation",
      "inflammatory response",
      "leukocyte adhesion to endothelial cells",
      "extracellular matrix organization",
      "transforming growth factor beta signaling pathway"
    ],
    "phenotypes": [
      "Acrodystrophic neuropathic pain",
      "Angiokeratomas",
      "Proteinuria",
      "Chronic kidney disease",
      "Left ventricular hypertrophy",
      "Cardiac arrhythmia",
      "Stroke"
    ],
    "phenotype_categories": [
      "Neurological",
      "Cutaneous",
      "Renal",
      "Cardiac"
    ],
    "phenotype_ids": [
      "HP:0012531",
      "HP:0001014",
      "HP:0000093",
      "HP:0012622",
      "HP:0001638",
      "HP:0011675",
      "HP:0001297"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "GLA gene mutations"
    ],
    "treatments": [
      "Enzyme replacement therapy",
      "Pharmacological chaperone therapy",
      "Gene therapy",
      "Supportive care"
    ],
    "environmental": [],
    "biochemical": [
      "Lyso-Gb3"
    ],
    "source_file": "Fabry_Disease.yaml",
    "page_url": "../pages/disorders/Fabry_disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 7,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Familial Mediterranean Fever",
    "disease_id": "MONDO:0018088",
    "category": "Genetic",
    "parents": [
      "Autoinflammatory Disease",
      "Inherited Disorder"
    ],
    "subtypes": [
      "Type 1",
      "Type 2"
    ],
    "description": "Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation.",
    "pathophysiology": [
      "MEFV Gene Mutation",
      "RhoA-PKN Regulatory Pathway Dysregulation",
      "Autoinflammatory Pathway Activation",
      "Gasdermin D-Mediated Pyroptosis"
    ],
    "cell_types": [
      "monocyte",
      "neutrophil",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000576",
      "CL:0000775",
      "CL:0000235"
    ],
    "biological_processes": [
      "interleukin-1 beta production",
      "pyroptotic inflammatory response"
    ],
    "phenotypes": [
      "Recurrent Fever",
      "Arthritis",
      "Peritonitis",
      "Pleuritis",
      "Pericarditis",
      "Amyloidosis",
      "Erysipelas-Like Erythema",
      "Myalgia"
    ],
    "phenotype_categories": [
      "Systemic",
      "Musculoskeletal",
      "Gastrointestinal",
      "Thoracic",
      "Cardiovascular",
      "Renal",
      "Integumentary"
    ],
    "phenotype_ids": [
      "HP:0001954",
      "HP:0001369",
      "HP:0002586",
      "HP:0002102",
      "HP:0001701",
      "HP:0011034",
      "HP:0003326"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "MEFV",
      "PKN1",
      "PKN2",
      "RHOA"
    ],
    "treatments": [
      "Colchicine",
      "Anti-IL-1 Therapy",
      "NSAIDs",
      "Lifestyle Modifications"
    ],
    "environmental": [
      "Physical Stress",
      "Emotional Stress"
    ],
    "biochemical": [],
    "source_file": "Familial_Mediterranean_Fever.yaml",
    "page_url": "../pages/disorders/Familial_Mediterranean_Fever.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 4
  },
  {
    "name": "Fanconi_Anemia",
    "disease_id": "MONDO:0019391",
    "category": "Genetic",
    "parents": [
      "Bone Marrow Failure",
      "Congenital Disorder"
    ],
    "subtypes": [],
    "description": "Fanconi anemia is a rare inherited bone marrow failure syndrome characterized by genomic instability, congenital abnormalities, progressive bone marrow failure, and increased susceptibility to malignancies. It results from biallelic mutations in genes encoding components of the Fanconi anemia DNA repair pathway.",
    "pathophysiology": [
      "DNA Repair Deficiency",
      "Bone Marrow Failure",
      "Genomic Instability",
      "Hematopoietic Stem Cell Attrition",
      "Translesion Synthesis Defect",
      "Homologous Recombination Impairment",
      "Aldehyde-Induced Genotoxicity"
    ],
    "cell_types": [
      "hematopoietic stem cell"
    ],
    "cell_type_ids": [
      "CL:0000037"
    ],
    "biological_processes": [
      "response to aldehyde",
      "cellular response to oxidative stress",
      "translesion synthesis",
      "homologous recombination"
    ],
    "phenotypes": [
      "Pancytopenia",
      "Increased Risk of Leukemia",
      "Aplastic Anemia",
      "Short Stature",
      "Skeletal Anomalies",
      "Caf\u00e9-au-Lait Spots",
      "Squamous Cell Carcinoma",
      "Structural Anomalies",
      "Genitourinary Malformations",
      "Microcephaly",
      "Radial Ray Defects"
    ],
    "phenotype_categories": [
      "Hematologic",
      "Developmental",
      "Skeletal",
      "Dermatologic",
      "Oncologic",
      "Gastrointestinal",
      "Reproductive",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0001876",
      "HP:0004808",
      "HP:0001903",
      "HP:0004322",
      "HP:0005775",
      "HP:0000957",
      "HP:0002860",
      "HP:0000119",
      "HP:0000252",
      "HP:0002984"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "FANCA",
      "FANCB",
      "FANCC",
      "FANCE",
      "FANCF",
      "FANCG",
      "FANCL",
      "FANCM",
      "UBE2T",
      "FANCD2",
      "FANCI",
      "SLX4",
      "BRCA2",
      "PALB2",
      "BRCA1",
      "RAD51C",
      "XRCC2",
      "REV7",
      "ALDH2",
      "ADH5",
      "KMT2D"
    ],
    "treatments": [
      "Hematopoietic Stem Cell Transplantation (HSCT)",
      "Androgen Therapy",
      "Growth Hormone Therapy",
      "Supportive Care",
      "Cancer Surveillance",
      "Genetic Counseling"
    ],
    "environmental": [
      "Protections from DNA-damaging Agents"
    ],
    "biochemical": [
      "Chromosomal Breakage Test",
      "Crosslinking Sensitivity"
    ],
    "source_file": "Fanconi_Anemia.yaml",
    "page_url": "../pages/disorders/Fanconi_Anemia.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 7,
    "num_genes": 21,
    "num_treatments": 6
  },
  {
    "name": "Fibrodysplasia Ossificans Progressiva",
    "disease_id": "MONDO:0007606",
    "category": "Genetic",
    "parents": [
      "Musculoskeletal Disease",
      "Genetic Disease"
    ],
    "subtypes": [],
    "description": "A rare, severely disabling genetic disorder characterized by progressive heterotopic ossification of skeletal muscles, fascia, tendons, and ligaments, with congenital malformation of the great toes. The condition is caused by gain-of-function mutations in the ACVR1 gene encoding a BMP type I receptor, leading to aberrant bone formation in soft tissues.",
    "pathophysiology": [
      "Constitutive BMP Signaling Activation",
      "Impaired FKBP1A Regulatory Binding",
      "Activin A Neomorphic Signaling",
      "Heterotopic Ossification",
      "Inflammatory Triggering of Flare-ups"
    ],
    "cell_types": [
      "Osteoblast",
      "Chondrocyte",
      "Macrophage",
      "Mast cell"
    ],
    "cell_type_ids": [
      "CL:0000062",
      "CL:0000138",
      "CL:0000235",
      "CL:0000097"
    ],
    "biological_processes": [
      "BMP signaling pathway",
      "ossification",
      "Endochondral ossification",
      "Cartilage development",
      "Inflammatory response"
    ],
    "phenotypes": [
      "Congenital Great Toe Malformation",
      "Heterotopic Ossification",
      "Progressive Joint Immobility",
      "Joint Stiffness",
      "Scoliosis",
      "Restrictive Ventilatory Defect"
    ],
    "phenotype_categories": [
      "Skeletal",
      "Musculoskeletal",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001844",
      "HP:0011987",
      "HP:0001376",
      "HP:0001387",
      "HP:0002650",
      "HP:0002091"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "ACVR1"
    ],
    "treatments": [
      "Palovarotene",
      "Corticosteroids",
      "Avoidance of Trauma",
      "Genetic Counseling",
      "Garetosmab"
    ],
    "environmental": [
      "Trauma",
      "Viral Illness"
    ],
    "biochemical": [],
    "source_file": "Fibrodysplasia_Ossificans_Progressiva.yaml",
    "page_url": "../pages/disorders/Fibrodysplasia_Ossificans_Progressiva.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 5,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Fibromyalgia",
    "disease_id": "MONDO:0005546",
    "category": "Complex",
    "parents": [
      "Musculoskeletal Disease",
      "Neurological Disease"
    ],
    "subtypes": [],
    "description": "Augmented pain processing in the central nervous system leads to amplified pain perception. Increased excitatory neurotransmitters (glutamate, substance P) and decreased inhibitory modulation.\n",
    "pathophysiology": [
      "Central Sensitization",
      "Descending Pain Modulation Dysfunction",
      "Neuroinflammation",
      "HPA Axis Dysregulation",
      "Small Fiber Pathology",
      "Genetic Susceptibility"
    ],
    "cell_types": [
      "Microglia",
      "Peripheral Sensory Neurons"
    ],
    "cell_type_ids": [
      "CL:0000129",
      "CL:0000101"
    ],
    "biological_processes": [
      "Pain Processing",
      "Neurotransmission",
      "Stress Response",
      "Pain Perception"
    ],
    "phenotypes": [
      "Chronic Widespread Pain",
      "Fatigue",
      "Sleep Disturbance",
      "Cognitive Dysfunction",
      "Headaches",
      "Depression",
      "Anxiety",
      "Hypersensitivity to Touch",
      "Joint Stiffness",
      "Autonomic Dysfunction"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Systemic",
      "Neurological",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0012532",
      "HP:0012378",
      "HP:0002360",
      "HP:0100543",
      "HP:0002315",
      "HP:0000716",
      "HP:0000739",
      "HP:0007328",
      "HP:0001387",
      "HP:0012332"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "COMT",
      "SLC6A4",
      "HTR2A",
      "TAAR1",
      "RGS4",
      "CNR1",
      "GRIA4",
      "TRPV2",
      "TRPV3"
    ],
    "treatments": [
      "Duloxetine",
      "Milnacipran",
      "Pregabalin",
      "Gabapentin",
      "Amitriptyline",
      "Aerobic Exercise",
      "Cognitive Behavioral Therapy",
      "Sleep Hygiene Education",
      "Mindfulness-Based Stress Reduction",
      "Aquatic Therapy"
    ],
    "environmental": [
      "Physical Trauma",
      "Psychological Stress",
      "Infections",
      "Sleep Disorders"
    ],
    "biochemical": [
      "Substance P",
      "Glutamate",
      "Serotonin"
    ],
    "source_file": "Fibromyalgia.yaml",
    "page_url": "../pages/disorders/Fibromyalgia.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 6,
    "num_genes": 9,
    "num_treatments": 10
  },
  {
    "name": "Fragile X Syndrome",
    "disease_id": "MONDO:0010383",
    "category": "Genetic",
    "parents": [
      "Intellectual Disability Syndrome",
      "Trinucleotide Repeat Disorder"
    ],
    "subtypes": [
      "Full Mutation",
      "Premutation Carrier"
    ],
    "description": "Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.\n",
    "pathophysiology": [
      "FMRP Deficiency",
      "Abnormal Synaptic Development"
    ],
    "cell_types": [
      "Neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [
      "Synaptic Plasticity",
      "Synapse Organization"
    ],
    "phenotypes": [
      "Intellectual Disability",
      "Autism Spectrum Features",
      "Macroorchidism",
      "Elongated Face",
      "Large Ears",
      "Hyperactivity",
      "Joint Hypermobility"
    ],
    "phenotype_categories": [
      "Neurological",
      "Behavioral",
      "Genitourinary",
      "Craniofacial",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0001249",
      "HP:0000729",
      "HP:0000053",
      "HP:0000276",
      "HP:0000400",
      "HP:0000752",
      "HP:0001382"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "FMR1"
    ],
    "treatments": [
      "Behavioral Therapy",
      "Speech Therapy",
      "Stimulant Medications",
      "SSRIs",
      "Genetic Counseling"
    ],
    "environmental": [],
    "biochemical": [
      "FMRP"
    ],
    "source_file": "Fragile_X_Syndrome.yaml",
    "page_url": "../pages/disorders/Fragile_X_Syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Frontotemporal Dementia",
    "disease_id": "MONDO:0017276",
    "category": "Complex",
    "parents": [
      "Dementia",
      "Neurodegenerative Disease"
    ],
    "subtypes": [],
    "description": "Frontotemporal Dementia (FTD) is a group of neurodegenerative disorders characterized by progressive deterioration of the frontal and temporal lobes of the brain. It presents with prominent changes in personality, behavior, and/or language, typically with onset before age 65. FTD is associated with abnormal accumulation of tau or TDP-43 proteins.\n",
    "pathophysiology": [
      "TDP-43 Proteinopathy",
      "Tau Proteinopathy",
      "Frontal and Temporal Lobe Atrophy",
      "Neuronal Death"
    ],
    "cell_types": [
      "neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Behavioral Changes",
      "Aphasia",
      "Personality Changes",
      "Dementia"
    ],
    "phenotype_categories": [
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0002381",
      "HP:0000751",
      "HP:0000726"
    ],
    "frequencies": [
      "VERY_FREQUENT"
    ],
    "genes": [
      "MAPT",
      "GRN",
      "C9orf72"
    ],
    "treatments": [
      "Symptomatic Management",
      "Speech and Language Therapy"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Frontotemporal_Dementia.yaml",
    "page_url": "../pages/disorders/Frontotemporal_Dementia.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 2
  },
  {
    "name": "Gastroesophageal Reflux Disease",
    "disease_id": "MONDO:0007186",
    "category": "Complex",
    "parents": [
      "Gastrointestinal Disease"
    ],
    "subtypes": [],
    "description": "Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.\n",
    "pathophysiology": [
      "Lower Esophageal Sphincter Dysfunction",
      "Esophageal Mucosal Injury",
      "Impaired Esophageal Clearance",
      "Visceral Hypersensitivity",
      "Gut Microbiota Dysbiosis",
      "Barrett's Esophagus Metaplastic Adaptation"
    ],
    "cell_types": [
      "Esophageal Epithelial Cell"
    ],
    "cell_type_ids": [
      "CL:0002252"
    ],
    "biological_processes": [
      "Smooth Muscle Contraction",
      "Digestion"
    ],
    "phenotypes": [
      "Heartburn",
      "Regurgitation",
      "Dysphagia",
      "Chronic Cough",
      "Hoarse Voice"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Respiratory",
      "ENT"
    ],
    "phenotype_ids": [
      "HP:0410281",
      "HP:0002020",
      "HP:0002015",
      "HP:0012735",
      "HP:0001609"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "FOXF1",
      "MHC region"
    ],
    "treatments": [
      "Proton Pump Inhibitors",
      "H2 Receptor Antagonists",
      "Antacids",
      "Lifestyle Modifications",
      "Fundoplication",
      "LINX Device"
    ],
    "environmental": [
      "Obesity",
      "Hiatal Hernia",
      "Smoking",
      "Alcohol",
      "Dietary Factors",
      "Medications"
    ],
    "biochemical": [
      "Esophageal pH"
    ],
    "source_file": "Gastroesophageal_Reflux_Disease.yaml",
    "page_url": "../pages/disorders/Gastroesophageal_Reflux_Disease.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 6,
    "num_genes": 2,
    "num_treatments": 6
  },
  {
    "name": "Gaucher Disease",
    "disease_id": "MONDO:0018150",
    "category": "Genetic",
    "parents": [
      "Lysosomal Storage Disorder",
      "Sphingolipidosis"
    ],
    "subtypes": [
      "Type 1 (Non-neuronopathic)",
      "Type 2 (Acute neuronopathic)",
      "Type 3 (Chronic neuronopathic)"
    ],
    "description": "Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.\n",
    "pathophysiology": [
      "Glucocerebrosidase Deficiency",
      "Gaucher Cell Formation"
    ],
    "cell_types": [
      "Macrophage"
    ],
    "cell_type_ids": [
      "CL:0000235"
    ],
    "biological_processes": [
      "Sphingolipid Catabolism",
      "Macrophage Activation"
    ],
    "phenotypes": [
      "Hepatomegaly",
      "Splenomegaly",
      "Thrombocytopenia",
      "Anemia",
      "Bone Pain",
      "Pathologic Fractures",
      "Erlenmeyer Flask Deformity"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Hematologic",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0002240",
      "HP:0001744",
      "HP:0001873",
      "HP:0001903",
      "HP:0002653",
      "HP:0002756",
      "HP:0004975"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "GBA"
    ],
    "treatments": [
      "Enzyme Replacement Therapy",
      "Substrate Reduction Therapy",
      "Supportive Care",
      "Genetic Counseling"
    ],
    "environmental": [],
    "biochemical": [
      "Beta-glucocerebrosidase Activity",
      "Chitotriosidase",
      "Glucosylsphingosine (Lyso-Gb1)"
    ],
    "source_file": "Gaucher_Disease.yaml",
    "page_url": "../pages/disorders/Gaucher_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Generalized Anxiety Disorder",
    "disease_id": "MONDO:0001942",
    "category": "Complex",
    "parents": [
      "Psychiatric Disease"
    ],
    "subtypes": [],
    "description": "Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.\n",
    "pathophysiology": [
      "Amygdala Hyperactivity",
      "GABA System Dysfunction",
      "Serotonin Dysregulation",
      "HPA Axis Dysregulation",
      "Noradrenergic Hyperactivity",
      "Oxidative Stress",
      "Epigenetic Alterations"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Fear Response",
      "GABAergic Transmission",
      "Serotonin Signaling",
      "Stress Response"
    ],
    "phenotypes": [
      "Excessive Worry",
      "Restlessness",
      "Fatigue",
      "Difficulty Concentrating",
      "Muscle Tension",
      "Sleep Disturbance",
      "Irritability"
    ],
    "phenotype_categories": [
      "Psychiatric",
      "Systemic",
      "Neurological",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0000739",
      "HP:0000711",
      "HP:0012378",
      "HP:0007018",
      "HP:0003552",
      "HP:0002360",
      "HP:0000737"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "SLC6A4",
      "COMT",
      "CRHR1",
      "NPY"
    ],
    "treatments": [
      "SSRIs",
      "SNRIs",
      "Buspirone",
      "Benzodiazepines",
      "Pregabalin",
      "Cognitive Behavioral Therapy",
      "Relaxation Training",
      "Mindfulness-Based Therapy"
    ],
    "environmental": [
      "Childhood Adversity",
      "Chronic Stress",
      "Trauma",
      "Caffeine"
    ],
    "biochemical": [
      "Cortisol",
      "GABA"
    ],
    "source_file": "Generalized_Anxiety_Disorder.yaml",
    "page_url": "../pages/disorders/Generalized_Anxiety_Disorder.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 7,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Giant Cell Arteritis",
    "disease_id": "MONDO:0008538",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Vasculitis"
    ],
    "subtypes": [],
    "description": "A systemic granulomatous vasculitis affecting large and medium-sized arteries, predominantly the extracranial branches of the carotid artery. Most common primary systemic vasculitis in adults over 50. Frequently associated with polymyalgia rheumatica.",
    "pathophysiology": [
      "Dendritic Cell Activation in Vessel Wall",
      "Th1 and Th17 T Cell Infiltration",
      "Giant Cell Formation and Intimal Hyperplasia"
    ],
    "cell_types": [
      "Dendritic Cell",
      "CD4+ T Cell",
      "Macrophage",
      "Smooth Muscle Cell"
    ],
    "cell_type_ids": [
      "CL:0000451",
      "CL:0000624",
      "CL:0000235",
      "CL:0000192"
    ],
    "biological_processes": [
      "Immune Response",
      "Inflammatory Response",
      "Cell Proliferation"
    ],
    "phenotypes": [
      "Headache",
      "Visual Loss",
      "Jaw Claudication",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Neurological",
      "Ophthalmological",
      "Musculoskeletal",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0002315",
      "HP:0000505",
      "HP:0003326",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*04"
    ],
    "treatments": [
      "High-Dose Corticosteroids",
      "Tocilizumab",
      "Methotrexate",
      "Low-Dose Aspirin",
      "JAK Inhibitors"
    ],
    "environmental": [],
    "biochemical": [
      "ESR",
      "CRP",
      "Interleukin-6"
    ],
    "source_file": "Giant_Cell_Arteritis.yaml",
    "page_url": "../pages/disorders/Giant_Cell_Arteritis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Glaucoma",
    "disease_id": "MONDO:0005041",
    "category": "Complex",
    "parents": [
      "Ophthalmological Disease"
    ],
    "subtypes": [
      "Primary Open-Angle Glaucoma",
      "Angle-Closure Glaucoma",
      "Normal-Tension Glaucoma",
      "Secondary Glaucoma"
    ],
    "description": "Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.\n",
    "pathophysiology": [
      "Elevated Intraocular Pressure",
      "Retinal Ganglion Cell Death",
      "Optic Nerve Degeneration",
      "Trabecular Meshwork Dysfunction"
    ],
    "cell_types": [
      "Retinal Ganglion Cell",
      "Trabecular Meshwork Cell"
    ],
    "cell_type_ids": [
      "CL:0000740",
      "CL:0002367"
    ],
    "biological_processes": [
      "Fluid Homeostasis",
      "Apoptosis"
    ],
    "phenotypes": [
      "Visual Field Loss",
      "Optic Disc Cupping",
      "Elevated Intraocular Pressure",
      "Halos Around Lights",
      "Eye Pain"
    ],
    "phenotype_categories": [
      "Ophthalmological"
    ],
    "phenotype_ids": [
      "HP:0001123",
      "HP:0000648",
      "HP:0012632",
      "HP:0000505",
      "HP:0200026"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "MYOC",
      "OPTN",
      "WDR36",
      "CAV1/CAV2"
    ],
    "treatments": [
      "Prostaglandin Analogs",
      "Beta-Blockers",
      "Alpha Agonists",
      "Carbonic Anhydrase Inhibitors",
      "Rho Kinase Inhibitors",
      "Laser Trabeculoplasty",
      "Trabeculectomy",
      "MIGS"
    ],
    "environmental": [
      "Age",
      "Family History",
      "African Ancestry",
      "Myopia",
      "Corticosteroid Use"
    ],
    "biochemical": [
      "Intraocular Pressure"
    ],
    "source_file": "Glaucoma.yaml",
    "page_url": "../pages/disorders/Glaucoma.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency",
    "disease_id": "MONDO:0005775",
    "category": "Genetic",
    "parents": [
      "Inborn Error of Metabolism",
      "Hemolytic Anemia"
    ],
    "subtypes": [],
    "description": "Mutations in the G6PD gene lead to reduced or absent enzyme activity.",
    "pathophysiology": [
      "Decreased G6PD Enzyme Activity",
      "Impaired Redox Homeostasis",
      "Oxidative Stress",
      "Acute Hemolytic Anemia"
    ],
    "cell_types": [
      "erythrocyte"
    ],
    "cell_type_ids": [
      "CL:0000232"
    ],
    "biological_processes": [
      "pentose-phosphate shunt",
      "NADPH regeneration",
      "glutathione metabolic process",
      "response to oxidative stress",
      "hemolysis in other organism"
    ],
    "phenotypes": [
      "Hemolytic Anemia",
      "Dark Urine",
      "Neonatal Jaundice",
      "Favism",
      "Leukocyte Dysfunction",
      "Pallor",
      "Fatigue",
      "Jaundice",
      "Shortness of Breath"
    ],
    "phenotype_categories": [
      "Hematologic",
      "Genitourinary",
      "Systemic",
      "Dermatologic",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001878",
      "HP:0040319",
      "HP:0003265",
      "HP:0000980",
      "HP:0012378",
      "HP:0000952",
      "HP:0002094"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "G6PD"
    ],
    "treatments": [
      "Avoidance of Oxidative Stressors",
      "Supportive Care During Acute Hemolysis",
      "Neonatal Screening and Monitoring"
    ],
    "environmental": [
      "Oxidative Stressors"
    ],
    "biochemical": [
      "G6PD Enzyme Activity",
      "Unconjugated Bilirubin",
      "Lactate Dehydrogenase (LDH)",
      "Heinz Bodies",
      "Glutathione/GSSG Ratio"
    ],
    "source_file": "Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml",
    "page_url": "../pages/disorders/Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 3
  },
  {
    "name": "Gout",
    "disease_id": "MONDO:0005393",
    "category": "Complex",
    "parents": [
      "Metabolic Disease",
      "Musculoskeletal Disease"
    ],
    "subtypes": [],
    "description": "Elevated serum uric acid from increased purine metabolism or decreased renal excretion leads to supersaturation and crystal formation. Urate is the end product of purine catabolism in humans.\n",
    "pathophysiology": [
      "Hyperuricemia",
      "Crystal Deposition",
      "Inflammasome Activation",
      "Neutrophil Recruitment",
      "Complement Activation",
      "Neutrophil Extracellular Trap Formation"
    ],
    "cell_types": [
      "Macrophage",
      "Neutrophil"
    ],
    "cell_type_ids": [
      "CL:0000235",
      "CL:0000775"
    ],
    "biological_processes": [
      "Purine Metabolism",
      "Inflammasome Activation"
    ],
    "phenotypes": [
      "Acute Arthritis",
      "Joint Swelling",
      "Joint Pain",
      "Nephrolithiasis"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Renal"
    ],
    "phenotype_ids": [
      "HP:0001369",
      "HP:0001386",
      "HP:0002829",
      "HP:0000787"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SLC2A9",
      "ABCG2",
      "SLC22A12"
    ],
    "treatments": [
      "NSAIDs",
      "Colchicine",
      "Corticosteroids",
      "Allopurinol",
      "Febuxostat",
      "Probenecid",
      "Pegloticase"
    ],
    "environmental": [
      "Purine-Rich Diet",
      "Alcohol",
      "Fructose",
      "Dehydration",
      "Diuretics"
    ],
    "biochemical": [
      "Serum Uric Acid",
      "CRP",
      "Synovial Fluid Crystals"
    ],
    "source_file": "Gout.yaml",
    "page_url": "../pages/disorders/Gout.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 6,
    "num_genes": 3,
    "num_treatments": 7
  },
  {
    "name": "Grange syndrome",
    "disease_id": "MONDO:0011243",
    "category": "Genetic",
    "parents": [
      "Vascular disease"
    ],
    "subtypes": [],
    "description": "A rare autosomal recessive disorder caused by biallelic loss-of-function mutations in YY1AP1, characterized by early-onset panvascular disease with stenosis or occlusion of multiple arterial beds (cerebral, renal, abdominal, coronary), intellectual disability or developmental delay, and distinctive craniofacial and acral features (hypertelorism, micrognathia, brachysyndactyly, syndactyly). Hypertension due to renal artery involvement is common, and cardiac defects, bone fragility, and osteopenia occur with variable penetrance. YY1AP1 deficiency impairs vascular smooth muscle cell differentiation through disruption of the INO80 chromatin-remodeling complex.",
    "pathophysiology": [
      "YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption",
      "Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "chromatin remodeling",
      "transcriptional regulation",
      "smooth muscle cell differentiation",
      "cell cycle arrest"
    ],
    "phenotypes": [
      "Intellectual disability",
      "Micrognathia",
      "Hypertelorism",
      "Brachydactyly",
      "Syndactyly",
      "Hypertension"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Craniofacial",
      "Limb",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0001249",
      "HP:0000347",
      "HP:0000316",
      "HP:0001156",
      "HP:0001159",
      "HP:0000822"
    ],
    "frequencies": [
      "OBLIGATE",
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "YY1AP1"
    ],
    "treatments": [
      "Antithrombotic Therapy",
      "Cardiovascular Management",
      "Neurosurgical Intervention",
      "Vascular Intervention",
      "Surgical Correction of Acral Features"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Grange_syndrome.yaml",
    "page_url": "../pages/disorders/Grange_syndrome.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Granulomatosis with Polyangiitis",
    "disease_id": "MONDO:0012105",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Vasculitis"
    ],
    "subtypes": [],
    "description": "An ANCA-associated systemic vasculitis characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract and necrotizing glomerulonephritis. Strongly associated with anti-PR3 (c-ANCA) antibodies. Formerly known as Wegener's granulomatosis.",
    "pathophysiology": [
      "ANCA-Mediated Neutrophil Activation",
      "Granuloma Formation",
      "Complement Alternative Pathway Activation"
    ],
    "cell_types": [
      "Neutrophil",
      "Macrophage"
    ],
    "cell_type_ids": [
      "CL:0000775",
      "CL:0000235"
    ],
    "biological_processes": [
      "Neutrophil Activation",
      "Inflammatory Response",
      "Complement Activation"
    ],
    "phenotypes": [
      "Sinusitis",
      "Pulmonary Nodules",
      "Glomerulonephritis",
      "Saddle Nose Deformity"
    ],
    "phenotype_categories": [
      "ENT",
      "Respiratory",
      "Renal"
    ],
    "phenotype_ids": [
      "HP:0000246",
      "HP:0002113",
      "HP:0000123",
      "HP:0000455"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DP",
      "SERPINA1"
    ],
    "treatments": [
      "Corticosteroids",
      "Rituximab",
      "Cyclophosphamide",
      "Avacopan"
    ],
    "environmental": [],
    "biochemical": [
      "PR3-ANCA (c-ANCA)",
      "MPO-ANCA (p-ANCA)",
      "ESR",
      "CRP"
    ],
    "source_file": "Granulomatosis_with_Polyangiitis.yaml",
    "page_url": "../pages/disorders/Granulomatosis_with_Polyangiitis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 2,
    "num_treatments": 4
  },
  {
    "name": "Graves' Disease",
    "disease_id": "MONDO:0005364",
    "category": "Endocrine Disorder",
    "parents": [
      "Autoimmune Disease",
      "Thyroid Disorder"
    ],
    "subtypes": [],
    "description": "The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.",
    "pathophysiology": [
      "Autoantibody Production",
      "Thyroid Overactivity",
      "Immune System Dysregulation",
      "TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts",
      "Germinal Center Autoantibody Production"
    ],
    "cell_types": [
      "B cell",
      "T cell",
      "T follicular helper cell",
      "CD4-positive, alpha-beta T cell",
      "regulatory T cell",
      "fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000236",
      "CL:0000084",
      "CL:0002038",
      "CL:0000624",
      "CL:0000815",
      "CL:0000057"
    ],
    "biological_processes": [
      "cAMP-mediated signaling",
      "thyroid hormone biosynthetic process",
      "B cell activation",
      "MAPK cascade",
      "phosphatidylinositol 3-kinase signaling",
      "adipocyte differentiation",
      "hyaluronan biosynthetic process",
      "extracellular matrix organization",
      "adaptive immune response",
      "germinal center formation"
    ],
    "phenotypes": [
      "Hyperthyroidism",
      "Exophthalmos (Proptosis)",
      "Goiter",
      "Tachycardia",
      "Tremor",
      "Anxiety",
      "Irritability",
      "Pretibial Myxedema",
      "Weight Loss",
      "Increased Appetite",
      "Heat Intolerance",
      "Sweating",
      "Diplopia",
      "Eyelid retraction",
      "Thyroid acropachy",
      "Atrial fibrillation"
    ],
    "phenotype_categories": [
      "Endocrine",
      "Ocular",
      "Cardiovascular",
      "Musculoskeletal",
      "Psychiatric",
      "Dermatologic",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0000836",
      "HP:0000853",
      "HP:0001649",
      "HP:0001337",
      "HP:0000739",
      "HP:0000737",
      "HP:0200028",
      "HP:0001824",
      "HP:0002591",
      "HP:0002046",
      "HP:0000975",
      "HP:0000651",
      "HP:0005110"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL",
      "VERY_RARE"
    ],
    "genes": [
      "HLA-DRB1",
      "CTLA4",
      "PTPN22",
      "CD40",
      "FCRL3",
      "TSHR"
    ],
    "treatments": [
      "Antithyroid Medications",
      "Radioactive Iodine Therapy",
      "Thyroidectomy",
      "Beta Blockers",
      "Corticosteroids"
    ],
    "environmental": [
      "Stress",
      "Smoking"
    ],
    "biochemical": [
      "Free Thyroxine (T4)",
      "Free Triiodothyronine (T3)",
      "Thyroid-Stimulating Hormone (TSH)",
      "Thyroid-Stimulating Immunoglobulins (TSI)"
    ],
    "source_file": "Graves_Disease.yaml",
    "page_url": "../pages/disorders/Graves'_Disease.html",
    "num_phenotypes": 16,
    "num_pathophysiology": 5,
    "num_genes": 6,
    "num_treatments": 5
  },
  {
    "name": "Guillain-Barre Syndrome",
    "disease_id": "MONDO:0016218",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Peripheral Neuropathy"
    ],
    "subtypes": [],
    "description": "An acute immune-mediated polyradiculoneuropathy characterized by rapidly progressive symmetric weakness and areflexia. Typically preceded by infection, with molecular mimicry between pathogen antigens and peripheral nerve gangliosides driving the autoimmune response.",
    "pathophysiology": [
      "Molecular Mimicry and Antiganglioside Antibodies",
      "Complement-Mediated Nerve Damage",
      "Macrophage-Mediated Demyelination"
    ],
    "cell_types": [
      "Schwann Cell",
      "Macrophage"
    ],
    "cell_type_ids": [
      "CL:0002573",
      "CL:0000235"
    ],
    "biological_processes": [
      "Immunoglobulin Production",
      "Complement Activation",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Areflexia",
      "Limb Weakness",
      "Respiratory Failure",
      "Paresthesia"
    ],
    "phenotype_categories": [
      "Neurological",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001284",
      "HP:0003690",
      "HP:0002093",
      "HP:0003401"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "IVIG",
      "Plasmapheresis",
      "Supportive Care",
      "Physical Therapy"
    ],
    "environmental": [
      "Campylobacter jejuni Infection",
      "Cytomegalovirus Infection",
      "Zika Virus Infection"
    ],
    "biochemical": [
      "CSF Protein",
      "Antiganglioside Antibodies"
    ],
    "source_file": "Guillain_Barre_Syndrome.yaml",
    "page_url": "../pages/disorders/Guillain-Barre_Syndrome.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "HIDEA_Syndrome",
    "disease_id": "MONDO:0032780",
    "category": "Genetic",
    "parents": [
      "Neurologic Disorder",
      "Developmental Disorder",
      "Epileptic Encephalopathy"
    ],
    "subtypes": [],
    "description": "HIDEA syndrome (Hypotonia, Hypoventilation, Impaired Intellectual Development, Dysautonomia, Epilepsy, and Eye Abnormalities) is a severe autosomal recessive neurodevelopmental disorder caused by biallelic loss-of-function variants in P4HTM, encoding the endoplasmic reticulum transmembrane prolyl 4-hydroxylase P4H-TM. The enzyme localizes to the ER membrane with its catalytic domain in the ER lumen and contains a unique EF-hand domain suggesting calcium regulation of enzymatic activity. Loss of P4H-TM leads to dysregulated HIF-1 signaling and calcium dynamics in astrocytes, affecting gliotransmission and central respiratory control circuits.",
    "pathophysiology": [
      "P4HTM Gene Loss-of-Function",
      "Dysregulated Astrocyte Calcium Signaling",
      "Central Respiratory Control Dysfunction",
      "Mitochondrial Dysfunction"
    ],
    "cell_types": [
      "Astrocyte",
      "Neuron"
    ],
    "cell_type_ids": [
      "CL:0000127",
      "CL:0000540"
    ],
    "biological_processes": [
      "Calcium ion transmembrane transport",
      "Gliotransmitter secretion",
      "Regulation of respiratory system process",
      "Response to hypoxia",
      "Oxidative phosphorylation"
    ],
    "phenotypes": [
      "Generalized Hypotonia",
      "Central Hypoventilation",
      "Global Developmental Delay",
      "Intellectual Disability",
      "Epilepsy",
      "Dysautonomia",
      "Abnormal Eye Movements",
      "Visual Impairment",
      "Gait Disturbance",
      "Recurrent Respiratory Infections",
      "Scoliosis",
      "Obesity",
      "Coarse Facial Features"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Respiratory",
      "Developmental",
      "Cognitive",
      "Autonomic",
      "Ophthalmologic",
      "Motor",
      "Skeletal",
      "Metabolic",
      "Craniofacial"
    ],
    "phenotype_ids": [
      "HP:0001290",
      "HP:0007110",
      "HP:0001263",
      "HP:0001249",
      "HP:0001250",
      "HP:0002270",
      "HP:0000486",
      "HP:0000505",
      "HP:0001288",
      "HP:0002205",
      "HP:0002650",
      "HP:0001513",
      "HP:0000280"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "P4HTM"
    ],
    "treatments": [
      "Respiratory Support",
      "Anticonvulsant Therapy",
      "Physical Therapy",
      "Ophthalmologic Management"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "HIDEA_Syndrome.yaml",
    "page_url": "../pages/disorders/HIDEA_Syndrome.html",
    "num_phenotypes": 13,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Hashimoto's Thyroiditis",
    "disease_id": "MONDO:0007699",
    "category": "Complex",
    "parents": [
      "Autoimmune Disease",
      "Endocrine Disease"
    ],
    "subtypes": [],
    "description": "T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.\n",
    "pathophysiology": [
      "Autoimmune Thyroid Destruction",
      "Lymphocytic Infiltration",
      "Thyroid Hormone Deficiency"
    ],
    "cell_types": [
      "Thyroid Epithelial Cell",
      "T Helper Cell",
      "B Cell"
    ],
    "cell_type_ids": [
      "CL:0002257",
      "CL:0000492",
      "CL:0000236"
    ],
    "biological_processes": [
      "Autoimmune Response",
      "Thyroid Hormone Synthesis"
    ],
    "phenotypes": [
      "Fatigue",
      "Weight Gain",
      "Constipation",
      "Dry Skin",
      "Goiter",
      "Depression"
    ],
    "phenotype_categories": [
      "Systemic",
      "Metabolic",
      "Gastrointestinal",
      "Dermatological",
      "Endocrine",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0012378",
      "HP:0004324",
      "HP:0002019",
      "HP:0000958",
      "HP:0000853",
      "HP:0000716"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DR3",
      "HLA-DR4",
      "CTLA4",
      "PTPN22"
    ],
    "treatments": [
      "Levothyroxine",
      "Selenium Supplementation",
      "Monitoring"
    ],
    "environmental": [
      "Iodine Excess",
      "Selenium Deficiency",
      "Viral Infections"
    ],
    "biochemical": [
      "TSH",
      "Free T4",
      "Anti-TPO Antibodies",
      "Anti-Thyroglobulin Antibodies"
    ],
    "source_file": "Hashimotos_Thyroiditis.yaml",
    "page_url": "../pages/disorders/Hashimoto's_Thyroiditis.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 3,
    "num_genes": 4,
    "num_treatments": 3
  },
  {
    "name": "Heart Failure",
    "disease_id": "MONDO:0005252",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease"
    ],
    "subtypes": [
      "Heart Failure with Reduced Ejection Fraction (HFrEF)",
      "Heart Failure with Preserved Ejection Fraction (HFpEF)",
      "Heart Failure with Mildly Reduced Ejection Fraction (HFmrEF)"
    ],
    "description": "Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.\n",
    "pathophysiology": [
      "Myocardial Contractile Dysfunction",
      "Neurohormonal Activation",
      "Ventricular Remodeling",
      "Fluid Retention"
    ],
    "cell_types": [
      "Cardiomyocyte",
      "Cardiac Fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000746",
      "CL:0002548"
    ],
    "biological_processes": [
      "Cardiac Contraction",
      "RAAS Activation",
      "Cardiac Remodeling"
    ],
    "phenotypes": [
      "Dyspnea",
      "Peripheral Edema",
      "Fatigue",
      "Orthopnea",
      "Exercise Intolerance",
      "Cardiomegaly"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Cardiovascular",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0002094",
      "HP:0012398",
      "HP:0012378",
      "HP:0012764",
      "HP:0003546",
      "HP:0001640"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "TTN",
      "MYH7",
      "LMNA"
    ],
    "treatments": [
      "ACE Inhibitors/ARBs",
      "Beta Blockers",
      "ARNI (Sacubitril/Valsartan)",
      "SGLT2 Inhibitors",
      "Mineralocorticoid Receptor Antagonists",
      "Diuretics",
      "Cardiac Resynchronization Therapy",
      "Implantable Cardioverter-Defibrillator"
    ],
    "environmental": [
      "Hypertension",
      "Coronary Artery Disease",
      "Alcohol Abuse",
      "Obesity"
    ],
    "biochemical": [
      "BNP/NT-proBNP",
      "Troponin"
    ],
    "source_file": "Heart_Failure.yaml",
    "page_url": "../pages/disorders/Heart_Failure.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 8
  },
  {
    "name": "Hemochromatosis",
    "disease_id": "MONDO:0006507",
    "category": "Mendelian",
    "parents": [
      "Iron Metabolism Disorders",
      "Hereditary Metabolic Diseases"
    ],
    "subtypes": [],
    "description": "Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction, leaving circulating hepcidin inappropriately low relative to body iron stores.\n",
    "pathophysiology": [
      "HFE Loss Lowers Hepcidin",
      "Low Hepcidin Leads to Ferroportin Hyperabsorption",
      "Hepatic Iron Toxicity",
      "Cardiac Iron Deposition",
      "Pancreatic Iron Toxicity"
    ],
    "cell_types": [
      "hepatocyte",
      "cardiac muscle cell",
      "type B pancreatic cell"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000746",
      "CL:0000169"
    ],
    "biological_processes": [
      "iron ion homeostasis",
      "iron ion transport",
      "cellular response to oxidative stress"
    ],
    "phenotypes": [
      "Hepatomegaly",
      "Skin Hyperpigmentation",
      "Diabetes Mellitus",
      "Arthropathy",
      "Cardiomyopathy",
      "Hypogonadism",
      "Fatigue"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0002240",
      "HP:0007574",
      "HP:0000819",
      "HP:0003040",
      "HP:0001638",
      "HP:0000044",
      "HP:0012378"
    ],
    "frequencies": [],
    "genes": [
      "HFE Mutations"
    ],
    "treatments": [
      "Phlebotomy (Therapeutic Venesection)",
      "Iron Chelation Therapy",
      "Dietary Modification",
      "Screening of Family Members"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Hemochromatosis.yaml",
    "page_url": "../pages/disorders/Hemochromatosis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Hemophilia A",
    "disease_id": "MONDO:0010602",
    "category": "Genetic",
    "parents": [
      "Bleeding Disorder",
      "Coagulation Disorder"
    ],
    "subtypes": [
      "Severe Hemophilia A",
      "Moderate Hemophilia A",
      "Mild Hemophilia A"
    ],
    "description": "Mutations in the F8 gene cause deficient or dysfunctional factor VIII protein. Factor VIII is a cofactor for factor IXa in the intrinsic coagulation pathway, essential for thrombin generation and fibrin clot formation.\n",
    "pathophysiology": [
      "Factor VIII Deficiency",
      "Impaired Thrombin Generation"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Blood Coagulation",
      "Fibrin Clot Formation"
    ],
    "phenotypes": [
      "Hemarthrosis",
      "Prolonged Bleeding",
      "Easy Bruising",
      "Muscle Hematomas",
      "Prolonged aPTT"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Hematologic",
      "Dermatological",
      "Laboratory"
    ],
    "phenotype_ids": [
      "HP:0005261",
      "HP:0001892",
      "HP:0000978",
      "HP:0012233",
      "HP:0003645"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "F8"
    ],
    "treatments": [
      "Factor VIII Replacement",
      "Emicizumab",
      "Desmopressin (DDAVP)",
      "Antifibrinolytics",
      "Gene Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "Factor VIII Activity",
      "aPTT",
      "PT/INR"
    ],
    "source_file": "Hemophilia_A.yaml",
    "page_url": "../pages/disorders/Hemophilia_A.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Hepatitis B",
    "disease_id": "MONDO:0005344",
    "category": "Infectious Disease",
    "parents": [
      "Viral Infection"
    ],
    "subtypes": [],
    "description": "Hepatitis B is a viral infection caused by Hepatitis B Virus (HBV) that primarily affects the liver. It can cause both acute and chronic disease, with chronic infection leading to cirrhosis, liver failure, and hepatocellular carcinoma. Transmission occurs through blood, sexual contact, and from mother to child during birth.",
    "pathophysiology": [
      "Hepatocyte Infection and cccDNA Formation",
      "HBV DNA Integration",
      "Chronic Inflammation",
      "Immune Evasion and T Cell Exhaustion",
      "Liver Fibrosis",
      "Cirrhosis"
    ],
    "cell_types": [
      "Hepatocyte",
      "CD8-positive, alpha-beta T cell",
      "natural killer cell",
      "inflammatory macrophage",
      "regulatory T cell"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000625",
      "CL:0000623",
      "CL:0000863",
      "CL:0000815"
    ],
    "biological_processes": [
      "viral entry into host cell",
      "epigenetic regulation of gene expression",
      "DNA integration",
      "negative regulation of T cell activation",
      "cGAS-STING signaling pathway"
    ],
    "phenotypes": [
      "Jaundice",
      "Fatigue",
      "Abdominal Pain",
      "Elevated Liver Enzymes",
      "Nausea",
      "Vomiting",
      "Fever",
      "Hepatomegaly",
      "Arthralgias",
      "Rash"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Hepatic",
      "Dermatologic"
    ],
    "phenotype_ids": [
      "HP:0000952",
      "HP:0012378",
      "HP:0002027",
      "HP:0002018",
      "HP:0002013",
      "HP:0001945",
      "HP:0002240",
      "HP:0002829",
      "HP:0000988"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL",
      "VERY_FREQUENT"
    ],
    "genes": [
      "HBV Genotype"
    ],
    "treatments": [
      "Antiviral Medications",
      "Interferon Therapy",
      "Liver Transplant",
      "Regular Monitoring",
      "Vaccination"
    ],
    "environmental": [
      "Poor Sterile Practices",
      "High-risk Behaviors"
    ],
    "biochemical": [
      "Hepatitis B Surface Antigen (HBsAg)",
      "Hepatitis B e Antigen (HBeAg)",
      "HBV DNA"
    ],
    "source_file": "Hepatitis_B.yaml",
    "page_url": "../pages/disorders/Hepatitis_B.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 6,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Hepatitis C",
    "disease_id": "MONDO:0005231",
    "category": "Infectious",
    "parents": [
      "Viral Hepatitis",
      "Liver Disease"
    ],
    "subtypes": [
      "Acute Hepatitis C",
      "Chronic Hepatitis C"
    ],
    "description": "Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It is primarily transmitted through blood-to-blood contact, including injection drug use, unsafe medical practices, and rarely through sexual transmission. Acute infection is often asymptomatic but progresses to chronic infection in 75-85% of cases. Chronic hepatitis C can lead to liver cirrhosis, hepatocellular carcinoma, and liver failure. Direct-acting antiviral therapies have revolutionized treatment, with cure rates exceeding 95%.\n",
    "pathophysiology": [
      "Viral Replication and Hepatocyte Injury",
      "Chronic Inflammation and Fibrosis",
      "Immune Evasion",
      "Hepatocellular Carcinoma Development"
    ],
    "cell_types": [
      "hepatocyte",
      "hepatic stellate cell",
      "T cell"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000632",
      "CL:0000084"
    ],
    "biological_processes": [
      "viral life cycle",
      "chronic inflammatory response",
      "hepatic stellate cell activation",
      "collagen biosynthetic process",
      "symbiont-mediated suppression of host type I interferon-mediated signaling pathway"
    ],
    "phenotypes": [
      "Fatigue",
      "Jaundice",
      "Hepatomegaly",
      "Elevated Transaminases",
      "Cirrhosis",
      "Hepatocellular Carcinoma"
    ],
    "phenotype_categories": [
      "Constitutional",
      "Hepatic",
      "Laboratory",
      "Neoplastic"
    ],
    "phenotype_ids": [
      "HP:0012378",
      "HP:0000952",
      "HP:0002240",
      "HP:0002910",
      "HP:0001394",
      "HP:0001402"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "IL28B Polymorphisms"
    ],
    "treatments": [
      "Direct-Acting Antivirals (DAAs)",
      "Liver Transplantation",
      "Hepatocellular Carcinoma Surveillance"
    ],
    "environmental": [
      "Injection Drug Use",
      "Unsafe Medical Practices",
      "Occupational Exposure",
      "Tattoos and Body Piercing"
    ],
    "biochemical": [
      "HCV RNA",
      "Anti-HCV Antibodies",
      "Elevated ALT",
      "Elevated Bilirubin"
    ],
    "source_file": "Hepatitis_C.yaml",
    "page_url": "../pages/disorders/Hepatitis_C.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 3
  },
  {
    "name": "Hirschsprung Disease",
    "disease_id": "MONDO:0018309",
    "category": "Genetic",
    "parents": [
      "Congenital Disorder",
      "Gastrointestinal Disorder"
    ],
    "subtypes": [
      "Short-Segment Hirschsprung Disease",
      "Long-Segment Hirschsprung Disease",
      "Total Colonic Aganglionosis"
    ],
    "description": "A congenital disorder characterized by absence of enteric ganglion cells in the distal bowel, resulting in functional intestinal obstruction and impaired motility.",
    "pathophysiology": [
      "Failure of Enteric Ganglion Cell Migration",
      "Disrupted Enteric Nervous System Development"
    ],
    "cell_types": [
      "enteric neuron"
    ],
    "cell_type_ids": [
      "CL:0007011"
    ],
    "biological_processes": [
      "neural crest cell migration",
      "cell population proliferation",
      "neuron differentiation",
      "peristalsis"
    ],
    "phenotypes": [
      "Chronic Constipation",
      "Abdominal Distension",
      "Megacolon",
      "Intestinal Obstruction",
      "Delayed Meconium Passage",
      "Failure to Thrive",
      "Enterocolitis",
      "Failure to Thrive",
      "Developmental Delay"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Developmental"
    ],
    "phenotype_ids": [
      "HP:0012450",
      "HP:0003270",
      "HP:6000852",
      "HP:0005214",
      "HP:0001508",
      "HP:0004387",
      "HP:0001263"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "RET",
      "EDNRB",
      "GDNF",
      "SOX10",
      "PHOX2B",
      "NRG1",
      "ZEB2",
      "NRTN",
      "NCAM1"
    ],
    "treatments": [
      "Surgical Resection",
      "Pull-Through Procedure",
      "Ostomy"
    ],
    "environmental": [
      "Perinatal Factors"
    ],
    "biochemical": [],
    "source_file": "Hirschsprung_Disease.yaml",
    "page_url": "../pages/disorders/Hirschsprung_Disease.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 2,
    "num_genes": 9,
    "num_treatments": 3
  },
  {
    "name": "Holt-Oram syndrome",
    "disease_id": "MONDO:0007732",
    "category": "Genetic",
    "parents": [],
    "subtypes": [],
    "description": "Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.\n",
    "pathophysiology": [
      "TBX5 Haploinsufficiency and Enhancer Dysfunction",
      "Cofactor and Chromatin Remodeling Dysfunction"
    ],
    "cell_types": [
      "Cardiac muscle cell"
    ],
    "cell_type_ids": [
      "CL:0000746"
    ],
    "biological_processes": [
      "Heart development",
      "Atrial septum morphogenesis",
      "Cardiac conduction",
      "Limb bud formation",
      "Regulation of gene expression, epigenetic"
    ],
    "phenotypes": [
      "Upper limb abnormality",
      "Radial ray defect",
      "Triphalangeal thumb",
      "Atrial septal defect",
      "Atrioventricular block",
      "Atrial fibrillation",
      "Ventricular septal defect"
    ],
    "phenotype_categories": [
      "Skeletal",
      "Cardiac"
    ],
    "phenotype_ids": [
      "HP:0002817",
      "HP:0002986",
      "HP:0001199",
      "HP:0001631",
      "HP:0001678",
      "HP:0005110",
      "HP:0001629"
    ],
    "frequencies": [
      "OBLIGATE",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "TBX5"
    ],
    "treatments": [
      "Cardiac monitoring and evaluation",
      "Surgical repair of cardiac defects",
      "Orthopedic management"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Holt_Oram.yaml",
    "page_url": "../pages/disorders/Holt-Oram_syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 3
  },
  {
    "name": "Huntington's Disease",
    "disease_id": "MONDO:0007739",
    "category": "Genetic",
    "parents": [
      "Neurodegenerative Disorder",
      "Movement Disorder"
    ],
    "subtypes": [
      "Juvenile Huntington's Disease",
      "Late-Onset Huntington's Disease"
    ],
    "description": "Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein.",
    "pathophysiology": [
      "CAG Repeat Expansion in the HTT Gene",
      "Mutant Huntingtin Protein Aggregation",
      "Excitotoxicity",
      "Mitochondrial Dysfunction",
      "Neuroinflammation",
      "D2 Receptor Medium Spiny Neuron Selective Vulnerability"
    ],
    "cell_types": [
      "medium spiny neuron",
      "astrocyte",
      "microglial cell"
    ],
    "cell_type_ids": [
      "CL:1001474",
      "CL:0000127",
      "CL:0000129"
    ],
    "biological_processes": [
      "DNA mismatch repair",
      "protein aggregation",
      "autophagy",
      "chemical synaptic transmission",
      "excitatory postsynaptic potential",
      "response to oxidative stress",
      "oxidative phosphorylation",
      "mitochondrion organization",
      "inflammatory response",
      "microglial cell activation",
      "synaptic transmission"
    ],
    "phenotypes": [
      "Chorea",
      "Dystonia",
      "Bradykinesia",
      "Cognitive Impairment",
      "Depression",
      "Weight Loss",
      "Dysphagia"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0002072",
      "HP:0001332",
      "HP:0002067",
      "HP:0100543",
      "HP:0000716",
      "HP:0001824",
      "HP:0002015"
    ],
    "frequencies": [],
    "genes": [
      "HTT",
      "MSH3",
      "MLH1",
      "PMS1",
      "PMS2",
      "LIG1",
      "PPARGC1A",
      "SLC1A2",
      "BDNF",
      "NTRK2",
      "DRD1",
      "DRD2",
      "SQSTM1"
    ],
    "treatments": [
      "Tetrabenazine",
      "Antipsychotic Medications",
      "Selective Serotonin Reuptake Inhibitors (SSRIs)",
      "Physical Therapy",
      "Speech Therapy",
      "Occupational Therapy",
      "Genetic Counseling"
    ],
    "environmental": [
      "None Applicable"
    ],
    "biochemical": [
      "Elevated Neuronal Inclusions"
    ],
    "source_file": "Huntingtons_Disease.yaml",
    "page_url": "../pages/disorders/Huntington's_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 6,
    "num_genes": 13,
    "num_treatments": 7
  },
  {
    "name": "Hypertensive Heart Disease",
    "disease_id": "MONDO:0001302",
    "category": "Cardiovascular",
    "parents": [
      "Hypertension",
      "Heart Disease"
    ],
    "subtypes": [
      "Left Ventricular Hypertrophy",
      "Coronary Artery Disease",
      "Heart Failure"
    ],
    "description": "Hypertension increases the pressure the heart must pump against, leading to cardiac remodeling and dysfunction over time.",
    "pathophysiology": [
      "Increased Cardiac Workload",
      "Left Ventricular Hypertrophy",
      "Myocardial Ischemia",
      "Cardiac Fibrosis",
      "Coronary Microvascular Dysfunction",
      "Oxidative Stress and Mitochondrial Dysfunction",
      "Inflammasome Activation"
    ],
    "cell_types": [
      "Cardiomyocyte",
      "Cardiac Fibroblast",
      "endothelial cell",
      "pericyte"
    ],
    "cell_type_ids": [
      "CL:0000746",
      "CL:0002548",
      "CL:0000115",
      "CL:0000669"
    ],
    "biological_processes": [
      "extracellular matrix organization",
      "collagen fibril organization",
      "angiogenesis",
      "regulation of nitric oxide biosynthetic process",
      "response to oxidative stress",
      "superoxide metabolic process",
      "mitochondrial electron transport",
      "inflammasome complex assembly",
      "interleukin-1 beta production"
    ],
    "phenotypes": [
      "Dyspnea",
      "Chest Pain",
      "Arrhythmias",
      "Fatigue",
      "Chest Pain",
      "Arrhythmias",
      "Aortic Dissection",
      "Stroke",
      "Fatigue",
      "Proteinuria",
      "Reduced Exercise Tolerance",
      "Microvascular Angina",
      "Palpitations",
      "Syncope",
      "Heart Failure Exacerbations",
      "Left Ventricular Diastolic Dysfunction",
      "Concentric Left Ventricular Hypertrophy",
      "Reduced Coronary Flow Reserve"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Systemic",
      "Neurologic",
      "Renal"
    ],
    "phenotype_ids": [
      "HP:0002094",
      "HP:0100749",
      "HP:0011675",
      "HP:0012378",
      "HP:0002647",
      "HP:0001297",
      "HP:0000093",
      "HP:0003546",
      "HP:0001962",
      "HP:0001279",
      "HP:0001635",
      "HP:0025168",
      "HP:0001712"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL",
      "VERY_FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Antihypertensive Therapy",
      "ACE Inhibitors or ARBs",
      "Beta Blockers",
      "Diuretics",
      "Mineralocorticoid Receptor Antagonists",
      "Lifestyle Modifications"
    ],
    "environmental": [
      "Uncontrolled Hypertension"
    ],
    "biochemical": [
      "Brain Natriuretic Peptide (BNP)",
      "Troponin"
    ],
    "source_file": "Hypertensive_Heart_Disease.yaml",
    "page_url": "../pages/disorders/Hypertensive_Heart_Disease.html",
    "num_phenotypes": 18,
    "num_pathophysiology": 7,
    "num_genes": 0,
    "num_treatments": 6
  },
  {
    "name": "Hypertrophic Cardiomyopathy",
    "disease_id": "MONDO:0005045",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease",
      "Genetic Disorder"
    ],
    "subtypes": [
      "Obstructive HCM",
      "Non-Obstructive HCM"
    ],
    "description": "Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.",
    "pathophysiology": [
      "Sarcomere Protein Mutations",
      "Myocyte Disarray",
      "Myocardial Fibrosis",
      "Altered Calcium Handling",
      "Mitochondrial Dysfunction",
      "Left Ventricular Outflow Tract Obstruction"
    ],
    "cell_types": [
      "Cardiomyocyte",
      "Interstitial Cells",
      "cardiac fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000746",
      "CL:4030031",
      "CL:0002548"
    ],
    "biological_processes": [
      "muscle contraction",
      "regulation of heart contraction",
      "ATP hydrolysis activity",
      "extracellular matrix organization",
      "response to TGF-beta",
      "calcium ion transport",
      "regulation of cardiac muscle contraction",
      "ATP metabolic process",
      "oxidative phosphorylation"
    ],
    "phenotypes": [
      "Chest Pain",
      "Dyspnea",
      "Syncope",
      "Arrhythmias",
      "Arrhythmias",
      "Mitral Valve Regurgitation",
      "Fatigue",
      "Palpitations",
      "Sudden Cardiac Death",
      "Left Ventricular Hypertrophy",
      "Atrial Fibrillation"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0100749",
      "HP:0002094",
      "HP:0001279",
      "HP:0011675",
      "HP:0012378",
      "HP:0001962",
      "HP:0001645",
      "HP:0001712",
      "HP:0005110"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL",
      "OBLIGATE"
    ],
    "genes": [
      "MYH7",
      "MYBPC3",
      "TNNT2",
      "ALPK3",
      "FHOD3",
      "TRIM63",
      "SVIL"
    ],
    "treatments": [
      "Beta Blockers",
      "Calcium Channel Blockers",
      "Septal Myectomy",
      "Alcohol Septal Ablation",
      "Implantable Cardioverter Defibrillator (ICD)"
    ],
    "environmental": [
      "None Applicable"
    ],
    "biochemical": [
      "Troponin"
    ],
    "source_file": "Hypertrophic_Cardiomyopathy.yaml",
    "page_url": "../pages/disorders/Hypertrophic_Cardiomyopathy.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 6,
    "num_genes": 7,
    "num_treatments": 5
  },
  {
    "name": "IgA Nephropathy",
    "disease_id": "MONDO:0005342",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Kidney Disease"
    ],
    "subtypes": [],
    "description": "The most common primary glomerulonephritis worldwide, characterized by mesangial IgA deposits. Caused by galactose-deficient IgA1 and corresponding autoantibodies forming immune complexes that deposit in the glomerulus. Variable progression from benign hematuria to end-stage renal disease.",
    "pathophysiology": [
      "Galactose-Deficient IgA1 Production",
      "Anti-Gd-IgA1 Autoantibody Formation",
      "Mesangial Cell Activation and Proliferation"
    ],
    "cell_types": [
      "B Cell",
      "Mesangial Cell"
    ],
    "cell_type_ids": [
      "CL:0000236",
      "CL:0000650"
    ],
    "biological_processes": [
      "Immunoglobulin Production",
      "Immune Complex Formation",
      "Cell Proliferation",
      "Complement Activation"
    ],
    "phenotypes": [
      "Hematuria",
      "Proteinuria",
      "Hypertension",
      "Renal Insufficiency"
    ],
    "phenotype_categories": [
      "Renal",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0000790",
      "HP:0000093",
      "HP:0000822",
      "HP:0000083"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CFHR1/CFHR3 Deletion",
      "HLA-DQB1",
      "DEFA"
    ],
    "treatments": [
      "ACE Inhibitors/ARBs",
      "SGLT2 Inhibitors",
      "Corticosteroids",
      "Sparsentan",
      "Budesonide (Targeted Release)"
    ],
    "environmental": [
      "Mucosal Infections"
    ],
    "biochemical": [
      "Serum IgA",
      "Serum Creatinine",
      "Gd-IgA1"
    ],
    "source_file": "IgA_Nephropathy.yaml",
    "page_url": "../pages/disorders/IgA_Nephropathy.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 5
  },
  {
    "name": "Immune Thrombocytopenia",
    "disease_id": "MONDO:0008558",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Hematologic Disease"
    ],
    "subtypes": [],
    "description": "An autoimmune disorder characterized by isolated thrombocytopenia due to autoantibody-mediated platelet destruction and impaired platelet production. Formerly known as idiopathic thrombocytopenic purpura (ITP). May be primary or secondary to infection, autoimmune disease, or malignancy.",
    "pathophysiology": [
      "Antiplatelet Antibody Production",
      "Impaired Megakaryopoiesis",
      "T Cell Dysregulation",
      "Complement Activation"
    ],
    "cell_types": [
      "Platelet",
      "Macrophage",
      "Megakaryocyte",
      "CD4+ T Cell"
    ],
    "cell_type_ids": [
      "CL:0000233",
      "CL:0000235",
      "CL:0000556",
      "CL:0000624"
    ],
    "biological_processes": [
      "Phagocytosis",
      "Platelet Formation",
      "Immune Regulation",
      "Complement Activation"
    ],
    "phenotypes": [
      "Thrombocytopenia",
      "Petechiae",
      "Epistaxis",
      "Easy Bruising"
    ],
    "phenotype_categories": [
      "Hematological",
      "Dermatological",
      "ENT"
    ],
    "phenotype_ids": [
      "HP:0001873",
      "HP:0000967",
      "HP:0000421",
      "HP:0000978"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Corticosteroids",
      "IVIG",
      "Thrombopoietin Receptor Agonists",
      "Rituximab",
      "Splenectomy"
    ],
    "environmental": [],
    "biochemical": [
      "Platelet Count",
      "Antiplatelet Antibodies",
      "MPV (Mean Platelet Volume)"
    ],
    "source_file": "Immune_Thrombocytopenia.yaml",
    "page_url": "../pages/disorders/Immune_Thrombocytopenia.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 0,
    "num_treatments": 5
  },
  {
    "name": "Irritable Bowel Syndrome",
    "disease_id": "MONDO:0005052",
    "category": "Complex",
    "parents": [
      "Gastrointestinal Disease"
    ],
    "subtypes": [],
    "description": "Enhanced perception of normal gut sensations leads to pain and discomfort. Lowered pain thresholds in response to balloon distension. Central sensitization contributes.\n",
    "pathophysiology": [
      "Visceral Hypersensitivity",
      "Gut Dysmotility",
      "Gut-Brain Axis Dysfunction",
      "Intestinal Barrier Dysfunction",
      "Immune Activation and Mast Cell Degranulation",
      "Microbiome Dysbiosis"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Pain Perception",
      "Gut Motility",
      "Nervous System Process",
      "Mast Cell Activation",
      "Host-Microbiome Interaction"
    ],
    "phenotypes": [
      "Abdominal Pain",
      "Altered Bowel Habits",
      "Bloating",
      "Constipation",
      "Diarrhea",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0002027",
      "HP:0025085",
      "HP:0003270",
      "HP:0002019",
      "HP:0002014",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HTR3E",
      "SCN5A"
    ],
    "treatments": [
      "Dietary Modification",
      "Antispasmodics",
      "Loperamide",
      "Linaclotide",
      "Rifaximin",
      "Tricyclic Antidepressants",
      "SSRIs",
      "Probiotics",
      "Cognitive Behavioral Therapy"
    ],
    "environmental": [
      "Psychological Stress",
      "Dietary Triggers",
      "Gastroenteritis",
      "Antibiotics",
      "Early Life Stress"
    ],
    "biochemical": [],
    "source_file": "Irritable_Bowel_Syndrome.yaml",
    "page_url": "../pages/disorders/Irritable_Bowel_Syndrome.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 6,
    "num_genes": 2,
    "num_treatments": 9
  },
  {
    "name": "Jeavons Syndrome",
    "disease_id": "MONDO:0015346",
    "category": "Complex",
    "parents": [
      "Epilepsy",
      "Neurological Disorder"
    ],
    "subtypes": [
      "Eyelid Myoclonia with Absences (EMA)",
      "Eyelid Myoclonia with Absences and Photosensitivity (EMA+)"
    ],
    "description": "Jeavons syndrome is a genetic generalized epilepsy characterized by eyelid myoclonia with or without absences, photosensitivity, and eyelid closure-induced seizures. Onset typically occurs in childhood and the condition often persists into adulthood with variable drug responsiveness.",
    "pathophysiology": [
      "Complex Genetic Predisposition",
      "Neuronal Hyperexcitability",
      "Disrupted Cortical Function"
    ],
    "cell_types": [
      "Excitatory Glutamatergic Neuron"
    ],
    "cell_type_ids": [
      "CL:0000679"
    ],
    "biological_processes": [
      "chemical synaptic transmission",
      "visual perception"
    ],
    "phenotypes": [
      "Eyelid Myoclonia",
      "Absences",
      "Generalized Tonic-Clonic Seizures",
      "Mild Cognitive Impairment",
      "Photosensitivity",
      "Developmental Delays",
      "Impaired Visual Functioning During Episodes"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Cognitive",
      "Developmental"
    ],
    "phenotype_ids": [
      "HP:0011149",
      "HP:0025190",
      "HP:0000572"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [
      "SYNGAP1",
      "NEXMIF",
      "RORB",
      "CHD2",
      "CSNK2B",
      "SLC2A1",
      "KCNB1",
      "NAA10",
      "GABRA1"
    ],
    "treatments": [
      "Valproic Acid",
      "Ethosuximide",
      "Levetiracetam",
      "Avoidance of Provocative Stimuli",
      "Avoidance of Triggering Stimuli",
      "Sunglasses or Blue Light Filtering Glasses"
    ],
    "environmental": [
      "Photic Stimulation",
      "Sleep Deprivation"
    ],
    "biochemical": [],
    "source_file": "Jeavons_Syndrome.yaml",
    "page_url": "../pages/disorders/Jeavons_Syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 9,
    "num_treatments": 6
  },
  {
    "name": "Kawasaki Disease",
    "disease_id": "MONDO:0012727",
    "category": "Pediatric Condition",
    "parents": [
      "Vasculitis"
    ],
    "subtypes": [],
    "description": "Kawasaki Disease is a condition in children that involves inflammation of blood vessels throughout the body and is characterized by fever, rash, and other symptoms.",
    "pathophysiology": [
      "Vascular Inflammation",
      "Immune Response Dysregulation"
    ],
    "cell_types": [
      "vascular endothelial cell",
      "neutrophil",
      "monocyte",
      "macrophage",
      "CD8-positive, alpha-beta T cell",
      "T-helper 17 cell",
      "regulatory T cell",
      "plasmablast",
      "plasma cell",
      "dendritic cell"
    ],
    "cell_type_ids": [
      "CL:0000071",
      "CL:0000775",
      "CL:0000576",
      "CL:0000235",
      "CL:0000625",
      "CL:0000899",
      "CL:0000815",
      "CL:0000980",
      "CL:0000786",
      "CL:0000451"
    ],
    "biological_processes": [
      "endothelial cell activation",
      "leukocyte adhesion to vascular endothelial cell",
      "inflammatory response",
      "NLRP3 inflammasome complex assembly",
      "interleukin-1 beta production",
      "tumor necrosis factor production",
      "interleukin-17 production",
      "calcium ion transmembrane transport",
      "T cell activation",
      "complement activation"
    ],
    "phenotypes": [
      "Fever",
      "Rash",
      "Conjunctivitis",
      "Swelling of Hands and Feet",
      "Peeling Skin",
      "Red, Cracked Lips",
      "Coronary Artery Aneurysms",
      "Thrombocytosis",
      "Cervical Lymphadenopathy",
      "Myocarditis",
      "Aneurysm Formation"
    ],
    "phenotype_categories": [
      "Systemic",
      "Dermatologic",
      "Ocular",
      "Musculoskeletal",
      "Oropharyngeal",
      "Cardiovascular",
      "Hematologic",
      "Lymphatic"
    ],
    "phenotype_ids": [
      "HP:0001945",
      "HP:0000988",
      "HP:0000509",
      "HP:0001894",
      "HP:0025289",
      "HP:0012819",
      "HP:0002617"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "ITPKC",
      "FCGR2A",
      "FCGR3A",
      "BLK",
      "CD40",
      "HLA-B",
      "CASP3",
      "ORAI1",
      "STIM1",
      "TGFBR2",
      "SMAD3",
      "TGFB2",
      "IL1B",
      "IL1R1",
      "TNF",
      "IL17A",
      "IL23A",
      "NLRP3",
      "NOS3",
      "ICAM1",
      "VCAM1"
    ],
    "treatments": [
      "Intravenous Immunoglobulin (IVIG)",
      "Aspirin",
      "Anakinra",
      "Cyclosporine",
      "Corticosteroids"
    ],
    "environmental": [],
    "biochemical": [
      "C-Reactive Protein (CRP)",
      "Erythrocyte Sedimentation Rate (ESR)",
      "Platelet Count"
    ],
    "source_file": "Kawasaki_Disease.yaml",
    "page_url": "../pages/disorders/Kawasaki_Disease.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 2,
    "num_genes": 21,
    "num_treatments": 5
  },
  {
    "name": "Klinefelter Syndrome",
    "disease_id": "MONDO:0006823",
    "category": "Genetic",
    "parents": [
      "Chromosomal Disorder"
    ],
    "subtypes": [],
    "description": "Typically results in a 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues.",
    "pathophysiology": [
      "Presence of Extra X Chromosome",
      "Testicular Microenvironment Dysfunction",
      "Progressive Germ Cell Loss",
      "Hypergonadotropic Hypogonadism"
    ],
    "cell_types": [
      "Sertoli Cell",
      "Leydig Cell",
      "Macrophage",
      "Endothelial Cell",
      "Spermatocyte"
    ],
    "cell_type_ids": [
      "CL:0000216",
      "CL:0000178",
      "CL:0000235",
      "CL:0000115",
      "CL:0000017"
    ],
    "biological_processes": [
      "Spermatogenesis",
      "Angiogenesis",
      "Inflammatory Response",
      "Extracellular Matrix Organization",
      "Apoptotic Process",
      "Testosterone Biosynthetic Process",
      "Hormone Secretion"
    ],
    "phenotypes": [
      "Hypogonadism",
      "Delayed Speech and Language Development",
      "Learning Disabilities",
      "Tall Stature",
      "Reduced Muscle Tone",
      "Micropenis",
      "Psychosocial Difficulties",
      "Attention Deficit",
      "Azoospermia",
      "Small Testes",
      "Gynecomastia",
      "Insulin Resistance",
      "Osteopenia",
      "Increased Cardiovascular Risk"
    ],
    "phenotype_categories": [
      "Reproductive",
      "Developmental",
      "Cognitive",
      "Musculoskeletal",
      "Behavioral",
      "Endocrine",
      "Metabolic",
      "Skeletal",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0000135",
      "HP:0000750",
      "HP:0000098",
      "HP:0000054",
      "HP:0007018",
      "HP:0000027",
      "HP:0008734",
      "HP:0000771",
      "HP:0000855",
      "HP:0000938",
      "HP:0001626"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "47,XXY Karyotype",
      "KDM6A",
      "SHOX",
      "TLR7",
      "AR",
      "INSL3",
      "Mosaicism (46,XY/47,XXY)"
    ],
    "treatments": [
      "Testosterone Replacement Therapy",
      "Educational Support",
      "Fertility Treatment",
      "Psychological Support",
      "Multidisciplinary Care"
    ],
    "environmental": [],
    "biochemical": [
      "Testosterone",
      "FSH (Follicle-Stimulating Hormone)"
    ],
    "source_file": "Klinefelter_Syndrome.yaml",
    "page_url": "../pages/disorders/Klinefelter_Syndrome.html",
    "num_phenotypes": 14,
    "num_pathophysiology": 4,
    "num_genes": 7,
    "num_treatments": 5
  },
  {
    "name": "Liver Cirrhosis",
    "disease_id": "MONDO:0005155",
    "category": "Complex",
    "parents": [
      "Hepatic Disease"
    ],
    "subtypes": [
      "Alcoholic Cirrhosis",
      "Viral Cirrhosis",
      "Non-Alcoholic Steatohepatitis Cirrhosis",
      "Primary Biliary Cholangitis",
      "Primary Sclerosing Cholangitis"
    ],
    "description": "Chronic liver injury from any cause leads to ongoing hepatocyte death, triggering inflammation and regenerative responses that promote fibrosis.\n",
    "pathophysiology": [
      "Hepatocyte Injury and Death",
      "Hepatic Stellate Cell Activation",
      "Portal Hypertension",
      "Synthetic Dysfunction"
    ],
    "cell_types": [
      "Hepatocyte",
      "Hepatic Stellate Cell",
      "Endothelial Cell of Hepatic Sinusoid"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000632",
      "CL:1000398"
    ],
    "biological_processes": [
      "Fibrosis",
      "Protein Synthesis"
    ],
    "phenotypes": [
      "Ascites",
      "Jaundice",
      "Hepatomegaly",
      "Splenomegaly",
      "Coagulopathy",
      "Hepatic Encephalopathy",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Hepatic",
      "Hematologic",
      "Neurological",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0001541",
      "HP:0000952",
      "HP:0002240",
      "HP:0001744",
      "HP:0003256",
      "HP:0002480",
      "HP:0012378"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL",
      "VERY_FREQUENT"
    ],
    "genes": [
      "HFE",
      "ATP7B",
      "SERPINA1"
    ],
    "treatments": [
      "Alcohol Abstinence",
      "Antiviral Therapy",
      "Diuretics",
      "Beta Blockers",
      "Lactulose",
      "Rifaximin",
      "Liver Transplantation",
      "Hepatocellular Carcinoma Surveillance"
    ],
    "environmental": [
      "Alcohol",
      "Hepatitis B/C Virus",
      "Obesity/Metabolic Syndrome",
      "Hepatotoxic Drugs"
    ],
    "biochemical": [
      "Albumin",
      "Bilirubin",
      "Prothrombin Time/INR",
      "Ammonia",
      "Transaminases"
    ],
    "source_file": "Liver_Cirrhosis.yaml",
    "page_url": "../pages/disorders/Liver_Cirrhosis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 8
  },
  {
    "name": "Long COVID",
    "disease_id": "MONDO:0100233",
    "category": "Complex",
    "parents": [
      "Post-viral syndrome",
      "COVID-19 complications"
    ],
    "subtypes": [],
    "description": "Long COVID, formally designated as Post-acute Sequelae of SARS-CoV-2 (PASC), is a complex, multisystem condition characterized by persistent symptoms following resolution of acute SARS-CoV-2 infection. The condition can develop following both mild and severe acute illness and affects an estimated 65 million individuals worldwide.\n",
    "pathophysiology": [
      "Viral Persistence",
      "Systemic Immune Activation",
      "T Cell Exhaustion and Tissue Trafficking",
      "Endothelial Dysfunction and Microclots",
      "Serotonin Depletion Mechanisms",
      "Vagus-Hippocampal Signaling Impairment",
      "Autonomic Nervous System Dysfunction",
      "Impaired Mitochondrial Energy Production",
      "Metabolic Shift and Oxidative Stress",
      "Mast Cell Activation",
      "Neuroinflammation"
    ],
    "cell_types": [
      "intestinal epithelial cell",
      "CD8-positive T cell",
      "CD4-positive T cell",
      "endothelial cell",
      "platelet",
      "mast cell",
      "microglial cell",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0002563",
      "CL:0000625",
      "CL:0000624",
      "CL:0000115",
      "CL:0000233",
      "CL:0000097",
      "CL:0000129",
      "CL:0000235"
    ],
    "biological_processes": [
      "inflammatory response",
      "JAK-STAT signaling",
      "T cell migration",
      "T cell activation",
      "fibrinolysis",
      "tryptophan transport",
      "platelet activation",
      "serotonin metabolic process",
      "regulation of synaptic plasticity",
      "memory",
      "mast cell activation",
      "oxidative phosphorylation",
      "ATP biosynthetic process",
      "glycolytic process",
      "response to oxidative stress"
    ],
    "phenotypes": [
      "Fatigue",
      "Cognitive Impairment",
      "Dyspnea",
      "Post-exertional Malaise",
      "Palpitations",
      "Tachycardia",
      "Chest Pain",
      "Headache",
      "Sleep Disturbance",
      "Anxiety",
      "Depression",
      "Anosmia",
      "Ageusia",
      "Myalgia",
      "Arthralgia",
      "Orthostatic Tachycardia",
      "Cough",
      "Pulmonary Opacity",
      "Insomnia",
      "Diarrhea",
      "Nausea"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0012378",
      "HP:0002354",
      "HP:0002094",
      "HP:0030973",
      "HP:0001962",
      "HP:0001649",
      "HP:0100749",
      "HP:0002315",
      "HP:0002360",
      "HP:0000739",
      "HP:0000716",
      "HP:0000458",
      "HP:0041051",
      "HP:0003326",
      "HP:0002829",
      "HP:0012173",
      "HP:0012735",
      "HP:0031457",
      "HP:0100785",
      "HP:0002014",
      "HP:0002018"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Pacing and Energy Management",
      "Symptom-directed Pharmacotherapy",
      "Rehabilitation Therapy",
      "Antihistamine Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "Serotonin Deficiency",
      "Elevated Inflammatory Cytokines"
    ],
    "source_file": "Long_COVID.yaml",
    "page_url": "../pages/disorders/Long_COVID.html",
    "num_phenotypes": 21,
    "num_pathophysiology": 11,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Lyme Disease",
    "disease_id": "MONDO:0019632",
    "category": "Infectious",
    "parents": [
      "Bacterial Infection",
      "Tick-Borne Disease"
    ],
    "subtypes": [
      "Early Localized Lyme Disease",
      "Early Disseminated Lyme Disease",
      "Late Disseminated Lyme Disease",
      "Post-Treatment Lyme Disease Syndrome"
    ],
    "description": "Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi and related Borrelia species. It is the most common vector-borne disease in North America and Europe. The disease progresses through stages: early localized (erythema migrans), early disseminated (multiple erythema migrans, neurological, cardiac involvement), and late disseminated (arthritis, chronic neurological). Early antibiotic treatment is highly effective, while delayed treatment may lead to persistent symptoms.\n",
    "pathophysiology": [
      "Spirochete Invasion and Dissemination",
      "Autoimmune Activation after Persistent Infection",
      "Inflammatory Response and Tissue Damage"
    ],
    "cell_types": [
      "endothelial cell",
      "T cell",
      "neutrophil",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000115",
      "CL:0000084",
      "CL:0000775",
      "CL:0000235"
    ],
    "biological_processes": [
      "cell adhesion",
      "immune system process",
      "inflammatory response"
    ],
    "phenotypes": [
      "Erythema Migrans",
      "Fatigue",
      "Arthralgia",
      "Facial Palsy",
      "Arthritis",
      "Atrioventricular Block",
      "Dementia (Reversible Neuroborreliosis)",
      "Myelitis",
      "Bullous Skin Lesions"
    ],
    "phenotype_categories": [
      "Dermatologic",
      "Constitutional",
      "Musculoskeletal",
      "Neurological",
      "Cardiac"
    ],
    "phenotype_ids": [
      "HP:0031180",
      "HP:0012378",
      "HP:0002829",
      "HP:0010628",
      "HP:0001369",
      "HP:0001678",
      "HP:0000726",
      "HP:0012486",
      "HP:0033804"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL",
      "RARE"
    ],
    "genes": [
      "HLA-DR4"
    ],
    "treatments": [
      "Oral Doxycycline",
      "Oral Amoxicillin",
      "Intravenous Ceftriaxone"
    ],
    "environmental": [
      "Tick Exposure",
      "Geographic Location",
      "Seasonal Exposure",
      "Outdoor Activities",
      "Non-Ixodes Tick Exposure"
    ],
    "biochemical": [
      "Anti-Borrelia Antibodies (IgM/IgG)",
      "Elevated ESR/CRP",
      "CSF Pleocytosis"
    ],
    "source_file": "Lyme_Disease.yaml",
    "page_url": "../pages/disorders/Lyme_Disease.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 3
  },
  {
    "name": "Lynch Syndrome",
    "disease_id": "MONDO:0005835",
    "category": "",
    "parents": [],
    "subtypes": [
      "MLH1 Mutation",
      "MSH2 Mutation",
      "MSH6 Mutation",
      "PMS2 Mutation",
      "EPCAM Deletion"
    ],
    "description": "Lynch syndrome is an autosomal dominant hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2). It significantly increases the risk of colorectal, endometrial, ovarian, and other cancers, typically presenting at younger ages than sporadic cancers.",
    "pathophysiology": [
      "DNA Mismatch Repair Deficiency",
      "Microsatellite Instability",
      "Accelerated Tumor Development",
      "Neoantigen Generation and Immune Activation"
    ],
    "cell_types": [
      "colonic epithelial cell",
      "endometrial epithelial cell",
      "CD8-positive, alpha-beta T cell"
    ],
    "cell_type_ids": [
      "CL:0000066",
      "CL:0002076",
      "CL:0000625"
    ],
    "biological_processes": [
      "DNA Repair",
      "response to DNA damage stimulus",
      "immune response",
      "type I interferon signaling pathway"
    ],
    "phenotypes": [
      "Colorectal Cancer",
      "Endometrial Cancer",
      "Stomach Cancer",
      "Urinary Tract Cancer",
      "Sebaceous Adenomas",
      "Urinary Tract Cancer",
      "Ovarian Cancer",
      "Sebaceous Adenomas",
      "Immunodeficiency",
      "Bowel Obstruction",
      "Metastatic Disease"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Gynecologic",
      "Genitourinary",
      "Dermatologic",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0012126",
      "HP:0002721",
      "HP:0005214",
      "HP:0002664"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "MLH1",
      "MSH2",
      "MSH6",
      "PMS2",
      "EPCAM"
    ],
    "treatments": [
      "Increased Cancer Surveillance",
      "Prophylactic Surgery",
      "Chemoprevention",
      "Targeted Therapies"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "Microsatellite Instability Testing",
      "Immunohistochemistry"
    ],
    "source_file": "Lynch_Syndrome.yaml",
    "page_url": "../pages/disorders/Lynch_Syndrome.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 4,
    "num_genes": 5,
    "num_treatments": 4
  },
  {
    "name": "Major Depressive Disorder",
    "disease_id": "MONDO:0002009",
    "category": "Complex",
    "parents": [
      "Psychiatric Disease",
      "Mood Disorder"
    ],
    "subtypes": [
      "Melancholic Depression",
      "Atypical Depression",
      "Psychotic Depression",
      "Seasonal Affective Disorder",
      "Peripartum Depression"
    ],
    "description": "Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.\n",
    "pathophysiology": [
      "Monoamine Deficiency",
      "HPA Axis Dysregulation",
      "Neuroplasticity Deficits",
      "Neuroinflammation",
      "Mitochondrial Dysfunction"
    ],
    "cell_types": [
      "Neuron",
      "Microglia"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0000129"
    ],
    "biological_processes": [
      "Serotonin Signaling",
      "Dopamine Signaling",
      "Cortisol Response",
      "Synaptic Plasticity"
    ],
    "phenotypes": [
      "Depressed Mood",
      "Anhedonia",
      "Sleep Disturbance",
      "Fatigue",
      "Poor Appetite",
      "Concentration Difficulties",
      "Psychomotor Changes"
    ],
    "phenotype_categories": [
      "Psychiatric",
      "Sleep",
      "Systemic",
      "Cognitive",
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0000716",
      "HP:0012154",
      "HP:0002360",
      "HP:0012378",
      "HP:0004396",
      "HP:0100543",
      "HP:0001266"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "SLC6A4",
      "BDNF",
      "FKBP5",
      "HTR2A"
    ],
    "treatments": [
      "Selective Serotonin Reuptake Inhibitors (SSRIs)",
      "Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)",
      "Cognitive Behavioral Therapy",
      "Electroconvulsive Therapy",
      "Ketamine/Esketamine",
      "Transcranial Magnetic Stimulation",
      "Behavioral Activation"
    ],
    "environmental": [
      "Childhood Trauma",
      "Chronic Stress",
      "Social Isolation",
      "Substance Abuse"
    ],
    "biochemical": [
      "Cortisol",
      "BDNF",
      "Inflammatory Markers"
    ],
    "source_file": "Major_Depressive_Disorder.yaml",
    "page_url": "../pages/disorders/Major_Depressive_Disorder.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 4,
    "num_treatments": 7
  },
  {
    "name": "Maple Syrup Urine Disease",
    "disease_id": "MONDO:0009563",
    "category": "Genetic",
    "parents": [
      "Metabolic Disease",
      "Inborn Error of Metabolism"
    ],
    "subtypes": [
      "Classic MSUD",
      "Intermediate MSUD",
      "Intermittent MSUD",
      "Thiamine-Responsive MSUD"
    ],
    "description": "Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.\n",
    "pathophysiology": [
      "Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency",
      "Leucine and Ketoacid Neurotoxicity",
      "Skeletal Muscle Dysfunction"
    ],
    "cell_types": [
      "hepatocyte",
      "neuron",
      "astrocyte",
      "skeletal muscle fiber"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000540",
      "CL:0000127",
      "CL:0008002"
    ],
    "biological_processes": [
      "branched-chain amino acid catabolic process",
      "generation of precursor metabolites and energy"
    ],
    "phenotypes": [
      "Abnormal Urinary Odor",
      "Poor Feeding",
      "Lethargy",
      "Encephalopathy",
      "Seizures",
      "Hypotonia",
      "Intellectual Disability",
      "Vomiting",
      "Coma",
      "Global Developmental Delay",
      "Elevated Branched Chain Amino Acids"
    ],
    "phenotype_categories": [
      "Other",
      "Neurological",
      "Biochemical"
    ],
    "phenotype_ids": [
      "HP:0012088",
      "HP:0008872",
      "HP:0001254",
      "HP:0006846",
      "HP:0001250",
      "HP:0001252",
      "HP:0001249",
      "HP:0002013",
      "HP:0001259",
      "HP:0001263",
      "HP:0008344"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OBLIGATE"
    ],
    "genes": [
      "BCKDHA",
      "BCKDHB",
      "DBT",
      "DLD"
    ],
    "treatments": [
      "BCAA-Restricted Diet",
      "Medical Formula",
      "Thiamine Supplementation",
      "Liver Transplantation",
      "Intravenous BCAA-Free Solution",
      "Acute Crisis Management",
      "Phenylbutyrate",
      "Metformin"
    ],
    "environmental": [
      "Dietary Protein",
      "Catabolic Stress",
      "Fever"
    ],
    "biochemical": [
      "Plasma Leucine",
      "Plasma Isoleucine",
      "Plasma Valine",
      "Alloisoleucine",
      "Alpha-Ketoisocaproic Acid (KIC)",
      "Alpha-Ketoisovaleric Acid (KIV)",
      "Alpha-Keto-beta-Methylvaleric Acid (KMV)"
    ],
    "source_file": "Maple_Syrup_Urine_Disease.yaml",
    "page_url": "../pages/disorders/Maple_Syrup_Urine_Disease.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 3,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Marfan Syndrome",
    "disease_id": "MONDO:0007947",
    "category": "Genetic",
    "parents": [
      "Connective Tissue Disorder"
    ],
    "subtypes": [],
    "description": "Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in FBN1, which encodes fibrillin-1. It affects multiple organ systems including the cardiovascular system (aortic root dilation and dissection), skeleton (tall stature, arachnodactyly, scoliosis), and eyes (ectopia lentis).",
    "pathophysiology": [
      "FBN1 Gene Mutation",
      "Dysregulated TGF-beta Signaling",
      "Extracellular Matrix Remodeling",
      "Impaired Mechanotransduction",
      "Vascular Inflammation",
      "Mitochondrial Dysfunction"
    ],
    "cell_types": [
      "vascular associated smooth muscle cell",
      "fibroblast",
      "endothelial cell",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000359",
      "CL:0000057",
      "CL:0000115",
      "CL:0000235"
    ],
    "biological_processes": [
      "transforming growth factor beta receptor signaling pathway",
      "SMAD protein signal transduction",
      "extracellular matrix organization",
      "proteolysis",
      "cellular response to mechanical stimulus",
      "integrin-mediated signaling pathway",
      "inflammatory response",
      "leukocyte migration",
      "mitochondrial ATP synthesis coupled electron transport",
      "response to oxidative stress"
    ],
    "phenotypes": [
      "Aortic Aneurysm",
      "Tall Stature",
      "Arachnodactyly",
      "Ectopia Lentis",
      "Scoliosis",
      "Pneumothorax",
      "Aortic Dissection",
      "Mitral Valve Prolapse",
      "Aortic Root Aneurysm"
    ],
    "phenotype_categories": [
      "Cardiovascular",
      "Musculoskeletal",
      "Ocular",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0004942",
      "HP:0000098",
      "HP:0001166",
      "HP:0001083",
      "HP:0002650",
      "HP:0002107",
      "HP:0002647",
      "HP:0001634",
      "HP:0002616"
    ],
    "frequencies": [
      "FREQUENT",
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "FBN1",
      "TGFBR1",
      "TGFBR2",
      "SMAD2",
      "SMAD3",
      "ACTA2",
      "AGTR1",
      "ITGAV",
      "NOS2",
      "VCAN"
    ],
    "treatments": [
      "Beta Blockers",
      "Angiotensin Receptor Blockers",
      "Aortic Surgery",
      "Orthopedic Interventions",
      "Vision Correction"
    ],
    "environmental": [
      "Physical Activity Restrictions"
    ],
    "biochemical": [
      "Fibrillin-1 Protein"
    ],
    "source_file": "Marfan_Syndrome.yaml",
    "page_url": "../pages/disorders/Marfan_Syndrome.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 6,
    "num_genes": 10,
    "num_treatments": 5
  },
  {
    "name": "Meckel Diverticulum",
    "disease_id": "MONDO:0007955",
    "category": "Congenital",
    "parents": [
      "Gastrointestinal Disease"
    ],
    "subtypes": [],
    "description": "Meckel diverticulum is the most common congenital malformation of the gastrointestinal tract, resulting from incomplete obliteration of the vitelline duct. It is a true diverticulum containing all layers of the intestinal wall and is typically located on the antimesenteric border of the ileum.",
    "pathophysiology": [
      "Incomplete Vitelline Duct Obliteration"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [],
    "phenotypes": [
      "Gastrointestinal Bleeding",
      "Intestinal Obstruction",
      "Diverticulitis",
      "Intestinal Perforation",
      "Intussusception",
      "Ectopic Gastric Mucosa"
    ],
    "phenotype_categories": [
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0002239",
      "HP:0005214",
      "MONDO:0004235",
      "MONDO:0006807",
      "MONDO:0007835"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [],
    "treatments": [
      "Surgical Resection for Symptomatic Cases",
      "Incidental Diverticulectomy with Stapling Devices"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Meckel_Diverticulum.yaml",
    "page_url": "../pages/disorders/Meckel_Diverticulum.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 1,
    "num_genes": 0,
    "num_treatments": 2
  },
  {
    "name": "Melanoma_in_Congenital_Melanocytic_Nevus",
    "disease_id": "MONDO:0850110",
    "category": "Skin Cancer",
    "parents": [
      "Congenital Melanocytic Nevus",
      "Melanoma"
    ],
    "subtypes": [],
    "description": "Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.",
    "pathophysiology": [
      "Genetic Mutations",
      "UV Exposure",
      "PI3K-AKT-mTOR Pathway Activation",
      "DNA Damage",
      "Uncontrolled Cell Growth"
    ],
    "cell_types": [
      "melanocyte",
      "neural crest cell"
    ],
    "cell_type_ids": [
      "CL:0000148",
      "CL:0011012"
    ],
    "biological_processes": [
      "MAPK cascade",
      "cellular senescence",
      "telomere maintenance",
      "phosphatidylinositol-mediated signaling",
      "TOR signaling"
    ],
    "phenotypes": [
      "Pigmented Lesion",
      "Nodules",
      "Lymphadenopathy",
      "Pruritus",
      "Ulceration",
      "Bleeding",
      "Hydrocephalus",
      "Seizures"
    ],
    "phenotype_categories": [
      "Dermatologic",
      "Systemic",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0002716",
      "HP:0000989",
      "HP:0000238",
      "HP:0001250"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "BRAF",
      "NRAS",
      "TERT",
      "CDKN2A",
      "TP53",
      "PTEN",
      "MET",
      "RAF1"
    ],
    "treatments": [
      "Surgical Excision",
      "Immunotherapy",
      "Targeted Therapy",
      "Radiation Therapy",
      "Chemotherapy"
    ],
    "environmental": [
      "UV Radiation"
    ],
    "biochemical": [],
    "source_file": "Melanoma_in_Congenital_Melanocytic_Nevus.yaml",
    "page_url": "../pages/disorders/Melanoma_in_Congenital_Melanocytic_Nevus.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 5,
    "num_genes": 8,
    "num_treatments": 5
  },
  {
    "name": "Meniere's Disease",
    "disease_id": "MONDO:0007972",
    "category": "Complex",
    "parents": [
      "Inner Ear Diseases",
      "Vestibular Disorders"
    ],
    "subtypes": [],
    "description": "Meniere's disease is characterized by distension of the endolymphatic space (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess production. This results in rupture of the membranous labyrinth and mixing of endolymph and perilymph, leading to vestibular and cochlear dysfunction.\n",
    "pathophysiology": [
      "Endolymphatic Hydrops",
      "Ion Transport Dysfunction",
      "Autoimmune and Inflammatory Mechanisms",
      "Blood-Labyrinth Barrier Dysfunction and Oxidative Stress"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "potassium ion transport",
      "sodium ion transport",
      "water homeostasis",
      "inflammatory response",
      "NF-kB signaling",
      "response to cytokine",
      "response to oxidative stress"
    ],
    "phenotypes": [
      "Episodic Vertigo",
      "Sensorineural Hearing Loss",
      "Tinnitus",
      "Aural Fullness",
      "Nausea and Vomiting"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0010532",
      "HP:0008573",
      "HP:0000360",
      "HP:0031704",
      "HP:0002017"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Low-Sodium Diet",
      "Diuretic Therapy",
      "Betahistine",
      "Intratympanic Injections",
      "Vestibular Rehabilitation",
      "Endolymphatic Sac Surgery"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Menieres_Disease.yaml",
    "page_url": "../pages/disorders/Meniere's_Disease.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 0,
    "num_treatments": 6
  },
  {
    "name": "Migraine",
    "disease_id": "MONDO:0005277",
    "category": "Complex",
    "parents": [
      "Neurological Disease"
    ],
    "subtypes": [
      "Migraine with Aura",
      "Migraine without Aura",
      "Chronic Migraine",
      "Vestibular Migraine"
    ],
    "description": "Wave of neuronal depolarization spreading across cortex underlies aura. Triggers activation of trigeminal pathways and may initiate headache phase.\n",
    "pathophysiology": [
      "Cortical Spreading Depression",
      "Trigeminovascular Activation",
      "Central Sensitization",
      "CGRP Pathway"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Neural Signaling",
      "Pain Signaling"
    ],
    "phenotypes": [
      "Headache",
      "Photophobia",
      "Phonophobia",
      "Nausea",
      "Visual Aura",
      "Vertigo"
    ],
    "phenotype_categories": [
      "Neurological",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0002315",
      "HP:0000613",
      "HP:0002183",
      "HP:0002018",
      "HP:0000505",
      "HP:0002321"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "CACNA1A",
      "ATP1A2",
      "SCN1A",
      "TRPM8",
      "LRP1"
    ],
    "treatments": [
      "Triptans",
      "NSAIDs",
      "CGRP Antagonists (Gepants)",
      "Beta Blockers",
      "Topiramate",
      "Valproate",
      "CGRP Monoclonal Antibodies",
      "Botulinum Toxin",
      "Neuromodulation"
    ],
    "environmental": [
      "Stress",
      "Sleep Disturbance",
      "Hormonal Changes",
      "Dietary Triggers",
      "Weather Changes",
      "Sensory Stimuli"
    ],
    "biochemical": [
      "CGRP",
      "Serotonin"
    ],
    "source_file": "Migraine.yaml",
    "page_url": "../pages/disorders/Migraine.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 5,
    "num_treatments": 9
  },
  {
    "name": "Mixed Connective Tissue Disease",
    "disease_id": "MONDO:0005854",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Connective Tissue Disease"
    ],
    "subtypes": [],
    "description": "An autoimmune overlap syndrome characterized by features of systemic lupus erythematosus, systemic sclerosis, and polymyositis, with high titers of anti-U1 RNP antibodies. Patients typically present with Raynaud's phenomenon, swollen hands, arthritis, and myositis.",
    "pathophysiology": [
      "Anti-U1 RNP Autoimmunity",
      "T Cell-Mediated Inflammation",
      "Vascular Dysfunction",
      "Muscle Inflammation",
      "Type I Interferon Signature"
    ],
    "cell_types": [
      "CD4+ T Cell",
      "Endothelial Cell",
      "Skeletal Muscle Cell"
    ],
    "cell_type_ids": [
      "CL:0000624",
      "CL:0000115",
      "CL:0000188"
    ],
    "biological_processes": [
      "Immunoglobulin Production",
      "Adaptive Immune Response",
      "Blood Vessel Development",
      "Inflammatory Response",
      "Type I Interferon Signaling Pathway"
    ],
    "phenotypes": [
      "Raynaud Phenomenon",
      "Arthritis",
      "Myopathy",
      "Edema"
    ],
    "phenotype_categories": [
      "Vascular",
      "Musculoskeletal",
      "Dermatological"
    ],
    "phenotype_ids": [
      "HP:0030880",
      "HP:0001369",
      "HP:0003198",
      "HP:0000969"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DR4"
    ],
    "treatments": [
      "NSAIDs",
      "Corticosteroids",
      "Methotrexate",
      "Hydroxychloroquine"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-U1 RNP Antibodies",
      "ANA"
    ],
    "source_file": "Mixed_Connective_Tissue_Disease.yaml",
    "page_url": "../pages/disorders/Mixed_Connective_Tissue_Disease.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 5,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Monkeypox",
    "disease_id": "MONDO:0002594",
    "category": "Viral Disease",
    "parents": [
      "Zoonotic Infection",
      "Orthopoxvirus Infection"
    ],
    "subtypes": [
      "West African Clade",
      "Central African (Congo Basin) Clade"
    ],
    "description": "MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.",
    "pathophysiology": [
      "Viral Entry and Initial Replication",
      "Lymphatic Dissemination",
      "Hematogenous Spread and Viremia",
      "Viral Factory Formation",
      "Extracellular Enveloped Virion Formation",
      "Immune Evasion",
      "Skin Lesion Pathogenesis"
    ],
    "cell_types": [
      "keratinocyte",
      "Langerhans cell",
      "dendritic cell",
      "monocyte",
      "natural killer cell"
    ],
    "cell_type_ids": [
      "CL:0000312",
      "CL:0000453",
      "CL:0000451",
      "CL:0000576",
      "CL:0000623"
    ],
    "biological_processes": [
      "viral entry into host cell",
      "viral genome replication",
      "leukocyte migration",
      "virion attachment to host cell",
      "virion assembly",
      "viral budding via host ESCRT complex",
      "viral release from host cell",
      "type I interferon signaling pathway",
      "innate immune response",
      "I-kappaB kinase/NF-kappaB signaling"
    ],
    "phenotypes": [
      "Rash",
      "Fever",
      "Myalgia",
      "Lymphadenopathy",
      "Headache",
      "Fatigue",
      "Nausea",
      "Vomiting",
      "Sore Throat",
      "Conjunctivitis",
      "Pustule",
      "Vesicles",
      "Genital Lesions",
      "Scarring",
      "Secondary Infections"
    ],
    "phenotype_categories": [
      "Dermatologic",
      "Systemic",
      "Musculoskeletal",
      "Lymphatic",
      "Gastrointestinal",
      "Respiratory",
      "Ophthalmic"
    ],
    "phenotype_ids": [
      "HP:0000988",
      "HP:0001945",
      "HP:0003326",
      "HP:0002716",
      "HP:0002315",
      "HP:0012378",
      "HP:0002018",
      "HP:0002013",
      "HP:0000509",
      "HP:0033605",
      "HP:0200037",
      "HP:0100699",
      "HP:0002719"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "Monkeypox Virus Genome",
      "EGFR",
      "STAT1",
      "JAK2",
      "IRF3",
      "NFKB1",
      "IL6",
      "CXCL8",
      "IFNG"
    ],
    "treatments": [
      "Supportive Care",
      "Antiviral Therapy",
      "Vaccination",
      "Cidofovir",
      "Brincidofovir",
      "Isolation and Infection Control"
    ],
    "environmental": [],
    "biochemical": [
      "Monkeypox Virus PCR",
      "Serology for Orthopoxvirus Antibodies"
    ],
    "source_file": "Monkeypox.yaml",
    "page_url": "../pages/disorders/Monkeypox.html",
    "num_phenotypes": 15,
    "num_pathophysiology": 7,
    "num_genes": 9,
    "num_treatments": 6
  },
  {
    "name": "Multiple Sclerosis",
    "disease_id": "MONDO:0005301",
    "category": "Neurological Disorder",
    "parents": [
      "Autoimmune Disorder"
    ],
    "subtypes": [],
    "description": "The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.",
    "pathophysiology": [
      "Demyelination",
      "Axonal Damage",
      "Inflammatory Lesions"
    ],
    "cell_types": [
      "Oligodendrocyte",
      "T cell",
      "B cell",
      "Microglial cell",
      "Astrocyte",
      "CD4-positive, alpha-beta T cell"
    ],
    "cell_type_ids": [
      "CL:0000128",
      "CL:0000084",
      "CL:0000236",
      "CL:0000129",
      "CL:0000127",
      "CL:0000624"
    ],
    "biological_processes": [
      "Antigen processing and presentation of peptide antigen via MHC class II",
      "T cell activation",
      "Cytokine-mediated signaling pathway",
      "Complement activation",
      "Myelination"
    ],
    "phenotypes": [
      "Muscle Weakness",
      "Vision Problems",
      "Fatigue",
      "Gait and Balance Issues",
      "Spasticity",
      "Cognitive Impairment",
      "Bladder and Bowel Dysfunction",
      "Sensory Disturbances",
      "Ataxia",
      "Optic Neuritis",
      "Dysesthesia"
    ],
    "phenotype_categories": [
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0001324",
      "HP:0012378",
      "HP:0001257",
      "HP:0100543",
      "HP:0001251",
      "HP:0100653",
      "HP:0012534"
    ],
    "frequencies": [
      "FREQUENT",
      "VERY_FREQUENT",
      "COMMON"
    ],
    "genes": [
      "HLA-DRB1",
      "IL7R",
      "IL2RA",
      "TYK2",
      "CD40",
      "TNFRSF1A"
    ],
    "treatments": [
      "Disease-Modifying Therapies (DMTs)",
      "Symptomatic Treatments",
      "Physical Therapy and Rehabilitation",
      "Corticosteroids"
    ],
    "environmental": [
      "Vitamin D Deficiency",
      "Epstein-Barr Virus Infection"
    ],
    "biochemical": [
      "Oligoclonal Bands"
    ],
    "source_file": "Multiple_Sclerosis.yaml",
    "page_url": "../pages/disorders/Multiple_Sclerosis.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 3,
    "num_genes": 6,
    "num_treatments": 4
  },
  {
    "name": "Multisystem Inflammatory Syndrome in Children (MIS-C)",
    "disease_id": "MONDO:0100163",
    "category": "Complex",
    "parents": [
      "Pediatric Condition",
      "Inflammatory Syndrome"
    ],
    "subtypes": [],
    "description": "A rare but serious condition associated with COVID-19, causing systemic inflammation in children.",
    "pathophysiology": [
      "Post-Infectious Hyperinflammatory Response",
      "Cytokine Storm",
      "T-Cell Receptor V\u03b221.3 Skewing and IL-18-FAS Activation",
      "Molecular Mimicry and SNX8 Autoimmunity",
      "Endothelial Injury and Complement Activation",
      "Intestinal Barrier Dysfunction and Antigen Persistence",
      "Cardiac Involvement and Myocardial Dysfunction"
    ],
    "cell_types": [
      "monocyte",
      "T cell",
      "natural killer cell",
      "neutrophil",
      "B cell",
      "endothelial cell",
      "enterocyte",
      "cardiac muscle cell"
    ],
    "cell_type_ids": [
      "CL:0000576",
      "CL:0000084",
      "CL:0000623",
      "CL:0000775",
      "CL:0000236",
      "CL:0000115",
      "CL:0000584",
      "CL:0000746"
    ],
    "biological_processes": [
      "inflammatory response",
      "cytokine-mediated signaling pathway",
      "T cell activation",
      "immune response-activating signal transduction",
      "response to virus",
      "complement activation",
      "blood coagulation"
    ],
    "phenotypes": [
      "Fever",
      "Hypotension",
      "Abdominal Pain",
      "Rash",
      "Coagulopathy",
      "Headache",
      "Cough",
      "Myocarditis",
      "Reduced Left Ventricular Ejection Fraction",
      "Diarrhea",
      "Lymphopenia",
      "Conjunctival Injection"
    ],
    "phenotype_categories": [
      "Systemic",
      "Cardiovascular",
      "Gastrointestinal",
      "Dermatologic",
      "Hematologic",
      "Neurologic",
      "Respiratory",
      "Ophthalmic"
    ],
    "phenotype_ids": [
      "HP:0001945",
      "HP:0002615",
      "HP:0002027",
      "HP:0000988",
      "HP:0003256",
      "HP:0002315",
      "HP:0012735",
      "HP:0012819",
      "HP:0012664",
      "HP:0002014",
      "HP:0001888",
      "HP:0030953"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "IL6",
      "IL10",
      "TNF",
      "IL18",
      "FAS",
      "TRBV11-2",
      "SNX8",
      "MAVS",
      "CFH",
      "IL1RN",
      "IFNG",
      "IL17A",
      "IL1B",
      "CXCL9",
      "CXCL10",
      "PLA2G2A"
    ],
    "treatments": [
      "Intravenous Immunoglobulin (IVIG)",
      "Corticosteroids",
      "Aspirin",
      "Supportive Care"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "C-Reactive Protein (CRP)",
      "Erythrocyte Sedimentation Rate (ESR)",
      "Ferritin",
      "D-dimer"
    ],
    "source_file": "Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml",
    "page_url": "../pages/disorders/Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 7,
    "num_genes": 16,
    "num_treatments": 4
  },
  {
    "name": "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome",
    "disease_id": "MONDO:0005404",
    "category": "Complex",
    "parents": [
      "Neurological Disorder",
      "Immune Disorder"
    ],
    "subtypes": [],
    "description": "Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.",
    "pathophysiology": [
      "Innate Immune Hyperreactivity",
      "Natural Killer Cell Dysfunction",
      "T-Cell Immunometabolic Dysfunction",
      "Endothelial Dysfunction and Coagulopathy",
      "TRPM3 Ion Channel Dysfunction",
      "Neuroinflammation and Cerebral Hypoperfusion",
      "Mitochondrial Dysfunction"
    ],
    "cell_types": [
      "Natural Killer Cell",
      "Monocyte",
      "CD8+ T Cell",
      "CD4+ T Cell",
      "Endothelial Cell",
      "Platelet"
    ],
    "cell_type_ids": [
      "CL:0000623",
      "CL:0000576",
      "CL:0000625",
      "CL:0000624",
      "CL:0000115",
      "CL:0000233"
    ],
    "biological_processes": [
      "Innate Immune Response",
      "Complement Activation",
      "T Cell Activation",
      "Glycolysis",
      "Blood Coagulation",
      "Platelet Activation",
      "Calcium Ion Transmembrane Transport",
      "Fatty Acid Beta-Oxidation",
      "Response to Oxidative Stress"
    ],
    "phenotypes": [
      "Post-Exertional Malaise",
      "Fatigue",
      "Cognitive Impairment",
      "Orthostatic Intolerance",
      "Sleep Disturbance",
      "Myalgia",
      "Headache",
      "Recurrent Infections",
      "Gastrointestinal Symptoms",
      "Sensory Sensitivity"
    ],
    "phenotype_categories": [
      "Neurological",
      "Cardiovascular",
      "Musculoskeletal",
      "Immune",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0030973",
      "HP:0012378",
      "HP:0100543",
      "HP:0001278",
      "HP:0002360",
      "HP:0003326",
      "HP:0002315"
    ],
    "frequencies": [
      "OBLIGATE",
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DRB1"
    ],
    "treatments": [
      "Pacing",
      "Symptomatic Treatment",
      "Low-Dose Naltrexone"
    ],
    "environmental": [
      "Viral Infections",
      "SARS-CoV-2 Infection"
    ],
    "biochemical": [
      "Natural Killer Cell Cytotoxicity",
      "Inflammatory Cytokines",
      "Oxidative Stress Markers"
    ],
    "source_file": "Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml",
    "page_url": "../pages/disorders/Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 7,
    "num_genes": 1,
    "num_treatments": 3
  },
  {
    "name": "Myasthenia Gravis",
    "disease_id": "MONDO:0009688",
    "category": "Autoimmune",
    "parents": [
      "Neuromuscular Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [
      "AChR Antibody-Positive MG",
      "MuSK Antibody-Positive MG",
      "Seronegative MG",
      "Ocular MG",
      "Thymoma-Associated MG"
    ],
    "description": "Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.\n",
    "pathophysiology": [
      "Autoantibody-Mediated NMJ Dysfunction",
      "Complement Activation",
      "Thymic Abnormalities"
    ],
    "cell_types": [
      "Skeletal Muscle Cell",
      "Thymic Epithelial Cell"
    ],
    "cell_type_ids": [
      "CL:0000188",
      "CL:0002293"
    ],
    "biological_processes": [
      "Neuromuscular Transmission",
      "Complement Activation"
    ],
    "phenotypes": [
      "Muscle Weakness",
      "Ptosis",
      "Diplopia",
      "Dysphagia",
      "Dysarthria",
      "Respiratory Insufficiency",
      "Fatigability"
    ],
    "phenotype_categories": [
      "Neuromuscular",
      "Ocular",
      "Bulbar",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001324",
      "HP:0000508",
      "HP:0000651",
      "HP:0002015",
      "HP:0001260",
      "HP:0002093",
      "HP:0003473"
    ],
    "frequencies": [
      "OBLIGATE",
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-B8",
      "HLA-DR3",
      "CHRNA1"
    ],
    "treatments": [
      "Acetylcholinesterase Inhibitors",
      "Corticosteroids",
      "Thymectomy",
      "Azathioprine",
      "Mycophenolate Mofetil",
      "Rituximab",
      "Eculizumab",
      "Plasma Exchange",
      "Intravenous Immunoglobulin"
    ],
    "environmental": [
      "Infections",
      "Medications",
      "Stress",
      "Pregnancy"
    ],
    "biochemical": [
      "Anti-AChR Antibodies",
      "Anti-MuSK Antibodies",
      "Anti-LRP4 Antibodies"
    ],
    "source_file": "Myasthenia_Gravis.yaml",
    "page_url": "../pages/disorders/Myasthenia_Gravis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 9
  },
  {
    "name": "Narcolepsy",
    "disease_id": "MONDO:0021107",
    "category": "Neurological",
    "parents": [
      "Sleep Disorder",
      "Neurological Disease"
    ],
    "subtypes": [
      "Narcolepsy Type 1",
      "Narcolepsy Type 2"
    ],
    "description": "Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.\n",
    "pathophysiology": [
      "Orexin/Hypocretin Deficiency",
      "Autoimmune Destruction"
    ],
    "cell_types": [
      "Orexin Neuron"
    ],
    "cell_type_ids": [
      "CL:0011109"
    ],
    "biological_processes": [
      "Sleep-Wake Regulation",
      "Autoimmune Response"
    ],
    "phenotypes": [
      "Excessive Daytime Sleepiness",
      "Cataplexy",
      "Sleep Paralysis",
      "Hypnagogic Hallucinations",
      "Disrupted Nighttime Sleep"
    ],
    "phenotype_categories": [
      "Sleep",
      "Motor",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0002329",
      "HP:0002524",
      "HP:0025233",
      "HP:0002519",
      "HP:0002360"
    ],
    "frequencies": [
      "OBLIGATE",
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DQB1*06:02",
      "HCRT",
      "HCRTR2"
    ],
    "treatments": [
      "Sodium Oxybate",
      "Modafinil",
      "Pitolisant",
      "Solriamfetol",
      "Amphetamines",
      "Antidepressants",
      "Scheduled Naps"
    ],
    "environmental": [
      "H1N1 Infection",
      "Pandemrix Vaccine",
      "Streptococcal Infection"
    ],
    "biochemical": [
      "CSF Orexin/Hypocretin-1"
    ],
    "source_file": "Narcolepsy.yaml",
    "page_url": "../pages/disorders/Narcolepsy.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 2,
    "num_genes": 3,
    "num_treatments": 7
  },
  {
    "name": "Nephronophthisis",
    "disease_id": "MONDO:0019005",
    "category": "Genetic",
    "parents": [
      "Tubulointerstitial Kidney Disease",
      "Ciliopathy"
    ],
    "subtypes": [
      "Infantile Nephronophthisis",
      "Juvenile Nephronophthisis",
      "Adolescent Nephronophthisis"
    ],
    "description": "Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.",
    "pathophysiology": [
      "Ciliary Dysfunction",
      "Impaired Cell Signaling",
      "Renal Tubular Dysfunction",
      "Interstitial Fibrosis",
      "Renal Cyst Formation",
      "Renal Insufficiency",
      "Extrarenal Manifestations",
      "Progression and Severity",
      "Abnormal Cell Proliferation",
      "DNA Damage and Senescence",
      "Aberrant Actin Remodeling and Hippo Activation"
    ],
    "cell_types": [
      "Renal Tubular Epithelial Cell",
      "Renal Interstitial Fibroblast"
    ],
    "cell_type_ids": [
      "CL:1000494",
      "CL:1000692"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Progressive Renal Failure",
      "Hypertension",
      "Fibrosis",
      "Retinitis Pigmentosa",
      "Growth Retardation",
      "Bone Deformities",
      "Secondary Hyperparathyroidism",
      "Polyuria",
      "Polydipsia",
      "Electrolyte Imbalance",
      "End-Stage Renal Disease"
    ],
    "phenotype_categories": [
      "Renal",
      "Cardiovascular",
      "Hepatic",
      "Ophthalmologic",
      "Developmental",
      "Musculoskeletal",
      "Endocrine",
      "Systemic",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0000822",
      "HP:0000510",
      "HP:0001510",
      "HP:0000867",
      "HP:0000103",
      "HP:0001959",
      "HP:0003111",
      "HP:0003774"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "NPHP1",
      "NPHP3",
      "NPHP4",
      "INVS",
      "NEK8"
    ],
    "treatments": [
      "Renal Replacement Therapy",
      "Antihypertensive Therapy",
      "Supportive Care"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "Serum Creatinine",
      "Elevated Blood Urea Nitrogen (BUN)"
    ],
    "source_file": "Nephronophthisis.yaml",
    "page_url": "../pages/disorders/Nephronophthisis.html",
    "num_phenotypes": 11,
    "num_pathophysiology": 11,
    "num_genes": 5,
    "num_treatments": 3
  },
  {
    "name": "Non-Small Cell Lung Cancer",
    "disease_id": "MONDO:0005233",
    "category": "",
    "parents": [],
    "subtypes": [
      "Adenosquamous Carcinoma",
      "ALK-rearranged NSCLC",
      "EGFR-mutant NSCLC"
    ],
    "description": "Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival.",
    "pathophysiology": [
      "Oncogenic Driver Mutations",
      "Immune Evasion",
      "Angiogenesis",
      "Tumor Microenvironment Remodeling",
      "Metabolic Rewiring",
      "Metastasis"
    ],
    "cell_types": [
      "macrophage",
      "T cell",
      "natural killer cell",
      "fibroblast"
    ],
    "cell_type_ids": [
      "CL:0000235",
      "CL:0000084",
      "CL:0000623",
      "CL:0000057"
    ],
    "biological_processes": [
      "transmembrane receptor protein tyrosine kinase signaling pathway",
      "MAPK cascade",
      "epithelial to mesenchymal transition",
      "regulation of T cell activation",
      "pentose-phosphate shunt",
      "cellular response to oxidative stress"
    ],
    "phenotypes": [
      "Persistent Cough",
      "Hemoptysis",
      "Weight Loss",
      "Bone Pain",
      "Fatigue",
      "Bone Pain",
      "Chest Pain",
      "Recurrent Pneumonia",
      "Headache"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Systemic",
      "Musculoskeletal",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0002105",
      "HP:0001824",
      "HP:0002653",
      "HP:0012378",
      "HP:0100749",
      "HP:0006532",
      "HP:0002315"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "EGFR",
      "ALK",
      "ROS1",
      "KRAS",
      "STK11",
      "KEAP1",
      "TP53",
      "G6PD"
    ],
    "treatments": [
      "Surgery",
      "Chemotherapy",
      "Targeted Therapy",
      "Immunotherapy",
      "Radiation Therapy"
    ],
    "environmental": [
      "Smoking",
      "Radon Exposure"
    ],
    "biochemical": [
      "Carcinoembryonic Antigen",
      "Cytokeratin Fragment 21-1"
    ],
    "source_file": "Non-Small_Cell_Lung_Cancer.yaml",
    "page_url": "../pages/disorders/Non-Small_Cell_Lung_Cancer.html",
    "num_phenotypes": 9,
    "num_pathophysiology": 6,
    "num_genes": 8,
    "num_treatments": 5
  },
  {
    "name": "Obesity",
    "disease_id": "MONDO:0011122",
    "category": "Complex",
    "parents": [
      "Metabolic Disease"
    ],
    "subtypes": [],
    "description": "Chronic positive energy balance from excess caloric intake relative to expenditure leads to fat accumulation. Multiple regulatory systems (leptin, ghrelin, insulin) fail to restore balance.\n",
    "pathophysiology": [
      "Energy Imbalance",
      "Adipose Tissue Dysfunction",
      "Chronic Low-Grade Inflammation",
      "Hypothalamic Dysregulation",
      "Adipocyte Mitochondrial Dysfunction"
    ],
    "cell_types": [
      "Adipocyte",
      "Adipose Tissue Macrophage",
      "Hypothalamus Cell",
      "Microglial Cell"
    ],
    "cell_type_ids": [
      "CL:0000136",
      "CL:0000863",
      "CL:2000030",
      "CL:0000129"
    ],
    "biological_processes": [
      "Energy Homeostasis",
      "Adipokine Secretion",
      "Inflammatory Response",
      "Feeding Behavior",
      "Mitochondrial Fission",
      "Fatty Acid Oxidation"
    ],
    "phenotypes": [
      "Increased Body Mass Index",
      "Insulin Resistance",
      "Dyslipidemia",
      "Hypertension",
      "Obstructive Sleep Apnea",
      "Joint Pain",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Metabolic",
      "Cardiovascular",
      "Respiratory",
      "Musculoskeletal",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0001513",
      "HP:0000855",
      "HP:0003077",
      "HP:0000822",
      "HP:0010535",
      "HP:0002829",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "FTO",
      "MC4R",
      "LEP",
      "LEPR",
      "POMC"
    ],
    "treatments": [
      "Lifestyle Modification",
      "GLP-1 Receptor Agonists",
      "GLP-1/GIP Dual Agonists",
      "Bariatric Surgery",
      "Behavioral Therapy",
      "Orlistat"
    ],
    "environmental": [
      "High-Calorie Diet",
      "Sedentary Lifestyle",
      "Obesogenic Environment",
      "Sleep Deprivation",
      "Psychological Stress"
    ],
    "biochemical": [
      "Leptin",
      "Adiponectin",
      "C-Reactive Protein",
      "Fasting Insulin"
    ],
    "source_file": "Obesity.yaml",
    "page_url": "../pages/disorders/Obesity.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 5,
    "num_treatments": 6
  },
  {
    "name": "Obstructive Sleep Apnea",
    "disease_id": "MONDO:0007147",
    "category": "Complex",
    "parents": [
      "Respiratory Disease",
      "Sleep Disorder"
    ],
    "subtypes": [],
    "description": "During sleep, reduced muscle tone allows pharyngeal soft tissues to collapse, obstructing airflow. Anatomical factors (retrognathia, large tonsils, obesity) predispose to collapse.\n",
    "pathophysiology": [
      "Upper Airway Collapse",
      "Intermittent Hypoxia",
      "Sleep Fragmentation",
      "Sympathetic Overactivation",
      "Systemic Inflammation"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Muscle Relaxation",
      "Response to Hypoxia",
      "Sleep Regulation",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Snoring",
      "Witnessed Apneas",
      "Excessive Daytime Sleepiness",
      "Morning Headaches",
      "Nocturia",
      "Cognitive Impairment",
      "Hypertension"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Neurological",
      "Urological",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0025267",
      "HP:0010535",
      "HP:0001262",
      "HP:0002315",
      "HP:0000017",
      "HP:0100543",
      "HP:0000822"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "PHOX2B",
      "Craniofacial genes"
    ],
    "treatments": [
      "CPAP",
      "BiPAP",
      "Oral Appliances",
      "Weight Loss",
      "Positional Therapy",
      "Surgery",
      "Hypoglossal Nerve Stimulation"
    ],
    "environmental": [
      "Obesity",
      "Alcohol",
      "Sedatives",
      "Supine Sleep Position",
      "Nasal Congestion"
    ],
    "biochemical": [
      "Oxygen Saturation",
      "CRP",
      "Catecholamines"
    ],
    "source_file": "Obstructive_Sleep_Apnea.yaml",
    "page_url": "../pages/disorders/Obstructive_Sleep_Apnea.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 2,
    "num_treatments": 7
  },
  {
    "name": "Osteoarthritis",
    "disease_id": "MONDO:0005178",
    "category": "Complex",
    "parents": [
      "Musculoskeletal Disease",
      "Degenerative Joint Disease"
    ],
    "subtypes": [
      "Primary Osteoarthritis",
      "Secondary Osteoarthritis",
      "Erosive Osteoarthritis"
    ],
    "description": "Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.\n",
    "pathophysiology": [
      "Cartilage Degradation",
      "Subchondral Bone Changes",
      "Synovial Inflammation"
    ],
    "cell_types": [
      "Chondrocyte",
      "Osteoblast",
      "Osteoclast",
      "Synoviocyte",
      "Macrophage"
    ],
    "cell_type_ids": [
      "CL:0000138",
      "CL:0000062",
      "CL:0000092",
      "CL:0000214",
      "CL:0000235"
    ],
    "biological_processes": [
      "Cartilage Catabolism",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Joint Pain",
      "Joint Stiffness",
      "Joint Swelling",
      "Reduced Range of Motion",
      "Crepitus"
    ],
    "phenotype_categories": [
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0002829",
      "HP:0001387",
      "HP:0001386",
      "HP:0001376",
      "HP:0034431"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "GDF5",
      "FRZB",
      "ASPN",
      "COL2A1"
    ],
    "treatments": [
      "Acetaminophen",
      "NSAIDs",
      "Physical Therapy",
      "Weight Loss",
      "Intra-articular Corticosteroid Injections",
      "Intra-articular Hyaluronic Acid",
      "Joint Replacement Surgery"
    ],
    "environmental": [
      "Obesity",
      "Joint Injury",
      "Occupational Overuse",
      "Age"
    ],
    "biochemical": [],
    "source_file": "Osteoarthritis.yaml",
    "page_url": "../pages/disorders/Osteoarthritis.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 3,
    "num_genes": 4,
    "num_treatments": 7
  },
  {
    "name": "Osteoporosis",
    "disease_id": "MONDO:0005298",
    "category": "Complex",
    "parents": [
      "Musculoskeletal Disease",
      "Metabolic Disease"
    ],
    "subtypes": [],
    "description": "Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.\n",
    "pathophysiology": [
      "Bone Remodeling Imbalance",
      "RANKL/OPG Dysregulation",
      "Microarchitectural Deterioration"
    ],
    "cell_types": [
      "Osteoclast",
      "Osteoblast"
    ],
    "cell_type_ids": [
      "CL:0000092",
      "CL:0000062"
    ],
    "biological_processes": [
      "Bone Remodeling",
      "Osteoclast Differentiation"
    ],
    "phenotypes": [
      "Decreased Bone Mineral Density",
      "Vertebral Fractures",
      "Femur Fractures",
      "Kyphosis",
      "Height Loss"
    ],
    "phenotype_categories": [
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0004349",
      "HP:0002953",
      "HP:0031846",
      "HP:0002808",
      "HP:0004322"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "LRP5",
      "SOST",
      "ESR1",
      "VDR"
    ],
    "treatments": [
      "Bisphosphonates",
      "Denosumab",
      "Teriparatide",
      "Romosozumab",
      "Calcium Supplementation",
      "Vitamin D Supplementation",
      "Weight-Bearing Exercise"
    ],
    "environmental": [
      "Estrogen Deficiency",
      "Calcium Deficiency",
      "Vitamin D Deficiency",
      "Sedentary Lifestyle",
      "Smoking",
      "Glucocorticoid Use"
    ],
    "biochemical": [
      "Bone Turnover Markers",
      "Calcium",
      "Vitamin D",
      "PTH"
    ],
    "source_file": "Osteoporosis.yaml",
    "page_url": "../pages/disorders/Osteoporosis.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 3,
    "num_genes": 4,
    "num_treatments": 7
  },
  {
    "name": "Parkinson's Disease",
    "disease_id": "MONDO:0005180",
    "category": "Complex",
    "parents": [
      "Neurodegenerative Disease",
      "Movement Disorder"
    ],
    "subtypes": [],
    "description": "Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.\n",
    "pathophysiology": [
      "Dopaminergic Neuron Loss",
      "Alpha-Synuclein Aggregation",
      "Mitochondrial Dysfunction",
      "Neuroinflammation",
      "Autophagy-Lysosome Pathway Dysfunction",
      "Gut-Brain Axis Dysfunction",
      "Oxidative Stress",
      "Calcium Dysregulation",
      "Endoplasmic Reticulum Stress",
      "Synaptic Dysfunction",
      "Iron Accumulation and Ferroptosis",
      "Blood-Brain Barrier Dysfunction"
    ],
    "cell_types": [
      "Dopaminergic Neuron",
      "Microglia",
      "Astrocyte",
      "Enteric Neuron",
      "Enteroendocrine Cell",
      "Brain Endothelial Cell",
      "Pericyte"
    ],
    "cell_type_ids": [
      "CL:0000700",
      "CL:0000129",
      "CL:0000127",
      "CL:0000107",
      "CL:0000164",
      "CL:0002618",
      "CL:0000669"
    ],
    "biological_processes": [
      "Dopamine Biosynthesis",
      "inclusion body assembly",
      "mitochondrion organization",
      "Autophagy",
      "Chaperone-mediated Autophagy",
      "Inflammatory Response",
      "Response to Oxidative Stress",
      "ROS Metabolic Process",
      "Calcium Ion Homeostasis",
      "Calcium Ion Transport",
      "ER Stress Response",
      "Unfolded Protein Response",
      "Synaptic Vesicle Cycle",
      "Synaptic Vesicle Endocytosis",
      "Iron Ion Homeostasis",
      "Ferroptosis",
      "BBB Maintenance",
      "Vascular Permeability"
    ],
    "phenotypes": [
      "Resting Tremor",
      "Bradykinesia",
      "Rigidity",
      "Postural Instability",
      "Hyposmia",
      "Constipation",
      "Depression"
    ],
    "phenotype_categories": [
      "Neurological",
      "Sensory",
      "Gastrointestinal",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0002322",
      "HP:0002067",
      "HP:0002063",
      "HP:0002172",
      "HP:0004409",
      "HP:0002019",
      "HP:0000716"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "SNCA",
      "LRRK2",
      "GBA",
      "PARK2",
      "PINK1"
    ],
    "treatments": [
      "Levodopa/Carbidopa",
      "Dopamine Agonists",
      "MAO-B Inhibitors",
      "COMT Inhibitors",
      "Deep Brain Stimulation",
      "Physical Therapy"
    ],
    "environmental": [
      "Pesticide Exposure",
      "Rural Living",
      "Head Trauma"
    ],
    "biochemical": [],
    "source_file": "Parkinsons_Disease.yaml",
    "page_url": "../pages/disorders/Parkinson's_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 12,
    "num_genes": 5,
    "num_treatments": 6
  },
  {
    "name": "Parvovirus B19 Infection",
    "disease_id": "MONDO:0006544",
    "category": "Viral Disease",
    "parents": [
      "Infectious Disease",
      "Childhood Infection"
    ],
    "subtypes": [],
    "description": "Parvovirus B19 is a single-stranded DNA virus that primarily infects erythroid progenitor cells, causing erythema infectiosum (fifth disease) in children and arthropathy in adults. It can cause severe complications including transient aplastic crisis in patients with hemolytic disorders and hydrops fetalis in pregnant women.",
    "pathophysiology": [
      "Viral Replication",
      "Immune Response",
      "Receptor-Mediated Entry",
      "Cell Cycle Arrest and Apoptosis",
      "EPO-STAT5 Signaling Pathway"
    ],
    "cell_types": [
      "Erythroid Progenitor Cells"
    ],
    "cell_type_ids": [
      "CL:0000038"
    ],
    "biological_processes": [
      "viral genome replication",
      "DNA replication",
      "viral entry into host cell",
      "endocytosis",
      "DNA damage response",
      "cell cycle arrest",
      "apoptotic process",
      "JAK-STAT cascade"
    ],
    "phenotypes": [
      "Erythema Infectiosum (Fifth Disease)",
      "Transient Aplastic Crisis",
      "Arthropathy",
      "Hydrops Fetalis",
      "Slapped Cheek Rash",
      "Myocarditis"
    ],
    "phenotype_categories": [
      "Dermatologic",
      "Hematologic",
      "Musculoskeletal",
      "Fetal",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0003040",
      "HP:0001789",
      "HP:0025300",
      "HP:0012819"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT",
      "RARE"
    ],
    "genes": [],
    "treatments": [
      "Supportive Care",
      "Intravenous Immunoglobulin (IVIG)"
    ],
    "environmental": [
      "Personal Hygiene"
    ],
    "biochemical": [
      "Parvovirus B19 Serology",
      "Parvovirus B19 DNA PCR"
    ],
    "source_file": "Parvovirus_B19_Infection.yaml",
    "page_url": "../pages/disorders/Parvovirus_B19_Infection.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 5,
    "num_genes": 0,
    "num_treatments": 2
  },
  {
    "name": "Pemphigus Vulgaris",
    "disease_id": "MONDO:0008219",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Skin Disease"
    ],
    "subtypes": [],
    "description": "A potentially life-threatening autoimmune blistering disease caused by autoantibodies against desmoglein 3 (and often desmoglein 1), leading to loss of keratinocyte adhesion (acantholysis) and intraepidermal blister formation. Mucosal involvement often precedes skin lesions.",
    "pathophysiology": [
      "Anti-Desmoglein Autoantibodies",
      "Acantholysis and Blister Formation",
      "Signaling-Mediated Cytoskeletal Changes",
      "Immune Dysregulation and Th2/Th17 Skewing"
    ],
    "cell_types": [
      "Keratinocyte"
    ],
    "cell_type_ids": [
      "CL:0000312"
    ],
    "biological_processes": [
      "Immunoglobulin Production",
      "Cell Adhesion",
      "Signal Transduction",
      "T Cell Differentiation",
      "Cytokine Production"
    ],
    "phenotypes": [
      "Oral Ulcers",
      "Skin Blisters",
      "Skin Erosions",
      "Dysphagia"
    ],
    "phenotype_categories": [
      "Oral",
      "Dermatological",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0000155",
      "HP:0200037",
      "HP:0000951",
      "HP:0002015"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*04",
      "HLA-DRB1*14"
    ],
    "treatments": [
      "Corticosteroids",
      "Rituximab",
      "Azathioprine",
      "Mycophenolate Mofetil"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-Desmoglein 3 Antibodies",
      "Anti-Desmoglein 1 Antibodies"
    ],
    "source_file": "Pemphigus_Vulgaris.yaml",
    "page_url": "../pages/disorders/Pemphigus_Vulgaris.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 2,
    "num_treatments": 4
  },
  {
    "name": "Peripheral Artery Disease",
    "disease_id": "MONDO:0005386",
    "category": "Complex",
    "parents": [
      "Cardiovascular Disease"
    ],
    "subtypes": [],
    "description": "Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.\n",
    "pathophysiology": [
      "Atherosclerosis",
      "Endothelial Dysfunction",
      "Thrombosis",
      "Inflammation"
    ],
    "cell_types": [
      "Foam Cell",
      "Endothelial Cell"
    ],
    "cell_type_ids": [
      "CL:0000891",
      "CL:0000115"
    ],
    "biological_processes": [
      "Lipid Accumulation",
      "Vasodilation",
      "Thrombosis",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Intermittent Claudication",
      "Rest Pain",
      "Non-Healing Wounds",
      "Skin Changes"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Dermatological"
    ],
    "phenotype_ids": [
      "HP:0009763",
      "HP:0012532",
      "HP:0001058",
      "HP:0000951"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [
      "9p21.3 locus",
      "PCSK9",
      "LPA"
    ],
    "treatments": [
      "Smoking Cessation",
      "Antiplatelet Therapy",
      "Statins",
      "ACE Inhibitors",
      "Supervised Exercise Therapy",
      "Cilostazol",
      "Revascularization"
    ],
    "environmental": [
      "Smoking",
      "Diabetes",
      "Hypertension",
      "Dyslipidemia",
      "Sedentary Lifestyle"
    ],
    "biochemical": [
      "ABI (Ankle-Brachial Index)",
      "LDL Cholesterol",
      "HbA1c",
      "CRP"
    ],
    "source_file": "Peripheral_Artery_Disease.yaml",
    "page_url": "../pages/disorders/Peripheral_Artery_Disease.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 7
  },
  {
    "name": "Peroxisome Biogenesis Disorder",
    "disease_id": "MONDO:0019234",
    "category": "Genetic",
    "parents": [
      "Inborn Error of Metabolism",
      "Peroxisomal Disorder"
    ],
    "subtypes": [],
    "description": "Mutations in PEX genes disrupt the assembly and function of peroxisomes, leading to impaired metabolic processes.",
    "pathophysiology": [
      "Peroxisome Biogenesis Defect",
      "Accumulation of Toxic Metabolites",
      "Deficiency of Essential Compounds",
      "Neurological Dysfunction",
      "Hepatic Dysfunction",
      "Skeletal Abnormalities",
      "Multisystem Involvement",
      "Microglial Dysfunction and Neuroinflammation",
      "Peroxisome-Organelle Crosstalk Disruption",
      "Retinal Pigment Epithelium Dysfunction",
      "Impaired Peroxisome Biogenesis and Import"
    ],
    "cell_types": [
      "oligodendrocyte",
      "hepatocyte",
      "microglial cell",
      "retinal pigment epithelial cell",
      "photoreceptor cell"
    ],
    "cell_type_ids": [
      "CL:0000128",
      "CL:0000182",
      "CL:0000129",
      "CL:0002586",
      "CL:0000210"
    ],
    "biological_processes": [
      "fatty acid beta-oxidation",
      "very long-chain fatty acid metabolic process",
      "ether lipid biosynthetic process",
      "bile acid biosynthetic process",
      "protein import into peroxisome matrix",
      "peroxisome organization"
    ],
    "phenotypes": [
      "Hypotonia",
      "Developmental Delay",
      "Seizures",
      "Leukodystrophy",
      "Hepatomegaly",
      "Cholestasis",
      "Renal Dysfunction",
      "Retinopathy",
      "Hearing Loss",
      "Craniofacial Dysmorphism",
      "Adrenal Insufficiency",
      "Chondrodysplasia Punctata",
      "Thrombocytopenia",
      "Cardiomyopathy",
      "Heart Failure"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Hepatobiliary",
      "Renal",
      "Visual",
      "Auditory",
      "Craniofacial",
      "Endocrine",
      "Musculoskeletal",
      "Hematologic",
      "Cardiac",
      "Cardiovascular"
    ],
    "phenotype_ids": [
      "HP:0001252",
      "HP:0001263",
      "HP:0001250",
      "HP:0002415",
      "HP:0002240",
      "HP:0001396",
      "HP:0012622",
      "HP:0000488",
      "HP:0000365",
      "HP:0000846",
      "HP:0001873",
      "HP:0001638",
      "HP:0001635"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "PEX1",
      "PEX6",
      "PEX13",
      "PEX26",
      "PEX2",
      "PEX10",
      "PEX12",
      "PEX5",
      "PEX7",
      "Other PEX Genes"
    ],
    "treatments": [
      "Symptomatic Management",
      "Nutritional Support",
      "Liver Transplant",
      "Genetic Counseling"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "Very Long Chain Fatty Acids (VLCFA)",
      "Plasmalogens",
      "Bile Acid Intermediates"
    ],
    "source_file": "Peroxisome_Biogenesis_Disorder.yaml",
    "page_url": "../pages/disorders/Peroxisome_Biogenesis_Disorder.html",
    "num_phenotypes": 15,
    "num_pathophysiology": 11,
    "num_genes": 10,
    "num_treatments": 4
  },
  {
    "name": "Phenylketonuria",
    "disease_id": "MONDO:0009861",
    "category": "Genetic",
    "parents": [
      "Metabolic Disease",
      "Inborn Error of Metabolism"
    ],
    "subtypes": [
      "Classic PKU",
      "Mild PKU",
      "BH4-Responsive PKU"
    ],
    "description": "Mutations in PAH gene cause deficient phenylalanine hydroxylase enzyme activity. Phenylalanine cannot be converted to tyrosine, leading to phenylalanine accumulation in blood and tissues.\n",
    "pathophysiology": [
      "Phenylalanine Hydroxylase Deficiency",
      "Neurotoxicity",
      "Melanin Deficiency"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Phenylalanine Metabolism",
      "Neurodevelopment",
      "Melanin Biosynthesis"
    ],
    "phenotypes": [
      "Intellectual Disability",
      "Seizures",
      "Microcephaly",
      "Hypertonia",
      "Hypopigmentation",
      "Eczema",
      "Musty Odor"
    ],
    "phenotype_categories": [
      "Neurological",
      "Dermatological",
      "Other"
    ],
    "phenotype_ids": [
      "HP:0001249",
      "HP:0001250",
      "HP:0000252",
      "HP:0001276",
      "HP:0001010",
      "HP:0000964",
      "HP:0410021"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "PAH"
    ],
    "treatments": [
      "Phenylalanine-Restricted Diet",
      "Medical Formula",
      "Sapropterin (Kuvan)",
      "Pegvaliase (Palynziq)",
      "Large Neutral Amino Acids"
    ],
    "environmental": [
      "Dietary Phenylalanine",
      "Aspartame"
    ],
    "biochemical": [
      "Blood Phenylalanine",
      "Blood Tyrosine",
      "Phenylalanine to Tyrosine Ratio",
      "Phenylpyruvic Acid"
    ],
    "source_file": "Phenylketonuria.yaml",
    "page_url": "../pages/disorders/Phenylketonuria.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Pick Disease",
    "disease_id": "MONDO:0008243",
    "category": "Complex",
    "parents": [
      "Neurodegenerative Disorder",
      "Frontotemporal Dementia"
    ],
    "subtypes": [
      "Behavioral Variant Frontotemporal Dementia (bvFTD)",
      "Language Variant (Primary Progressive Aphasia)"
    ],
    "description": "Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.",
    "pathophysiology": [
      "Tauopathy",
      "Neuroinflammation",
      "Neuronal Loss"
    ],
    "cell_types": [
      "neuron",
      "astrocyte",
      "microglial cell",
      "T cell"
    ],
    "cell_type_ids": [
      "CL:0000540",
      "CL:0000127",
      "CL:0000129",
      "CL:0000084"
    ],
    "biological_processes": [
      "microtubule-based movement",
      "cytoskeleton organization"
    ],
    "phenotypes": [
      "Progressive Dementia",
      "Behavioral Changes",
      "Compulsive Behaviors",
      "Aphasia",
      "Parkinsonism",
      "Primitive Reflexes",
      "Executive Dysfunction",
      "Seizures",
      "Weight Loss",
      "Memory Impairment",
      "Inappropriate Behavior",
      "Loss of Social Awareness"
    ],
    "phenotype_categories": [
      "Neurologic",
      "Psychiatric",
      "Cognitive",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0000722",
      "HP:0002381",
      "HP:0001300",
      "HP:0001250",
      "HP:0001824",
      "HP:0002354",
      "HP:0000719"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL",
      "RARE"
    ],
    "genes": [
      "MAPT",
      "MAPT",
      "GRN"
    ],
    "treatments": [
      "Symptomatic Management",
      "Physical Therapy",
      "Occupational Therapy",
      "Speech Therapy",
      "Caregiver Support"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [
      "Tau Protein Accumulation"
    ],
    "source_file": "Pick_Disease.yaml",
    "page_url": "../pages/disorders/Pick_Disease.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 5
  },
  {
    "name": "Polycystic Kidney Disease",
    "disease_id": "MONDO:0020642",
    "category": "Mendelian",
    "parents": [
      "Genetic Kidney Disease",
      "Ciliopathy"
    ],
    "subtypes": [
      "Autosomal Dominant PKD (ADPKD)",
      "Autosomal Recessive PKD (ARPKD)"
    ],
    "description": "Polycystic kidney disease (PKD) is a genetic disorder characterized by the development of multiple fluid-filled cysts in the kidneys. The autosomal dominant form (ADPKD) is one of the most common inherited kidney diseases, affecting approximately 1 in 500-1000 people. ADPKD is caused by mutations in PKD1 or PKD2 genes and typically presents in adulthood with progressive renal enlargement, hypertension, and eventual kidney failure. Autosomal recessive PKD (ARPKD) is less common and typically presents in infancy or childhood.\n",
    "pathophysiology": [
      "Vasopressin/cAMP-Driven Cyst Expansion",
      "Epithelial Proliferation and Kidney Enlargement",
      "Ciliary Dysfunction",
      "Fibrosis and Inflammation"
    ],
    "cell_types": [
      "nephron tubule epithelial cell",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:1000494",
      "CL:0000235"
    ],
    "biological_processes": [
      "cAMP/PKA signal transduction",
      "regulation of cell proliferation",
      "cilium organization",
      "inflammatory response"
    ],
    "phenotypes": [
      "Multiple Renal Cysts",
      "Hypertension",
      "Chronic Kidney Disease",
      "Hepatic Cysts",
      "Intracranial Aneurysm",
      "Flank Pain"
    ],
    "phenotype_categories": [
      "Renal",
      "Cardiovascular",
      "Hepatic",
      "Vascular"
    ],
    "phenotype_ids": [
      "HP:0005562",
      "HP:0000822",
      "HP:0012622",
      "HP:0001407",
      "HP:0007029",
      "HP:0030157"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "PKD1 Mutations",
      "PKD2 Mutations",
      "PKHD1 Mutations"
    ],
    "treatments": [
      "Tolvaptan",
      "Blood Pressure Control",
      "Renal Dialysis",
      "Kidney Transplantation"
    ],
    "environmental": [
      "Caffeine Consumption"
    ],
    "biochemical": [
      "Elevated Creatinine",
      "Decreased GFR"
    ],
    "source_file": "Polycystic_Kidney_Disease.yaml",
    "page_url": "../pages/disorders/Polycystic_Kidney_Disease.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 3,
    "num_treatments": 4
  },
  {
    "name": "Polycystic Ovary Syndrome",
    "disease_id": "MONDO:0008487",
    "category": "Complex",
    "parents": [
      "Endocrine Disease",
      "Reproductive Disease"
    ],
    "subtypes": [],
    "description": "Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.\n",
    "pathophysiology": [
      "Hyperandrogenism",
      "Insulin Resistance",
      "Ovulatory Dysfunction",
      "Chronic Low-Grade Inflammation"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Androgen Biosynthesis",
      "Insulin Signaling",
      "Ovulation",
      "Inflammatory Response"
    ],
    "phenotypes": [
      "Irregular Menstruation",
      "Hirsutism",
      "Acne",
      "Obesity",
      "Infertility",
      "Alopecia"
    ],
    "phenotype_categories": [
      "Reproductive",
      "Dermatological",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0000858",
      "HP:0001007",
      "HP:0001061",
      "HP:0001513",
      "HP:0000789",
      "HP:0001596"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "DENND1A",
      "THADA",
      "LHCGR",
      "FSHR"
    ],
    "treatments": [
      "Combined Oral Contraceptives",
      "Metformin",
      "Spironolactone",
      "Letrozole",
      "Clomiphene Citrate",
      "Lifestyle Modification"
    ],
    "environmental": [
      "Obesity",
      "Sedentary Lifestyle",
      "Prenatal Androgen Exposure"
    ],
    "biochemical": [
      "Testosterone",
      "LH",
      "SHBG",
      "Fasting Insulin",
      "Anti-Mullerian Hormone"
    ],
    "source_file": "Polycystic_Ovary_Syndrome.yaml",
    "page_url": "../pages/disorders/Polycystic_Ovary_Syndrome.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 6
  },
  {
    "name": "Polymyositis",
    "disease_id": "MONDO:0019127",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Inflammatory Myopathy"
    ],
    "subtypes": [],
    "description": "An idiopathic inflammatory myopathy characterized by symmetric proximal muscle weakness without the skin manifestations of dermatomyositis. CD8+ T cell-mediated attack on muscle fibers is the primary pathogenic mechanism.",
    "pathophysiology": [
      "CD8+ T Cell-Mediated Cytotoxicity",
      "Aberrant MHC Class I Expression",
      "Myositis-Specific Autoantibodies",
      "Pro-inflammatory Cytokine Production",
      "ER Stress and Unfolded Protein Response",
      "Necroptosis and DAMP Release",
      "Apoptosis of Muscle Fibers"
    ],
    "cell_types": [
      "CD8+ T Cell",
      "Skeletal Muscle Cell"
    ],
    "cell_type_ids": [
      "CL:0000625",
      "CL:0000188"
    ],
    "biological_processes": [
      "T Cell Cytotoxicity",
      "MHC Class I Antigen Presentation",
      "Immunoglobulin Production",
      "Inflammatory Response",
      "Endoplasmic Reticulum Stress Response",
      "Necroptotic Process",
      "Apoptotic Process"
    ],
    "phenotypes": [
      "Proximal Muscle Weakness",
      "Dysphagia",
      "Pulmonary Fibrosis",
      "Arthritis"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Gastrointestinal",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0003690",
      "HP:0002015",
      "HP:0002206",
      "HP:0001369"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*0301"
    ],
    "treatments": [
      "Corticosteroids",
      "Methotrexate",
      "Azathioprine",
      "IVIG"
    ],
    "environmental": [],
    "biochemical": [
      "Creatine Kinase",
      "Aldolase",
      "Anti-Jo-1 Antibodies",
      "Anti-SRP Antibodies"
    ],
    "source_file": "Polymyositis.yaml",
    "page_url": "../pages/disorders/Polymyositis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 7,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Primary Biliary Cholangitis",
    "disease_id": "MONDO:0005388",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Liver Disease"
    ],
    "subtypes": [],
    "description": "A chronic autoimmune liver disease characterized by progressive destruction of small intrahepatic bile ducts, leading to cholestasis, fibrosis, and eventually cirrhosis. Highly associated with anti-mitochondrial antibodies (AMA) targeting pyruvate dehydrogenase complex.",
    "pathophysiology": [
      "Anti-Mitochondrial Antibody Response",
      "Biliary Epithelial Cell Targeting",
      "Progressive Ductopenia and Cholestasis"
    ],
    "cell_types": [
      "Cholangiocyte",
      "CD8+ T Cell"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000625"
    ],
    "biological_processes": [
      "Immunoglobulin Production",
      "T Cell Cytotoxicity",
      "Bile Acid Metabolic Process"
    ],
    "phenotypes": [
      "Pruritus",
      "Fatigue",
      "Jaundice",
      "Hepatomegaly"
    ],
    "phenotype_categories": [
      "Dermatological",
      "Systemic",
      "Hepatic"
    ],
    "phenotype_ids": [
      "HP:0000989",
      "HP:0012378",
      "HP:0000952",
      "HP:0002240"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*08",
      "IL12A",
      "IL12RB2"
    ],
    "treatments": [
      "Ursodeoxycholic Acid (UDCA)",
      "Obeticholic Acid",
      "Fibrates",
      "Liver Transplantation"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-Mitochondrial Antibodies (AMA)",
      "Alkaline Phosphatase",
      "IgM",
      "Anti-sp100 Antibodies"
    ],
    "source_file": "Primary_Biliary_Cholangitis.yaml",
    "page_url": "../pages/disorders/Primary_Biliary_Cholangitis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 4
  },
  {
    "name": "Primary_Ciliary_Dyskinesia",
    "disease_id": "MONDO:0016575",
    "category": "Genetic",
    "parents": [
      "Ciliopathy",
      "Respiratory Disease"
    ],
    "subtypes": [],
    "description": "Defects in the structure and function of motile cilia impair mucociliary clearance.",
    "pathophysiology": [
      "Ciliary Dysfunction",
      "Impaired Mucociliary Clearance",
      "Situs Inversus"
    ],
    "cell_types": [
      "respiratory ciliated cell",
      "ependymal cell"
    ],
    "cell_type_ids": [
      "CL:0002368",
      "CL:0000065"
    ],
    "biological_processes": [
      "cilium movement",
      "cilium assembly",
      "axoneme assembly",
      "mucociliary clearance",
      "determination of left/right symmetry",
      "nodal cilium assembly"
    ],
    "phenotypes": [
      "Chronic Cough",
      "Recurrent Respiratory Infections",
      "Bronchiectasis",
      "Chronic Otitis Media",
      "Hearing Loss",
      "Nasal Polyps",
      "Situs Inversus Totalis",
      "Chronic Respiratory Infections",
      "Sinusitis",
      "Otitis Media",
      "Neonatal Respiratory Distress",
      "Male Infertility",
      "Chronic Rhinosinusitis"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Otologic",
      "Gastrointestinal",
      "Cardiac",
      "Reproductive"
    ],
    "phenotype_ids": [
      "HP:0034315",
      "HP:0002205",
      "HP:0002110",
      "HP:0000389",
      "HP:0000365",
      "HP:0001696",
      "HP:0000246",
      "HP:0000388",
      "HP:0002643",
      "HP:0003251",
      "HP:0011109"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "DNAI1",
      "DNAH5",
      "DNAH11",
      "CCDC39",
      "CCDC40",
      "RSPH1",
      "RSPH4A",
      "RSPH9",
      "CCNO",
      "FOXJ1",
      "MCIDAS",
      "ODAD1"
    ],
    "treatments": [
      "Airway Clearance Techniques",
      "Antibiotic Therapy",
      "Bronchodilators",
      "Nasal Steroids",
      "Hearing Aids",
      "Genetic Counseling"
    ],
    "environmental": [
      "Air Pollution"
    ],
    "biochemical": [
      "Nitric Oxide"
    ],
    "source_file": "Primary_Ciliary_Dyskinesia.yaml",
    "page_url": "../pages/disorders/Primary_Ciliary_Dyskinesia.html",
    "num_phenotypes": 13,
    "num_pathophysiology": 3,
    "num_genes": 12,
    "num_treatments": 6
  },
  {
    "name": "Primary Sclerosing Cholangitis",
    "disease_id": "MONDO:0013433",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Liver Disease"
    ],
    "subtypes": [],
    "description": "A chronic cholestatic liver disease characterized by inflammation and fibrosis of intrahepatic and extrahepatic bile ducts, leading to multifocal strictures and eventual biliary cirrhosis. Strongly associated with inflammatory bowel disease, particularly ulcerative colitis.",
    "pathophysiology": [
      "Bile Duct Inflammation and Fibrosis",
      "Gut-Liver Axis Dysregulation",
      "Cholangiocyte Senescence"
    ],
    "cell_types": [
      "Fibroblast",
      "T Cell"
    ],
    "cell_type_ids": [
      "CL:0000057",
      "CL:0000084"
    ],
    "biological_processes": [
      "Inflammatory Response",
      "Cell Migration",
      "Cellular Senescence"
    ],
    "phenotypes": [
      "Pruritus",
      "Fatigue",
      "Jaundice",
      "Abdominal Pain"
    ],
    "phenotype_categories": [
      "Dermatological",
      "Systemic",
      "Hepatic",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0000989",
      "HP:0012378",
      "HP:0000952",
      "HP:0002027"
    ],
    "frequencies": [
      "FREQUENT",
      "VERY_FREQUENT"
    ],
    "genes": [
      "HLA-DRB1*03",
      "HLA-B8"
    ],
    "treatments": [
      "Ursodeoxycholic Acid",
      "Endoscopic Therapy",
      "Liver Transplantation",
      "Cholangiocarcinoma Surveillance"
    ],
    "environmental": [
      "Inflammatory Bowel Disease"
    ],
    "biochemical": [
      "Alkaline Phosphatase",
      "GGT",
      "p-ANCA"
    ],
    "source_file": "Primary_Sclerosing_Cholangitis.yaml",
    "page_url": "../pages/disorders/Primary_Sclerosing_Cholangitis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 2,
    "num_treatments": 4
  },
  {
    "name": "Primary_Tonsillar_Lymphoma",
    "disease_id": "MONDO:0044884",
    "category": "Hematologic Malignancy",
    "parents": [
      "Lymphoma"
    ],
    "subtypes": [],
    "description": "Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.",
    "pathophysiology": [
      "Malignant B-cell Proliferation (Germinal Center Type)",
      "Malignant B-cell Proliferation (Activated B-cell Type)",
      "IRF4-rearranged Large B-cell Lymphoma",
      "EBV-positive Diffuse Large B-cell Lymphoma",
      "Double/Triple-hit High-grade B-cell Lymphoma"
    ],
    "cell_types": [
      "germinal center B cell",
      "B cell",
      "plasmablast"
    ],
    "cell_type_ids": [
      "CL:0000844",
      "CL:0000236",
      "CL:0000980"
    ],
    "biological_processes": [
      "regulation of apoptotic process",
      "histone H3-K27 methylation",
      "germinal center formation",
      "B cell receptor signaling pathway",
      "NF-kappaB signaling",
      "plasma cell differentiation",
      "response to virus",
      "immune evasion",
      "regulation of transcription by RNA polymerase II",
      "negative regulation of apoptotic process"
    ],
    "phenotypes": [
      "Enlarged Tonsil",
      "Fever",
      "Night Sweats",
      "Weight Loss",
      "Lymphadenopathy",
      "Sore Throat",
      "Dysphagia"
    ],
    "phenotype_categories": [
      "ENT",
      "Systemic",
      "Hematologic"
    ],
    "phenotype_ids": [
      "HP:0030812",
      "HP:0001945",
      "HP:0030166",
      "HP:0001824",
      "HP:0002716",
      "HP:0002015"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Chemotherapy",
      "Radiation Therapy",
      "Targeted Therapy",
      "Stem Cell Transplant"
    ],
    "environmental": [],
    "biochemical": [
      "Lactate Dehydrogenase (LDH)"
    ],
    "source_file": "Primary_Tonsillar_Lymphoma.yaml",
    "page_url": "../pages/disorders/Primary_Tonsillar_Lymphoma.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Psoriasis",
    "disease_id": "MONDO:0005083",
    "category": "Complex",
    "parents": [
      "Dermatological Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [
      "Plaque Psoriasis",
      "Guttate Psoriasis",
      "Inverse Psoriasis",
      "Pustular Psoriasis",
      "Erythrodermic Psoriasis",
      "Psoriatic Arthritis"
    ],
    "description": "Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.\n",
    "pathophysiology": [
      "T Cell-Mediated Inflammation",
      "Keratinocyte Hyperproliferation",
      "Dendritic Cell Activation",
      "IL-23/IL-17 Axis"
    ],
    "cell_types": [
      "T Helper 17 Cell",
      "T Helper 1 Cell",
      "Keratinocyte",
      "Dendritic Cell"
    ],
    "cell_type_ids": [
      "CL:0000899",
      "CL:0000545",
      "CL:0000312",
      "CL:0000451"
    ],
    "biological_processes": [
      "T Cell Activation",
      "Cell Proliferation",
      "Cytokine Signaling"
    ],
    "phenotypes": [
      "Erythematous Plaques",
      "Silvery Scales",
      "Pruritus",
      "Nail Changes",
      "Joint Pain"
    ],
    "phenotype_categories": [
      "Dermatological",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0200034",
      "HP:0040189",
      "HP:0000989",
      "HP:0008404",
      "HP:0002829"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-C*06:02",
      "IL12B",
      "IL23R",
      "TNFAIP3",
      "CARD14"
    ],
    "treatments": [
      "Topical Corticosteroids",
      "Topical Vitamin D Analogues",
      "Phototherapy",
      "Methotrexate",
      "TNF Inhibitors",
      "IL-17 Inhibitors",
      "IL-23 Inhibitors",
      "IL-12/23 Inhibitor",
      "JAK Inhibitors"
    ],
    "environmental": [
      "Streptococcal Infection",
      "Stress",
      "Smoking",
      "Obesity",
      "Medications",
      "Skin Trauma"
    ],
    "biochemical": [],
    "source_file": "Psoriasis.yaml",
    "page_url": "../pages/disorders/Psoriasis.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 5,
    "num_treatments": 9
  },
  {
    "name": "Pulmonary_hypertension",
    "disease_id": "MONDO:0005149",
    "category": "Cardiovascular Disorder",
    "parents": [
      "Heart Disease",
      "Lung Disease"
    ],
    "subtypes": [
      "Pulmonary Arterial Hypertension (PAH)",
      "Secondary Pulmonary Hypertension"
    ],
    "description": "Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.",
    "pathophysiology": [
      "Vascular Remodeling",
      "Endothelial Dysfunction",
      "Inflammation and Immune Activation",
      "Metabolic Reprogramming",
      "Hypoxia Signaling",
      "Increased Pulmonary Vascular Resistance",
      "Right Ventricular Hypertrophy"
    ],
    "cell_types": [
      "Smooth Muscle Cell",
      "Endothelial Cell",
      "fibroblast",
      "pericyte",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000192",
      "CL:0000115",
      "CL:0000057",
      "CL:0000669",
      "CL:0000235"
    ],
    "biological_processes": [
      "extracellular matrix organization",
      "smooth muscle cell proliferation",
      "endothelial to mesenchymal transition",
      "apoptotic process",
      "BMP signaling pathway",
      "inflammatory response",
      "NF-kappaB signaling",
      "glycolytic process",
      "oxidative phosphorylation",
      "response to hypoxia",
      "HIF-1-alpha signaling pathway"
    ],
    "phenotypes": [
      "Dyspnea",
      "Chest Pain",
      "Syncope",
      "Palpitations",
      "Fatigue",
      "Edema",
      "Reduced Exercise Tolerance",
      "Cyanosis"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Cardiovascular",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0002094",
      "HP:0100749",
      "HP:0001279",
      "HP:0001962",
      "HP:0012378",
      "HP:0000969",
      "HP:0003546",
      "HP:0000961"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "BMPR2",
      "SMAD9",
      "ACVRL1",
      "ENG",
      "EIF2AK4",
      "KCNK3",
      "TBX4",
      "SOX17",
      "CAV1"
    ],
    "treatments": [
      "Phosphodiesterase-5 Inhibitors",
      "Endothelin Receptor Antagonists",
      "Prostacyclin Analogues",
      "Oxygen Therapy",
      "Anticoagulation"
    ],
    "environmental": [
      "High-Altitude Exposure"
    ],
    "biochemical": [
      "N-terminal pro b-type Natriuretic Peptide (NT-proBNP)"
    ],
    "source_file": "Pulmonary_hypertension.yaml",
    "page_url": "../pages/disorders/Pulmonary_hypertension.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 7,
    "num_genes": 9,
    "num_treatments": 5
  },
  {
    "name": "Retrograde Cricopharyngeus Dysfunction",
    "disease_id": "MONDO:0100099",
    "category": "Syndromic",
    "parents": [
      "Neuromuscular Disorder",
      "Gastrointestinal Disorder"
    ],
    "subtypes": [],
    "description": "A syndrome characterized by the inability to belch due to failure of the upper esophageal sphincter (cricopharyngeus muscle) to relax in response to retrograde esophageal gaseous distension. The associated symptom complex includes abdominal bloating, chest pain, gurgling noises in the chest, nausea, and excessive flatulence.",
    "pathophysiology": [
      "Failure of Upper Esophageal Sphincter Relaxation",
      "Elevated Upper Esophageal Sphincter Basal Pressure"
    ],
    "cell_types": [
      "muscle cell",
      "sensory neuron"
    ],
    "cell_type_ids": [
      "CL:0000187",
      "CL:0000101"
    ],
    "biological_processes": [
      "regulation of muscle contraction",
      "skeletal muscle contraction",
      "muscle contraction"
    ],
    "phenotypes": [
      "Inability to Belch",
      "Abdominal Distention",
      "Chest Pain",
      "Nausea",
      "Gurgling Sounds"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0025031",
      "HP:0003270",
      "HP:0100749",
      "HP:0002018"
    ],
    "frequencies": [
      "Common",
      "Variable"
    ],
    "genes": [],
    "treatments": [
      "Botulinum Toxin Injection"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Retrograde_Cricopharyngeus_Dysfunction.yaml",
    "page_url": "../pages/disorders/Retrograde_Cricopharyngeus_Dysfunction.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 2,
    "num_genes": 0,
    "num_treatments": 1
  },
  {
    "name": "Rett Syndrome",
    "disease_id": "MONDO:0010726",
    "category": "Genetic",
    "parents": [
      "Neurodevelopmental Disorder",
      "X-linked Dominant Disorder"
    ],
    "subtypes": [
      "Classic Rett Syndrome",
      "Atypical Rett Syndrome"
    ],
    "description": "Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.\n",
    "pathophysiology": [
      "MECP2 Dysfunction",
      "Abnormal Neuronal Development"
    ],
    "cell_types": [
      "Neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [
      "Gene Expression Regulation",
      "Synaptic Transmission"
    ],
    "phenotypes": [
      "Developmental Regression",
      "Stereotypical Hand Movements",
      "Gait Abnormalities",
      "Secondary Microcephaly",
      "Seizures",
      "Breathing Abnormalities",
      "Scoliosis"
    ],
    "phenotype_categories": [
      "Neurological",
      "Respiratory",
      "Musculoskeletal"
    ],
    "phenotype_ids": [
      "HP:0002376",
      "HP:0012171",
      "HP:0002066",
      "HP:0005484",
      "HP:0001250",
      "HP:0005957",
      "HP:0002650"
    ],
    "frequencies": [
      "VERY_FREQUENT"
    ],
    "genes": [
      "MECP2"
    ],
    "treatments": [
      "Seizure Management",
      "Physical Therapy",
      "Occupational Therapy",
      "Speech Therapy",
      "Nutritional Support"
    ],
    "environmental": [],
    "biochemical": [
      "MECP2 Protein"
    ],
    "source_file": "Rett_Syndrome.yaml",
    "page_url": "../pages/disorders/Rett_Syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Rheumatoid Arthritis",
    "disease_id": "MONDO:0008383",
    "category": "Complex",
    "parents": [
      "Autoimmune Disease",
      "Inflammatory Arthritis"
    ],
    "subtypes": [
      "Seropositive Rheumatoid Arthritis",
      "Seronegative Rheumatoid Arthritis",
      "Juvenile Idiopathic Arthritis (JIA)"
    ],
    "description": "The immune system mistakenly attacks the body's own tissues, particularly the synovial membrane lining the joints.",
    "pathophysiology": [
      "Autoimmune Response",
      "Inflammatory Cytokine Production",
      "Synovial Hyperplasia",
      "Cartilage and Bone Destruction",
      "JAK/STAT Signaling",
      "NF-\u03baB Activation",
      "Neutrophil Extracellular Trap Formation",
      "B Cell and Plasma Cell Responses",
      "Mucosal Origins and Dysbiosis"
    ],
    "cell_types": [
      "Th17 Cell",
      "Synoviocyte",
      "Macrophage",
      "Fibroblast",
      "Neutrophil",
      "B cell",
      "Plasma cell"
    ],
    "cell_type_ids": [
      "CL:0000899",
      "CL:0000214",
      "CL:0000235",
      "CL:0000057",
      "CL:0000775",
      "CL:0000236",
      "CL:0000786"
    ],
    "biological_processes": [
      "cytokine production",
      "cytokine-mediated signaling pathway",
      "immune response"
    ],
    "phenotypes": [
      "Symmetric Polyarthritis",
      "Morning Stiffness",
      "Fatigue",
      "Rheumatoid Nodules",
      "Interstitial Lung Disease",
      "Boutonniere Deformity",
      "Swan-neck Deformity",
      "Sicca Syndrome",
      "Scleritis",
      "Pericarditis",
      "Felty's Syndrome",
      "Joint Deformity",
      "Reduced Mobility",
      "Joint Swelling",
      "Erosive Arthritis"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Systemic",
      "Extra-articular",
      "Cardiovascular",
      "Hematologic"
    ],
    "phenotype_ids": [
      "HP:0040311",
      "HP:0005197",
      "HP:0012378",
      "HP:0100532",
      "HP:0001701",
      "HP:0001367",
      "HP:0001288",
      "HP:0001386",
      "HP:0001369"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DRB1",
      "PTPN22",
      "STAT4",
      "CTLA4",
      "PADI4",
      "PADI2",
      "TNF",
      "IL6R",
      "TYK2"
    ],
    "treatments": [
      "Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)",
      "Disease-Modifying Antirheumatic Drugs (DMARDs)",
      "Biologics",
      "Glucocorticoids",
      "Physical Therapy"
    ],
    "environmental": [
      "Smoking",
      "Infections"
    ],
    "biochemical": [
      "Rheumatoid Factor (RF)",
      "Anti-Cyclic Citrullinated Peptide (anti-CCP) Antibodies",
      "Erythrocyte Sedimentation Rate (ESR)",
      "C-Reactive Protein (CRP)"
    ],
    "source_file": "Rheumatoid_Arthritis.yaml",
    "page_url": "../pages/disorders/Rheumatoid_Arthritis.html",
    "num_phenotypes": 15,
    "num_pathophysiology": 9,
    "num_genes": 9,
    "num_treatments": 5
  },
  {
    "name": "Roifman-syndrome",
    "disease_id": "MONDO:0014722",
    "category": "Genetic",
    "parents": [
      "Immunodeficiency",
      "Skeletal Dysplasia"
    ],
    "subtypes": [],
    "description": "Mutations in the RNU4ATAC gene result in defective minor spliceosomal RNAs, affecting normal cellular processes.",
    "pathophysiology": [
      "RNU4ATAC Gene Mutation",
      "Decreased NK Cell Function",
      "Decreased total and memory B cells",
      "Hypogammaglobulinemia"
    ],
    "cell_types": [
      "NK Cell",
      "Memory B cell"
    ],
    "cell_type_ids": [
      "CL:0000623",
      "CL:0000787"
    ],
    "biological_processes": [],
    "phenotypes": [
      "Recurrent Infections",
      "Growth Retardation",
      "Intellectual Disability",
      "Dysmorphic Facial Features",
      "Strabismus"
    ],
    "phenotype_categories": [
      "Immunologic",
      "Skeletal",
      "Neurologic",
      "Craniofacial",
      "Ophthalmologic"
    ],
    "phenotype_ids": [
      "HP:0002719",
      "HP:0001510",
      "HP:0001249",
      "HP:0000486"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "RNU4ATAC"
    ],
    "treatments": [
      "Immunoglobulin Replacement Therapy",
      "Antibiotic Prophylaxis",
      "Growth Hormone Therapy",
      "Supportive Educational Programs",
      "Surgical Interventions"
    ],
    "environmental": [
      "Immunizations"
    ],
    "biochemical": [
      "Immunoglobulin Levels"
    ],
    "source_file": "Roifman-syndrome.yaml",
    "page_url": "../pages/disorders/Roifman-syndrome.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 4,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Sarcoidosis",
    "disease_id": "MONDO:0019338",
    "category": "Immune",
    "parents": [
      "Granulomatous Disease",
      "Immune-Mediated Disease"
    ],
    "subtypes": [
      "Pulmonary Sarcoidosis",
      "Cardiac Sarcoidosis",
      "Neurosarcoidosis",
      "Cutaneous Sarcoidosis"
    ],
    "description": "Sarcoidosis is a multisystem inflammatory disease of unknown etiology characterized by the formation of non-caseating granulomas, most commonly affecting the lungs and lymph nodes. It predominantly affects adults aged 20-40 years, with higher incidence in African Americans and Northern Europeans. Clinical presentation ranges from asymptomatic to severe organ dysfunction. While many cases resolve spontaneously, chronic progressive disease occurs in a significant subset.\n",
    "pathophysiology": [
      "Granuloma Formation",
      "Dysregulated Immune Response",
      "Fibrosis"
    ],
    "cell_types": [
      "epithelioid macrophage",
      "CD4-positive helper T cell"
    ],
    "cell_type_ids": [
      "CL:0002150",
      "CL:0000492"
    ],
    "biological_processes": [
      "granuloma formation",
      "inflammatory response"
    ],
    "phenotypes": [
      "Mediastinal Lymphadenopathy",
      "Dyspnea",
      "Nonproductive Cough",
      "Fatigue",
      "Erythema Nodosum",
      "Uveitis"
    ],
    "phenotype_categories": [
      "Pulmonary",
      "Constitutional",
      "Dermatologic",
      "Ophthalmologic"
    ],
    "phenotype_ids": [
      "HP:0100721",
      "HP:0002094",
      "HP:0031246",
      "HP:0012378",
      "HP:0012219",
      "HP:0000554"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DRB1 Variants",
      "BTNL2 Variants"
    ],
    "treatments": [
      "Corticosteroid Therapy",
      "Methotrexate",
      "Anti-TNF Therapy"
    ],
    "environmental": [
      "Occupational Exposures",
      "Infectious Triggers"
    ],
    "biochemical": [
      "Elevated ACE",
      "Hypercalcemia",
      "Elevated Inflammatory Markers"
    ],
    "source_file": "Sarcoidosis.yaml",
    "page_url": "../pages/disorders/Sarcoidosis.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 3,
    "num_genes": 2,
    "num_treatments": 3
  },
  {
    "name": "Schizophrenia",
    "disease_id": "MONDO:0005090",
    "category": "Psychiatric",
    "parents": [
      "Psychotic Disorder",
      "Mental Health Disorder"
    ],
    "subtypes": [],
    "description": "Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways.",
    "pathophysiology": [
      "Dysregulation of Dopamine Neurotransmission",
      "Abnormality of Glutamergic Signaling",
      "Abnormality of GABAergic Signaling",
      "Complement-Mediated Excessive Synaptic Pruning",
      "Oligodendrocyte and Myelin Dysfunction",
      "Mitochondrial Dysfunction and Oxidative Stress",
      "Blood-Brain Barrier Dysfunction"
    ],
    "cell_types": [
      "parvalbumin-positive interneuron",
      "microglial cell",
      "oligodendrocyte",
      "endothelial cell",
      "astrocyte"
    ],
    "cell_type_ids": [
      "CL:0000099",
      "CL:0000129",
      "CL:0000128",
      "CL:0000115",
      "CL:0000127"
    ],
    "biological_processes": [
      "dopamine secretion",
      "synaptic transmission, glutamatergic",
      "synaptic transmission, GABAergic",
      "complement activation",
      "synapse pruning",
      "myelination",
      "oxidative phosphorylation",
      "cellular response to oxidative stress"
    ],
    "phenotypes": [
      "Hallucinations",
      "Delusions",
      "Disorganized Thinking",
      "Social Withdrawal",
      "Flat Affect",
      "Working Memory Deficits",
      "Catatonia"
    ],
    "phenotype_categories": [
      "Psychiatric",
      "Cognitive",
      "Occupational",
      "Mood",
      "Behavioral"
    ],
    "phenotype_ids": [
      "HP:0000738",
      "HP:0000746"
    ],
    "frequencies": [
      "FREQUENT",
      "COMMON",
      "OCCASIONAL"
    ],
    "genes": [
      "DRD2",
      "GRIN1",
      "GRIN2A",
      "GAD1",
      "RELN",
      "C4A",
      "C3",
      "DISC1",
      "COMT",
      "NRG1",
      "DTNBP1"
    ],
    "treatments": [
      "Antipsychotic Medications",
      "Cognitive Behavioral Therapy (CBT)",
      "Social Skills Training",
      "Supportive Therapy",
      "Vocational Rehabilitation"
    ],
    "environmental": [
      "Prenatal Stress",
      "Cannabis Use"
    ],
    "biochemical": [
      "Dopamine Metabolites",
      "Glutamate Levels"
    ],
    "source_file": "Schizophrenia.yaml",
    "page_url": "../pages/disorders/Schizophrenia.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 7,
    "num_genes": 11,
    "num_treatments": 5
  },
  {
    "name": "Scurvy",
    "disease_id": "MONDO:0009412",
    "category": "Nutritional",
    "parents": [
      "Vitamin Deficiency Disease"
    ],
    "subtypes": [],
    "description": "Vitamin C (ascorbic acid) is essential for hydroxylation of proline and lysine residues in collagen synthesis by prolyl and lysyl hydroxylases. Deficiency leads to inadequate hydroxyproline and hydroxylysine formation, preventing triple-helix stability and mature cross-links, resulting in defective collagen formation that affects connective tissues throughout the body.\n",
    "pathophysiology": [
      "Collagen Synthesis Impairment",
      "Vascular Integrity Failure"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [],
    "phenotypes": [
      "Perifollicular Hemorrhages",
      "Ecchymoses",
      "Skin Discoloration",
      "Gingival Bleeding",
      "Arthralgias",
      "Fatigue",
      "Impaired Wound Healing"
    ],
    "phenotype_categories": [
      "Dermatological",
      "Oral",
      "Musculoskeletal",
      "Constitutional"
    ],
    "phenotype_ids": [
      "HP:0000967",
      "HP:0000978",
      "HP:0000225",
      "HP:0002829",
      "HP:0012378",
      "HP:0001058"
    ],
    "frequencies": [
      "FREQUENT",
      "VERY_FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Vitamin C Supplementation"
    ],
    "environmental": [
      "Vitamin C Deficiency"
    ],
    "biochemical": [],
    "source_file": "Scurvy.yaml",
    "page_url": "../pages/disorders/Scurvy.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 0,
    "num_treatments": 1
  },
  {
    "name": "Semicircular Canal Dehiscence Syndrome",
    "disease_id": "MONDO:0018484",
    "category": "Structural",
    "parents": [
      "Inner Ear Disease",
      "Vestibular Disorder"
    ],
    "subtypes": [],
    "description": "An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger.",
    "pathophysiology": [
      "Bony Dehiscence of Semicircular Canal",
      "Third Window Effect",
      "Abnormal Sound and Pressure Transmission",
      "Otic Capsule Bone Biology"
    ],
    "cell_types": [
      "vestibular hair cell",
      "osteoclast",
      "osteoblast"
    ],
    "cell_type_ids": [
      "CL:0000609",
      "CL:0000092",
      "CL:0000062"
    ],
    "biological_processes": [
      "mechanotransduction",
      "vestibular receptor stimulus detection",
      "bone remodeling"
    ],
    "phenotypes": [
      "Vertigo",
      "Sound-Induced Nystagmus",
      "Oscillopsia",
      "Autophony",
      "Pulsatile Tinnitus",
      "Conductive Hearing Loss",
      "Chronic Disequilibrium",
      "Hyperacusis"
    ],
    "phenotype_categories": [
      "Vestibular",
      "Auditory"
    ],
    "phenotype_ids": [
      "HP:0002321",
      "HP:0000639",
      "HP:0034773",
      "HP:6000032",
      "HP:0008629",
      "HP:0000405",
      "HP:0002141",
      "HP:0010780"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [],
    "treatments": [
      "Observation and Symptom Management",
      "Surgical Canal Plugging",
      "Surgical Resurfacing"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Semicircular_Canal_Dehiscence_Syndrome.yaml",
    "page_url": "../pages/disorders/Semicircular_Canal_Dehiscence_Syndrome.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 4,
    "num_genes": 0,
    "num_treatments": 3
  },
  {
    "name": "Sickle Cell Disease",
    "disease_id": "MONDO:0011382",
    "category": "Mendelian",
    "parents": [
      "Hematological Disease",
      "Genetic Disease"
    ],
    "subtypes": [],
    "description": "Deoxygenated HbS polymerizes into rigid fibers, deforming red blood cells into sickle shape. HbS has glutamic acid to valine substitution at position 6 of beta-globin.\n",
    "pathophysiology": [
      "Hemoglobin Polymerization",
      "Red Blood Cell Sickling",
      "Vaso-Occlusion",
      "Chronic Hemolysis",
      "Chronic Organ Damage"
    ],
    "cell_types": [
      "Red Blood Cell",
      "Endothelial Cell"
    ],
    "cell_type_ids": [
      "CL:0000232",
      "CL:0000115"
    ],
    "biological_processes": [
      "Protein Polymerization",
      "Hemolysis",
      "Cell Adhesion",
      "Tissue Damage"
    ],
    "phenotypes": [
      "Pain Crises",
      "Chronic Anemia",
      "Jaundice",
      "Splenic Sequestration",
      "Acute Chest Syndrome",
      "Stroke",
      "Priapism",
      "Leg Ulcers"
    ],
    "phenotype_categories": [
      "Musculoskeletal",
      "Hematologic",
      "Respiratory",
      "Neurological",
      "Urological",
      "Dermatological"
    ],
    "phenotype_ids": [
      "HP:0012531",
      "HP:0001878",
      "HP:0000952",
      "HP:0001744",
      "HP:0002098",
      "HP:0001297",
      "HP:0200023",
      "HP:0200042"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HBB",
      "BCL11A",
      "HBS1L-MYB"
    ],
    "treatments": [
      "Hydroxyurea",
      "Voxelotor",
      "Crizanlizumab",
      "L-Glutamine",
      "Blood Transfusions",
      "Pain Management",
      "Penicillin Prophylaxis",
      "Hematopoietic Stem Cell Transplant",
      "Gene Therapy"
    ],
    "environmental": [
      "Dehydration",
      "Hypoxia",
      "Cold Exposure",
      "High Altitude",
      "Infections"
    ],
    "biochemical": [
      "Hemoglobin",
      "Reticulocytes",
      "Bilirubin",
      "LDH",
      "HbS"
    ],
    "source_file": "Sickle_Cell_Disease.yaml",
    "page_url": "../pages/disorders/Sickle_Cell_Disease.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 5,
    "num_genes": 3,
    "num_treatments": 9
  },
  {
    "name": "Sjogren's Syndrome",
    "disease_id": "MONDO:0010030",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease"
    ],
    "subtypes": [],
    "description": "A chronic autoimmune disease characterized by lymphocytic infiltration and destruction of exocrine glands, primarily the salivary and lacrimal glands, leading to sicca symptoms (dry eyes and dry mouth). Can occur as primary disease or secondary to other autoimmune conditions.",
    "pathophysiology": [
      "Exocrine Gland Lymphocytic Infiltration",
      "Autoantibody Production",
      "Type I Interferon Signature",
      "Epithelial Cell Dysfunction"
    ],
    "cell_types": [
      "CD4+ T Cell",
      "B Cell",
      "Epithelial Cell"
    ],
    "cell_type_ids": [
      "CL:0000624",
      "CL:0000236",
      "CL:0000066"
    ],
    "biological_processes": [
      "Adaptive Immune Response",
      "Immunoglobulin Production",
      "Type I Interferon Response",
      "Apoptotic Process"
    ],
    "phenotypes": [
      "Xerostomia",
      "Keratoconjunctivitis Sicca",
      "Arthritis",
      "Fatigue"
    ],
    "phenotype_categories": [
      "Oral",
      "Ophthalmological",
      "Musculoskeletal",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0000217",
      "HP:0001097",
      "HP:0001369",
      "HP:0012378"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DR3",
      "HLA-DQ2",
      "IRF5",
      "STAT4"
    ],
    "treatments": [
      "Artificial Tears",
      "Pilocarpine",
      "Hydroxychloroquine",
      "Rituximab"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-Ro/SSA Antibodies",
      "Anti-La/SSB Antibodies",
      "Rheumatoid Factor",
      "Hypergammaglobulinemia",
      "BAFF (B-cell Activating Factor)"
    ],
    "source_file": "Sjogrens_Syndrome.yaml",
    "page_url": "../pages/disorders/Sjogren's_Syndrome.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 4,
    "num_genes": 4,
    "num_treatments": 4
  },
  {
    "name": "Small Intestinal Bacterial Overgrowth",
    "disease_id": "MONDO:0400000",
    "category": "Complex",
    "parents": [
      "Gastrointestinal disorders",
      "Dysbiosis syndromes"
    ],
    "subtypes": [],
    "description": "Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.\n",
    "pathophysiology": [
      "Bacterial overgrowth in small intestine"
    ],
    "cell_types": [
      "enterocyte"
    ],
    "cell_type_ids": [
      "CL:0000584"
    ],
    "biological_processes": [
      "response to bile acid",
      "tight junction assembly"
    ],
    "phenotypes": [
      "Abdominal bloating",
      "Diarrhea",
      "Malabsorption",
      "Abdominal pain",
      "Vitamin B12 deficiency"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Metabolic"
    ],
    "phenotype_ids": [
      "HP:0003270",
      "HP:0002014",
      "HP:0002024",
      "HP:0002027",
      "HP:0100502"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [],
    "treatments": [
      "Antibiotic therapy",
      "Dietary modification",
      "Prokinetic agents"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Small_Intestinal_Bacterial_Overgrowth.yaml",
    "page_url": "../pages/disorders/Small_Intestinal_Bacterial_Overgrowth.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 1,
    "num_genes": 0,
    "num_treatments": 3
  },
  {
    "name": "Spinal Muscular Atrophy",
    "disease_id": "MONDO:0001516",
    "category": "Genetic",
    "parents": [
      "Motor Neuron Disease",
      "Neuromuscular Disease"
    ],
    "subtypes": [
      "SMA Type 1 (Werdnig-Hoffmann)",
      "SMA Type 2",
      "SMA Type 3 (Kugelberg-Welander)",
      "SMA Type 4"
    ],
    "description": "Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.\n",
    "pathophysiology": [
      "SMN Protein Deficiency",
      "Motor Neuron Degeneration"
    ],
    "cell_types": [
      "Motor Neuron"
    ],
    "cell_type_ids": [
      "CL:0000100"
    ],
    "biological_processes": [
      "Motor Neuron Development",
      "Neurodegeneration"
    ],
    "phenotypes": [
      "Hypotonia",
      "Progressive Muscle Weakness",
      "Areflexia",
      "Fasciculations",
      "Respiratory Failure",
      "Scoliosis"
    ],
    "phenotype_categories": [
      "Neurological",
      "Musculoskeletal",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0001252",
      "HP:0003323",
      "HP:0001284",
      "HP:0002380",
      "HP:0002878",
      "HP:0002650"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "SMN1",
      "SMN2"
    ],
    "treatments": [
      "Nusinersen (Spinraza)",
      "Onasemnogene abeparvovec (Zolgensma)",
      "Risdiplam (Evrysdi)",
      "Supportive Care"
    ],
    "environmental": [],
    "biochemical": [
      "Creatine Kinase"
    ],
    "source_file": "Spinal_Muscular_Atrophy.yaml",
    "page_url": "../pages/disorders/Spinal_Muscular_Atrophy.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 2,
    "num_genes": 2,
    "num_treatments": 4
  },
  {
    "name": "Stiff Person Syndrome",
    "disease_id": "MONDO:0008491",
    "category": "Autoimmune",
    "parents": [
      "Neurological Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [
      "Classic Stiff Person Syndrome",
      "Stiff Limb Syndrome",
      "Progressive Encephalomyelitis with Rigidity and Myoclonus"
    ],
    "description": "A rare autoimmune neurological disorder characterized by progressive rigidity and stiffness of axial muscles, particularly those of the trunk and legs, with superimposed painful muscle spasms triggered by unexpected stimuli, anxiety, or emotional upset. The condition is associated with high-titer anti-GAD65 antibodies that impair GABAergic inhibitory neurotransmission.",
    "pathophysiology": [
      "GABAergic Inhibition Impairment",
      "Loss of Reciprocal Inhibition",
      "Intrathecal B-cell Autoimmunity"
    ],
    "cell_types": [
      "GABAergic Interneuron",
      "Purkinje cell",
      "Motor Neuron",
      "B cell"
    ],
    "cell_type_ids": [
      "CL:0011005",
      "CL:0000121",
      "CL:0000100",
      "CL:0000236"
    ],
    "biological_processes": [
      "GABAergic synaptic transmission",
      "Inhibitory chemical synaptic transmission"
    ],
    "phenotypes": [
      "Muscle Rigidity",
      "Painful Muscle Spasms",
      "Exaggerated Startle Response",
      "Gait Disturbance",
      "Lumbar Hyperlordosis",
      "Frequent Falls",
      "Anxiety"
    ],
    "phenotype_categories": [
      "Neurological",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0002063",
      "HP:0011964",
      "HP:0002267",
      "HP:0001288",
      "HP:0003307",
      "HP:0002359",
      "HP:0000739"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1"
    ],
    "treatments": [
      "Benzodiazepines",
      "Baclofen",
      "Intravenous Immunoglobulin",
      "Rituximab"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-GAD65 Antibodies",
      "Anti-Amphiphysin Antibodies",
      "Anti-Glycine Receptor Antibodies",
      "CSF GABA Levels"
    ],
    "source_file": "Stiff_Person_Syndrome.yaml",
    "page_url": "../pages/disorders/Stiff_Person_Syndrome.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Systemic Lupus Erythematosus",
    "disease_id": "MONDO:0007915",
    "category": "Complex",
    "parents": [
      "Autoimmune Disease"
    ],
    "subtypes": [
      "Discoid Lupus Erythematosus",
      "Neonatal Lupus",
      "Drug-Induced Lupus"
    ],
    "description": "An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific",
    "pathophysiology": [
      "Formation of Immune Complexes",
      "Deposition of immune complexes in tissues",
      "Inflammation And Tissue Damage",
      "Chronic Inflammation",
      "Flare-Ups",
      "Type I Interferon Pathway Activation",
      "TLR7/TLR9-Mediated Nucleic Acid Sensing",
      "NETosis and Neutrophil Extracellular Trap Formation",
      "Age-Associated B Cell Expansion",
      "T Follicular Helper Cell Dysregulation",
      "Impaired Apoptotic Cell Clearance",
      "Complement Pathway Dysregulation"
    ],
    "cell_types": [
      "B cell",
      "plasma cell",
      "macrophage",
      "plasmacytoid dendritic cell",
      "T cell",
      "neutrophil",
      "T follicular helper cell"
    ],
    "cell_type_ids": [
      "CL:0000236",
      "CL:0000786",
      "CL:0000235",
      "CL:0000784",
      "CL:0000084",
      "CL:0000775",
      "CL:0002038"
    ],
    "biological_processes": [
      "type I interferon signaling pathway",
      "toll-like receptor signaling pathway",
      "toll-like receptor 7 signaling pathway",
      "toll-like receptor 9 signaling pathway",
      "neutrophil degranulation",
      "neutrophil extracellular trap formation",
      "B cell activation",
      "B cell differentiation",
      "T cell activation",
      "germinal center formation",
      "apoptotic cell clearance",
      "efferocytosis",
      "complement activation, classical pathway"
    ],
    "phenotypes": [
      "Malar Rash",
      "Photosensitivity",
      "Arthritis",
      "Kidney Involvement",
      "Kidney Involvement",
      "Lupus Nephritis",
      "Leukopenia",
      "Thrombocytopenia",
      "Hemolytic Anemia",
      "Pericarditis",
      "Pleuritis",
      "Seizures",
      "Psychosis"
    ],
    "phenotype_categories": [
      "Cutaneoous",
      "Musculoskeletal",
      "Renal",
      "Hematologic",
      "Cardiac",
      "Pulmonary",
      "Neuropsychiatric"
    ],
    "phenotype_ids": [
      "HP:0025300",
      "HP:0000992",
      "HP:0001369",
      "HP:0033726",
      "HP:0001882",
      "HP:0001873",
      "HP:0001878",
      "HP:0001701",
      "HP:0002102",
      "HP:0001250",
      "HP:0000709"
    ],
    "frequencies": [
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DR2",
      "HLA-DR3",
      "PTPN22",
      "STAT4",
      "IRF5",
      "TLR7",
      "TLR9",
      "MYD88",
      "CYBB",
      "TNFSF13B",
      "IL21"
    ],
    "treatments": [
      "Type I Interferon Receptor Antagonist",
      "B Cell Depletion Therapy",
      "BAFF Pathway Inhibition",
      "Immunosuppressive Therapy",
      "Supportive Care"
    ],
    "environmental": [
      "UV Exposure",
      "Infection",
      "Stress"
    ],
    "biochemical": [
      "Anti-Nuclear Antibodies (ANA)",
      "Anti-dsDNA Antibodies",
      "Anti-Smith Antibodies",
      "Anti-Histone Antibodies"
    ],
    "source_file": "Systemic_Lupus_Erythematosus.yaml",
    "page_url": "../pages/disorders/Systemic_Lupus_Erythematosus.html",
    "num_phenotypes": 13,
    "num_pathophysiology": 12,
    "num_genes": 11,
    "num_treatments": 5
  },
  {
    "name": "Systemic Sclerosis",
    "disease_id": "MONDO:0005100",
    "category": "Autoimmune",
    "parents": [
      "Autoimmune Disease",
      "Connective Tissue Disease"
    ],
    "subtypes": [],
    "description": "A chronic autoimmune connective tissue disease characterized by vasculopathy, immune dysregulation, and progressive fibrosis of the skin and internal organs. Classified into limited cutaneous and diffuse cutaneous subtypes based on extent of skin involvement.",
    "pathophysiology": [
      "Vascular Injury and Endothelial Dysfunction",
      "Immune Activation and Autoantibody Production",
      "Fibroblast Activation and Fibrosis"
    ],
    "cell_types": [
      "Endothelial Cell",
      "CD4+ T Cell",
      "Macrophage",
      "Fibroblast",
      "Myofibroblast"
    ],
    "cell_type_ids": [
      "CL:0000115",
      "CL:0000624",
      "CL:0000235",
      "CL:0000057",
      "CL:0000186"
    ],
    "biological_processes": [
      "Blood Vessel Development",
      "Immunoglobulin Production",
      "Extracellular Matrix Organization",
      "TGF-beta Signaling"
    ],
    "phenotypes": [
      "Raynaud Phenomenon",
      "Skin Thickening",
      "Pulmonary Fibrosis",
      "Dysphagia"
    ],
    "phenotype_categories": [
      "Vascular",
      "Dermatological",
      "Respiratory",
      "Gastrointestinal"
    ],
    "phenotype_ids": [
      "HP:0030880",
      "HP:0001072",
      "HP:0002206",
      "HP:0002015"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HLA-DRB1",
      "IRF5",
      "STAT4"
    ],
    "treatments": [
      "Calcium Channel Blockers",
      "Mycophenolate Mofetil",
      "Nintedanib",
      "ACE Inhibitors"
    ],
    "environmental": [],
    "biochemical": [
      "Anti-Scl-70 (Anti-Topoisomerase I)",
      "Anti-Centromere Antibodies",
      "Anti-RNA Polymerase III"
    ],
    "source_file": "Systemic_Sclerosis.yaml",
    "page_url": "../pages/disorders/Systemic_Sclerosis.html",
    "num_phenotypes": 4,
    "num_pathophysiology": 3,
    "num_genes": 3,
    "num_treatments": 4
  },
  {
    "name": "TARP syndrome",
    "disease_id": "MONDO:0010711",
    "category": "Mendelian",
    "parents": [
      "X-linked genetic disorder"
    ],
    "subtypes": [],
    "description": "Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.",
    "pathophysiology": [
      "RBM10-mediated alternative splicing dysregulation",
      "RBM10 splicing-independent replication fork dysfunction"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [
      "Regulation of alternative mRNA splicing via spliceosome",
      "Notch signaling pathway",
      "Extracellular matrix organization",
      "Cytoskeleton organization",
      "DNA replication",
      "H4-K16 deacetylation"
    ],
    "phenotypes": [
      "Atrial septal defect",
      "Micrognathia",
      "Cleft palate",
      "Talipes equinovarus",
      "Glossoptosis",
      "Vitelline vascular remnant",
      "Horseshoe kidney",
      "Optic nerve atrophy",
      "Intellectual disability",
      "Esotropia",
      "Scoliosis",
      "Prominent nose"
    ],
    "phenotype_categories": [
      "Cardiac",
      "Craniofacial",
      "Skeletal",
      "Gastrointestinal",
      "Renal",
      "Ophthalmic",
      "Neurologic"
    ],
    "phenotype_ids": [
      "HP:0001631",
      "HP:0000347",
      "HP:0000175",
      "HP:0001762",
      "HP:0000162",
      "HP:0011024",
      "HP:0000085",
      "HP:0000648",
      "HP:0001249",
      "HP:0000565",
      "HP:0002650",
      "HP:0000448"
    ],
    "frequencies": [
      "OBLIGATE",
      "FREQUENT",
      "RARE",
      "VERY_FREQUENT"
    ],
    "genes": [
      "RBM10",
      "NUMB",
      "VCL",
      "CD44",
      "TNC"
    ],
    "treatments": [
      "Cardiac surgery",
      "Palatal cleft repair",
      "Orthopedic surgery",
      "Airway management",
      "Multidisciplinary supportive care"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "TARP_syndrome.yaml",
    "page_url": "../pages/disorders/TARP_syndrome.html",
    "num_phenotypes": 12,
    "num_pathophysiology": 2,
    "num_genes": 5,
    "num_treatments": 5
  },
  {
    "name": "Tay-Sachs Disease",
    "disease_id": "MONDO:0010100",
    "category": "Genetic",
    "parents": [
      "Lysosomal Storage Disorder",
      "Neurodegenerative Disease"
    ],
    "subtypes": [
      "Infantile Tay-Sachs",
      "Juvenile Tay-Sachs",
      "Late-Onset Tay-Sachs"
    ],
    "description": "Mutations in the HEXA gene cause deficient beta-hexosaminidase A enzyme. This enzyme is essential for degrading GM2 ganglioside in lysosomes. Without it, GM2 accumulates in neurons causing progressive neurodegeneration.\n",
    "pathophysiology": [
      "Hexosaminidase A Deficiency",
      "Neuronal GM2 Accumulation"
    ],
    "cell_types": [
      "Neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [
      "Ganglioside Catabolism",
      "Neurodegeneration"
    ],
    "phenotypes": [
      "Developmental Regression",
      "Cherry-Red Spot",
      "Exaggerated Startle Response",
      "Hypotonia",
      "Seizures",
      "Macrocephaly",
      "Blindness"
    ],
    "phenotype_categories": [
      "Neurological",
      "Ophthalmologic"
    ],
    "phenotype_ids": [
      "HP:0002376",
      "HP:0010729",
      "HP:0002267",
      "HP:0001252",
      "HP:0001250",
      "HP:0000256",
      "HP:0000618"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "HEXA"
    ],
    "treatments": [
      "Supportive Care",
      "Genetic Counseling",
      "Substrate Reduction Therapy",
      "Gene Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "Hexosaminidase A Activity",
      "GM2 Ganglioside"
    ],
    "source_file": "Tay-Sachs_Disease.yaml",
    "page_url": "../pages/disorders/Tay-Sachs_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 2,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "Tetanus",
    "disease_id": "MONDO:0005526",
    "category": "Infectious",
    "parents": [
      "Bacterial Infections",
      "Neuromuscular Diseases"
    ],
    "subtypes": [],
    "description": "Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.\n",
    "pathophysiology": [
      "Tetanus Toxin (Tetanospasmin) Action",
      "Autonomic Nervous System Dysfunction",
      "Wound Colonization"
    ],
    "cell_types": [
      "motor neuron",
      "noradrenergic neuron"
    ],
    "cell_type_ids": [
      "CL:0000100",
      "CL:0008025"
    ],
    "biological_processes": [
      "synaptic transmission, GABAergic",
      "synaptic transmission, glycinergic",
      "negative regulation of neurotransmitter secretion",
      "synaptic transmission, noradrenergic"
    ],
    "phenotypes": [
      "Trismus (Lockjaw)",
      "Generalized Muscle Rigidity",
      "Opisthotonus",
      "Reflex Spasms",
      "Dysphagia",
      "Respiratory Failure"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0000211",
      "HP:0002063",
      "HP:0002179",
      "HP:0003394",
      "HP:0002015",
      "HP:0002878"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Tetanus Immunoglobulin (TIG)",
      "Wound Debridement",
      "Antibiotic Therapy",
      "Muscle Relaxants and Sedation",
      "Supportive Care",
      "Active Immunization"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Tetanus.yaml",
    "page_url": "../pages/disorders/Tetanus.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 3,
    "num_genes": 0,
    "num_treatments": 6
  },
  {
    "name": "Transient Neonatal Pustular Melanosis",
    "disease_id": null,
    "category": "Skin Disorder",
    "parents": [
      "Neonatal Condition"
    ],
    "subtypes": [],
    "description": "An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.",
    "pathophysiology": [
      "Melanocyte Activation",
      "Melanin Accumulation",
      "Pustule Formation",
      "Hyper pigmentation",
      "Desquamation",
      "Spontaneous Resolution",
      "Benign Course"
    ],
    "cell_types": [
      "Melanocyte",
      "neutrophil",
      "keratinocyte"
    ],
    "cell_type_ids": [
      "CL:0000148",
      "CL:0000775",
      "CL:0000312"
    ],
    "biological_processes": [
      "pigmentation",
      "neutrophil chemotaxis",
      "epidermis development",
      "keratinization"
    ],
    "phenotypes": [
      "Pustules",
      "Hyperpigmented Macules",
      "Scaling Skin",
      "Benign Course",
      "No Systemic Symptoms"
    ],
    "phenotype_categories": [
      "Dermatologic",
      "Systemic"
    ],
    "phenotype_ids": [
      "HP:0200039",
      "HP:0000953",
      "HP:0000988"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "No specific genes identified"
    ],
    "treatments": [
      "None Required"
    ],
    "environmental": [
      "Not Applicable"
    ],
    "biochemical": [],
    "source_file": "Transient_Neonatal_Pustular_Melanosis.yaml",
    "page_url": "../pages/disorders/Transient_Neonatal_Pustular_Melanosis.html",
    "num_phenotypes": 5,
    "num_pathophysiology": 7,
    "num_genes": 1,
    "num_treatments": 1
  },
  {
    "name": "Traveler's Diarrhea",
    "disease_id": "MONDO:0001673",
    "category": "Infectious",
    "parents": [
      "Infectious diarrhea",
      "Travel-related infections"
    ],
    "subtypes": [],
    "description": "Most commonly caused by enterotoxigenic Escherichia coli (ETEC), which produces heat-labile and heat-stable enterotoxins that stimulate intestinal fluid secretion. Other pathogens include Campylobacter, Salmonella, and Shigella.\n",
    "pathophysiology": [
      "Enterotoxigenic bacterial infection"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [],
    "phenotypes": [
      "Acute watery diarrhea",
      "Abdominal cramps",
      "Nausea"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0002014",
      "HP:0032155",
      "HP:0002018"
    ],
    "frequencies": [],
    "genes": [],
    "treatments": [
      "Oral rehydration therapy",
      "Loperamide",
      "Fluoroquinolone antibiotics"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Travelers_Diarrhea.yaml",
    "page_url": "../pages/disorders/Traveler's_Diarrhea.html",
    "num_phenotypes": 3,
    "num_pathophysiology": 1,
    "num_genes": 0,
    "num_treatments": 3
  },
  {
    "name": "Tuberculosis",
    "disease_id": "MONDO:0018076",
    "category": "Infectious Disease",
    "parents": [
      "Bacterial Infection"
    ],
    "subtypes": [],
    "description": "Tuberculosis is a contagious bacterial infection caused by Mycobacterium tuberculosis that primarily affects the lungs but can involve any organ. It spreads through airborne transmission and can exist in latent or active forms, with the active form causing characteristic symptoms including chronic cough, fever, night sweats, and weight loss.",
    "pathophysiology": [
      "Phagocytosis",
      "Granuloma Formation",
      "Neutrophil Activation and NETosis",
      "Tissue Damage"
    ],
    "cell_types": [
      "Macrophage",
      "T Cell",
      "neutrophil",
      "dendritic cell"
    ],
    "cell_type_ids": [
      "CL:0000235",
      "CL:0000084",
      "CL:0000775",
      "CL:0000451"
    ],
    "biological_processes": [
      "type I interferon signaling pathway",
      "autophagy",
      "phagosome maturation",
      "lipid metabolic process",
      "cholesterol transport",
      "inflammatory response",
      "neutrophil degranulation",
      "neutrophil extracellular trap formation"
    ],
    "phenotypes": [
      "Chronic Cough",
      "Fever",
      "Night Sweats",
      "Weight Loss",
      "Hemoptysis",
      "Chest Pain",
      "Dyspnea",
      "Fatigue",
      "Back Pain",
      "Lymphadenopathy"
    ],
    "phenotype_categories": [
      "Respiratory",
      "Systemic",
      "Hematologic",
      "Musculoskeletal",
      "Lymphatic"
    ],
    "phenotype_ids": [
      "HP:0034315",
      "HP:0001945",
      "HP:0030166",
      "HP:0001824",
      "HP:0002105",
      "HP:0100749",
      "HP:0002094",
      "HP:0012378",
      "HP:0003418",
      "HP:0002716"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "TREM2",
      "APOE",
      "NPC2",
      "PLIN2",
      "LIPA",
      "TBK1",
      "IRF3"
    ],
    "treatments": [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Directly Observed Therapy (DOT)",
      "Latent TB Treatment",
      "Host-Directed Therapy"
    ],
    "environmental": [],
    "biochemical": [
      "Tuberculin Skin Test (TST)",
      "Interferon-Gamma Release Assay (IGRA)"
    ],
    "source_file": "Tuberculosis.yaml",
    "page_url": "../pages/disorders/Tuberculosis.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 4,
    "num_genes": 7,
    "num_treatments": 6
  },
  {
    "name": "Type 2 Diabetes Mellitus",
    "disease_id": "MONDO:0005148",
    "category": "Complex",
    "parents": [
      "Metabolic Disease",
      "Endocrine Disease"
    ],
    "subtypes": [],
    "description": "Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.\n",
    "pathophysiology": [
      "Insulin Resistance",
      "Beta Cell Dysfunction",
      "Hepatic Glucose Overproduction",
      "Mitochondrial Dysfunction and Oxidative Stress",
      "Incretin Axis Dysfunction"
    ],
    "cell_types": [
      "Hepatocyte",
      "Skeletal Muscle Cell",
      "Adipocyte",
      "Pancreatic Beta Cell",
      "Enteroendocrine Cell"
    ],
    "cell_type_ids": [
      "CL:0000182",
      "CL:0000188",
      "CL:0000136",
      "CL:0000169",
      "CL:0000164"
    ],
    "biological_processes": [
      "Insulin Signaling",
      "Insulin Secretion",
      "Gluconeogenesis",
      "Oxidative Stress Response",
      "Mitophagy",
      "cAMP Signaling",
      "Insulin Secretion Regulation"
    ],
    "phenotypes": [
      "Hyperglycemia",
      "Polydipsia",
      "Polyuria",
      "Obesity",
      "Fatigue",
      "Insulin Resistance",
      "Impaired Glucose Tolerance",
      "Hyperinsulinemia",
      "Diabetic Retinopathy",
      "Peripheral Neuropathy"
    ],
    "phenotype_categories": [
      "Metabolic",
      "Systemic",
      "Renal",
      "Ophthalmologic",
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0003074",
      "HP:0001959",
      "HP:0000103",
      "HP:0001513",
      "HP:0012378",
      "HP:0000855",
      "HP:0001952",
      "HP:0000842",
      "HP:0000488",
      "HP:0009830"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "TCF7L2",
      "PPARG",
      "KCNJ11",
      "SLC30A8"
    ],
    "treatments": [
      "Metformin",
      "Lifestyle Modification",
      "GLP-1 Receptor Agonists",
      "SGLT2 Inhibitors",
      "Insulin Therapy",
      "GLP-1/GIP Dual Agonists"
    ],
    "environmental": [
      "Sedentary Lifestyle",
      "High-Calorie Diet",
      "Obesity"
    ],
    "biochemical": [],
    "source_file": "Type_2_Diabetes_Mellitus.yaml",
    "page_url": "../pages/disorders/Type_2_Diabetes_Mellitus.html",
    "num_phenotypes": 10,
    "num_pathophysiology": 5,
    "num_genes": 4,
    "num_treatments": 6
  },
  {
    "name": "Type I Diabetes",
    "disease_id": "MONDO:0005147",
    "category": "Metabolic",
    "parents": [
      "Autoimmune Disease",
      "Diabetes Mellitus"
    ],
    "subtypes": [],
    "description": "Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.",
    "pathophysiology": [
      "Genetic Susceptibility",
      "Environmental Triggers",
      "Interferon-Driven Beta Cell Response",
      "Autoimmune Destruction of Beta Cells",
      "Insulin Deficiency",
      "Hyperglycemia",
      "Impaired Glucose Utilization",
      "ER Stress and Unfolded Protein Response",
      "Increased Lipolysis",
      "Chronic Complications",
      "Diabetic Ketoacidosis (DKA)"
    ],
    "cell_types": [
      "type B pancreatic cell",
      "CD8-positive, alpha-beta cytotoxic T cell",
      "CD4-positive, alpha-beta T cell",
      "regulatory T cell",
      "B cell",
      "dendritic cell",
      "macrophage"
    ],
    "cell_type_ids": [
      "CL:0000169",
      "CL:0000794",
      "CL:0000624",
      "CL:0000815",
      "CL:0000236",
      "CL:0000451",
      "CL:0000235"
    ],
    "biological_processes": [
      "type I interferon signaling pathway",
      "antigen processing and presentation of peptide antigen via MHC class I",
      "chemokine production",
      "oxidative phosphorylation",
      "T cell mediated cytotoxicity",
      "autoantibody production",
      "cytokine-mediated signaling pathway",
      "endoplasmic reticulum unfolded protein response",
      "apoptotic process"
    ],
    "phenotypes": [
      "Hyperglycemia",
      "Weight Loss",
      "Polyuria",
      "Polydipsia",
      "Diabetic Ketoacidosis",
      "Diabetic Retinopathy",
      "Diabetic Neuropathy",
      "Diabetic Nephropathy",
      "Glucosuria",
      "Fatigue",
      "Retinopathy",
      "Neuropathy",
      "Nephropathy",
      "Cardiovascular Disease",
      "Abdominal Pain",
      "Vomiting",
      "Rapid Breathing",
      "Confusion"
    ],
    "phenotype_categories": [
      "Endocrine",
      "Systemic",
      "Ophthalmologic",
      "Neurologic",
      "Renal",
      "Ocular",
      "Cardiovascular",
      "Gastrointestinal",
      "Respiratory"
    ],
    "phenotype_ids": [
      "HP:0003074",
      "HP:0001824",
      "HP:0000103",
      "HP:0001959",
      "HP:0001953",
      "HP:0003076",
      "HP:0012378",
      "HP:0000488",
      "HP:0009830",
      "HP:0000112",
      "HP:0001626",
      "HP:0002027",
      "HP:0002013",
      "HP:0002789",
      "HP:0001289"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "HLA-DQ2",
      "HLA-DQ8",
      "INS",
      "PTPN22",
      "IL2RA",
      "CTLA4",
      "TYK2",
      "IFIH1",
      "BACH2"
    ],
    "treatments": [
      "Insulin Therapy",
      "Blood Glucose Monitoring",
      "Lifestyle Modifications",
      "Immunotherapy (Teplizumab)",
      "Continuous Glucose Monitoring"
    ],
    "environmental": [
      "Viral Infections",
      "Early Dietary Factors"
    ],
    "biochemical": [
      "Blood Glucose",
      "Hemoglobin A1c (HbA1c)"
    ],
    "source_file": "Type_I_Diabetes.yaml",
    "page_url": "../pages/disorders/Type_I_Diabetes.html",
    "num_phenotypes": 18,
    "num_pathophysiology": 11,
    "num_genes": 9,
    "num_treatments": 5
  },
  {
    "name": "Ulcerative Colitis",
    "disease_id": "MONDO:0005101",
    "category": "Complex",
    "parents": [
      "Gastrointestinal Disease",
      "Autoimmune Disease"
    ],
    "subtypes": [],
    "description": "Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.\n",
    "pathophysiology": [
      "Mucosal Inflammation",
      "Dysregulated Immune Response",
      "Epithelial Barrier Dysfunction",
      "Microbiome Dysbiosis",
      "NLRP3 Inflammasome-Mediated Pyroptosis"
    ],
    "cell_types": [
      "Colonic Epithelial Cell",
      "T Helper 2 Cell"
    ],
    "cell_type_ids": [
      "CL:0011108",
      "CL:0000546"
    ],
    "biological_processes": [
      "Inflammatory Response",
      "Epithelial Barrier Function",
      "Pyroptosis"
    ],
    "phenotypes": [
      "Bloody Diarrhea",
      "Abdominal Pain",
      "Urgency",
      "Tenesmus",
      "Weight Loss",
      "Fatigue",
      "Anemia"
    ],
    "phenotype_categories": [
      "Gastrointestinal",
      "Systemic",
      "Hematologic"
    ],
    "phenotype_ids": [
      "HP:0025085",
      "HP:0002027",
      "HP:0002607",
      "HP:0001824",
      "HP:0012378",
      "HP:0001903"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "IL23R",
      "HNF4A",
      "CDH1",
      "HLA-DRB1"
    ],
    "treatments": [
      "5-Aminosalicylates",
      "Corticosteroids",
      "Thiopurines",
      "Anti-TNF Therapy",
      "Vedolizumab",
      "Tofacitinib",
      "Ustekinumab",
      "Colectomy"
    ],
    "environmental": [
      "Appendectomy",
      "Smoking",
      "NSAIDs",
      "Infections",
      "Stress"
    ],
    "biochemical": [
      "Fecal Calprotectin",
      "CRP",
      "ESR"
    ],
    "source_file": "Ulcerative_Colitis.yaml",
    "page_url": "../pages/disorders/Ulcerative_Colitis.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 5,
    "num_genes": 4,
    "num_treatments": 8
  },
  {
    "name": "Visual Snow Syndrome",
    "disease_id": "MONDO:0018486",
    "category": "Complex",
    "parents": [
      "Neurological Disease"
    ],
    "subtypes": [],
    "description": "Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.\n",
    "pathophysiology": [
      "Visual Cortex Hyperexcitability",
      "Thalamocortical Network Dysfunction"
    ],
    "cell_types": [
      "cortical interneuron"
    ],
    "cell_type_ids": [
      "CL:0008031"
    ],
    "biological_processes": [
      "visual perception",
      "synaptic transmission"
    ],
    "phenotypes": [
      "Visual Snow",
      "Palinopsia",
      "Photophobia",
      "Nyctalopia",
      "Entoptic Phenomena",
      "Photopsia",
      "Tinnitus",
      "Vitreous Floaters"
    ],
    "phenotype_categories": [
      "Neurological"
    ],
    "phenotype_ids": [
      "HP:0000613",
      "HP:0000662",
      "HP:0030786",
      "HP:0000360",
      "HP:0100832"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [],
    "treatments": [
      "Lamotrigine",
      "Tinted Lenses",
      "Cognitive Behavioral Therapy",
      "Benzodiazepines"
    ],
    "environmental": [
      "Migraine Comorbidity",
      "Anxiety and Depression"
    ],
    "biochemical": [],
    "source_file": "Visual_Snow_Syndrome.yaml",
    "page_url": "../pages/disorders/Visual_Snow_Syndrome.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 2,
    "num_genes": 0,
    "num_treatments": 4
  },
  {
    "name": "Vitiligo",
    "disease_id": "MONDO:0008661",
    "category": "Complex",
    "parents": [
      "Autoimmune Disease",
      "Skin Disorder"
    ],
    "subtypes": [
      "Non-Segmental Vitiligo (NSV)",
      "Segmental Vitiligo (SV)",
      "Mixed Vitiligo"
    ],
    "description": "An autoimmune skin disorder characterized by the loss of skin pigmentation due to the destruction of melanocytes.",
    "pathophysiology": [
      "Melanocyte Destruction",
      "Genetic Predisposition",
      "Autoimmune Reaction",
      "Oxidative Stress",
      "IFN-gamma-CXCL9/CXCL10 Chemokine Axis",
      "IL-15 and Tissue-Resident Memory T Cells",
      "Innate Immune Activation"
    ],
    "cell_types": [
      "Melanocyte",
      "CD8+ T Lymphocyte",
      "keratinocyte",
      "CD8+ T cell",
      "CD8+ tissue-resident memory T cell",
      "dendritic cell",
      "natural killer cell"
    ],
    "cell_type_ids": [
      "CL:0000148",
      "CL:0000625",
      "CL:0000312",
      "CL:0000451",
      "CL:0000623"
    ],
    "biological_processes": [
      "response to type II interferon",
      "leukocyte chemotaxis"
    ],
    "phenotypes": [
      "Depigmented Patches",
      "Premature Hair Whitening",
      "Associated Autoimmune Disorders",
      "Uveitis",
      "Depression/Anxiety",
      "Increased Sensitivity To Sunlight"
    ],
    "phenotype_categories": [
      "Dermatological",
      "Autoimmune",
      "Ophthalmologic",
      "Psychological"
    ],
    "phenotype_ids": [
      "HP:0000554",
      "HP:0000992"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "NALP1",
      "TYR",
      "PTPN22",
      "MC1R",
      "HLA-A",
      "HLA-DRB1",
      "IFIH1",
      "BACH2",
      "IRF4",
      "FOXP3"
    ],
    "treatments": [
      "Topical Corticosteroid",
      "JAK Inhibitor Therapy",
      "Phototherapy",
      "Skin Graft",
      "Melanocyte Transplantation",
      "Monobenzone Cream"
    ],
    "environmental": [
      "UV Exposure",
      "Stress",
      "Chemical Exposure"
    ],
    "biochemical": [
      "Autoantibodies to Melanocytes",
      "Inflammatory Cytokines"
    ],
    "source_file": "Vitiligo.yaml",
    "page_url": "../pages/disorders/Vitiligo.html",
    "num_phenotypes": 6,
    "num_pathophysiology": 7,
    "num_genes": 10,
    "num_treatments": 6
  },
  {
    "name": "Wilson Disease",
    "disease_id": "MONDO:0010200",
    "category": "Genetic",
    "parents": [
      "Metabolic Disease",
      "Liver Disease"
    ],
    "subtypes": [],
    "description": "ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in liver, brain, and other organs. Free copper causes oxidative damage and cellular toxicity.\n",
    "pathophysiology": [
      "Copper Accumulation",
      "Hepatocyte Injury",
      "Neurodegeneration"
    ],
    "cell_types": [
      "Hepatocyte"
    ],
    "cell_type_ids": [
      "CL:0000182"
    ],
    "biological_processes": [
      "Copper Transport",
      "Oxidative Stress",
      "Neurodegeneration"
    ],
    "phenotypes": [
      "Hepatomegaly",
      "Cirrhosis",
      "Kayser-Fleischer Rings",
      "Tremor",
      "Dysarthria",
      "Dystonia",
      "Psychiatric Symptoms"
    ],
    "phenotype_categories": [
      "Hepatic",
      "Ocular",
      "Neurological",
      "Psychiatric"
    ],
    "phenotype_ids": [
      "HP:0002240",
      "HP:0001394",
      "HP:0200032",
      "HP:0001337",
      "HP:0001260",
      "HP:0001332",
      "HP:0000708"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT"
    ],
    "genes": [
      "ATP7B"
    ],
    "treatments": [
      "D-Penicillamine",
      "Trientine",
      "Zinc Acetate",
      "Low Copper Diet",
      "Liver Transplantation"
    ],
    "environmental": [
      "Dietary Copper"
    ],
    "biochemical": [
      "Ceruloplasmin",
      "Serum Copper",
      "Free Copper",
      "24-Hour Urinary Copper",
      "Hepatic Copper"
    ],
    "source_file": "Wilsons_Disease.yaml",
    "page_url": "../pages/disorders/Wilson_Disease.html",
    "num_phenotypes": 7,
    "num_pathophysiology": 3,
    "num_genes": 1,
    "num_treatments": 5
  },
  {
    "name": "Wolf-Hirschhorn_Syndrome",
    "disease_id": null,
    "category": "Genetic",
    "parents": [
      "Chromosomal Disorder"
    ],
    "subtypes": [],
    "description": "Wolf-Hirschhorn syndrome (WHS) is a developmental disorder characterized by typical craniofacial features, prenatal and postnatal growth impairment, intellectual disability, severe delayed psychomotor development, seizures, and hypotonia. It is caused by a deletion in the short arm of chromosome 4 (4p16.3).",
    "pathophysiology": [
      "Chromosome 4p16.3 Deletion"
    ],
    "cell_types": [],
    "cell_type_ids": [],
    "biological_processes": [],
    "phenotypes": [
      "Characteristic Facial Features",
      "Microcephaly",
      "Hypertelorism",
      "Intrauterine Growth Retardation",
      "Postnatal Growth Retardation",
      "Intellectual Disability",
      "Severe Delayed Psychomotor Development",
      "Seizures",
      "Hypotonia",
      "Corpus Callosum Abnormalities",
      "Congenital Heart Defects",
      "Skeletal Anomalies",
      "Renal Anomalies",
      "Immunodeficiency",
      "Cleft Lip or Palate"
    ],
    "phenotype_categories": [
      "Craniofacial",
      "Growth",
      "Neurologic",
      "Cardiac",
      "Skeletal",
      "Genitourinary",
      "Immunologic"
    ],
    "phenotype_ids": [
      "HP:0001999",
      "HP:0000252",
      "HP:0000316",
      "HP:0001511",
      "HP:0008897",
      "HP:0001249",
      "HP:0001263",
      "HP:0001250",
      "HP:0001252",
      "HP:0001273",
      "HP:0001627",
      "HP:0000924",
      "HP:0000077",
      "HP:0002721",
      "HP:0000175"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "OCCASIONAL",
      "FREQUENT"
    ],
    "genes": [
      "Chromosome 4p16.3 Deletion"
    ],
    "treatments": [
      "Seizure Management with Levetiracetam",
      "Seizure Management with Valproic Acid",
      "Growth Hormone Therapy",
      "Early Aggressive Seizure Management"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "Wolf-Hirschhorn_Syndrome.yaml",
    "page_url": "../pages/disorders/Wolf-Hirschhorn_Syndrome.html",
    "num_phenotypes": 15,
    "num_pathophysiology": 1,
    "num_genes": 1,
    "num_treatments": 4
  },
  {
    "name": "You-Hoover-Fong Syndrome",
    "disease_id": "MONDO:0014848",
    "category": "Mendelian",
    "parents": [
      "Neurodevelopmental disorders",
      "TTT complex disorders"
    ],
    "subtypes": [],
    "description": "An autosomal recessive neurodevelopmental disorder caused by biallelic variants in TELO2, which encodes a core subunit of the TTT co-chaperone complex essential for PIKK (phosphatidylinositol 3-kinase-related kinase) maturation. Clinical features include severe intellectual disability, microcephaly, congenital cataracts, and variable multisystem involvement.\n",
    "pathophysiology": [
      "TTT complex dysfunction"
    ],
    "cell_types": [
      "Neuron"
    ],
    "cell_type_ids": [
      "CL:0000540"
    ],
    "biological_processes": [
      "Nonsense-mediated decay"
    ],
    "phenotypes": [
      "Global developmental delay",
      "Intellectual disability",
      "Microcephaly",
      "Congenital cataract",
      "Hypotonia",
      "Hearing impairment",
      "Seizures",
      "Congenital heart defect"
    ],
    "phenotype_categories": [],
    "phenotype_ids": [
      "HP:0001263",
      "HP:0001249",
      "HP:0000252",
      "HP:0000518",
      "HP:0001252",
      "HP:0000365",
      "HP:0001250",
      "HP:0001627"
    ],
    "frequencies": [
      "VERY_FREQUENT",
      "FREQUENT",
      "OCCASIONAL"
    ],
    "genes": [
      "TELO2 mutations"
    ],
    "treatments": [
      "Supportive care",
      "Cataract surgery"
    ],
    "environmental": [],
    "biochemical": [],
    "source_file": "You-Hoover-Fong_Syndrome.yaml",
    "page_url": "../pages/disorders/You-Hoover-Fong_Syndrome.html",
    "num_phenotypes": 8,
    "num_pathophysiology": 1,
    "num_genes": 1,
    "num_treatments": 2
  }
];
window.dispatchEvent(new Event('searchDataReady'));
